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Abstract 
Characterising the MLL complex: epigenetic regulation of Hoxa genes 
The Mixed-Lineage Leukaemia (MLL1) protein is a key developmental factor that acts to 
regulate genes via its histone methyl-transferase activity. This study aimed to examine how 
MLL1 and its associated complex contribute to gene regulation in a functionally relevant cell 
background. To assess dynamic processes involved, we developed a haematopoietic Stem 
Cell (hSC) -based system, in which Hoxa genes are down-regulated in a differentiation-
induced manner. 
I characterised the histone modification distribution on two MLL-target genes showing the 
largest changes upon differentiation: Hoxa4 and Hoxa5. When active, these genes are 
associated with a peak of “activating” histone marks (H3K4me3, H3K9ac, H4K16ac) over 
the transcriptional start site, which are lost when the gene is repressed. This correlated with 
the recruitment of enzymes that deposit these marks, including components of the MLL 
complex (MLLC, MLLN and menin) as well as HATs that may be associated with the 
complex (CBP and MOF). Interestingly, the location of these proteins does not always 
correlate with the marks they deposit. We show that the dual mark H3K9acS10p is present on 
active Hoxa4 and Hoxa5 genes, and correlates with the presence of the histone kinase Msk1. 
We speculate that Msk1 contributes to regulating MLL1 HMT’ase activity on these genes. 
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Abbreviations 
abd-A: abdominal A 
Abd-B: Abdominal-B 
Acetyl CoA: acetyl Coenzyme A 
Antp: Antennapedia 
AIRE: AutoImmune Regulator 
ALL: Acute Lymphoid Leukaemia 
AML: Acute Myeloid Leukaemia 
APS: Ammonium Persulfate 
ASH2L: Absent, Small or Homeotic-Like 2 
ATP: Adenosine TriPhosphate 
AUT: Acid Urea Triton 
bp: base pair 
BPTF: Bromodomain and PHD finger Transcription Factor 
BRM: Brahma 
BSA: Bovine Serum Albumin 
CBP: CREB-Binding Protein 
C-ChIP: Carrier-Chromatin Immunoprecipitation 
cDNA: complementary DNA 
Chd1p: Chomo-ATPase/helicase-DNA binding domain 1 
CHO: Chinese Hamster Ovary 
Chromodomain: Chomatin Organisation Modifier 
CLP: Common Lymphoid Progenitor 
CMP: Common Myeloid Progenitor 
COMPASS: Complex of Protein Associated with Set1 
Co-REST: Co-repressor to RE1 Silencing Transcription factor/neural restrictive silencing 
factor 
Cps35: Compass 35 
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DCC: Dosage Compensation Complex 
Dfd: Deformed 
DMEM: Dulbecco’s Modified Eagle Medium 
DNA: DeoxyriboNucleic Acid 
DNMT: DNA Methyl-Transferase 
DPY-30:DumPY-30 
EDTA: Ethylene Diamine Tetraacetic Acid 
EGTA: Ethylene Glycol Tetraacetic  Acid 
ENL: Eleven-Nineteen Leukaemia 
ESC: Embryonic Stem Cell 
ESC: Extra Sex Combs 
E(Z): Enhancer of Zeste 
FACS: Fluorescence-Activated Cell Sorting 
FAD: Flavin Adenine Dinucleotide 
FBS: Foetal Bovine Serum 
GAPDH: GlycerAldehyde 3-Phosphate DeHydrogenase 
GASC-1: Gene Amplified in Squamous protein 2C 
Gcn5p: General control of amino acid synthesis protein 5 
GMP: Granulocyte-Macrophage Progenitor 
GNAT: Gcn5p-related Acetul-Transferase 
GP6: Glycoprotein VI 
HAT: Histone Acetyl-Transferase 
HDAC: Histone Deacetylase 
HDM: Histone Demethylase 
HMG: High Mobility Group 
HMT: Histone Methyl-Transferase 
Hos2: High osmolarity sensitivity protein 2 
Hox: Homeobox 
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HP1: Heterochromatin-associated Protein 1 
HPC: Haematopoietic Progenitor Cell 
HRX: Homologue of trithorax  
hSC: haematopoietic Stem Cell 
ING2: Inhibitor of Growth 2 
JHDM1: JmjC domain-containing Histone Demethylase 1 
Jmjc: Jumonji c 
JMJD2A: Jumonji Domain-containing protein-2-A 
Jnk: Jun N-terminal Kinase 
lab: labial 
LEGDF: Lens Epithelium-Derived Growth Factor 
LSD1: Lysine Specific Demethylase 1 
MeCP2: Methyl-CpG-binding protein 
MEP: Megakaryocyte-Erythrocyte Progenitor 
MLL: Myeloid/Lymphoid or Mixed Lineage Leukaemia 
MOF: Males absent On the First 
Msk1: Mitogen- and Stress- activated Protein Kinase 1 
N-ChIP: Native-Chomatin Immunoprecipitation 
NF!B: Nuclear Factor kappa-light-chain-enhancer of activated B 
NuRD: Nucleosome Remodelling and histone Deacetylation 
NURF: Nucleosome Remodelling Factor 
PAGE: PolyAcrylamide Gel Electrophoresis 
Pb: Proboscipedia 
PBS: Phosphate Buffered Saline 
Pc: Polycomb 
PCA: Perchloric Acid 
PCAF: P300/CBP Associated Factor 
PcG: Polycomb Group 
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PCR: Polymerisation in Chain Reaction 
PH: Polyhomeotic 
PHD: Plant Bromodomain 
PRMT: Protein Arginine Methyl-Transferase 
PSC: Posterior Sex Combs 
PTD: Partial genomic Tandem Duplication 
RBBP5: Retinoblastoma Binding Protein 5 
RNA: RiboNucleic Acid 
RTQ-PCR: Real-Time Quantitative- PCR 
SAGA: Spt-Ada-Gcn5-Acetyl-transferase 
SAM: S-adenosyl Methionine 
Sbf1: SET binding factor 1 
Scr: Sex comb reduced 
SDS: Sodium Dodecyl Sulfate 
SET: Suppressor of variegation, Enhancer of zeste andTrithorax 
SL2: Schneider line-2 
SUV39H1: Suppressor of Variegation 3-9 Homolog 1) 
SU(Z): Suppressor of Zeste 
SWI/SNF: SWItch/Sucrose Non-Fermentable 
TAC: Trithorax Activating Complex 
TAD: Transcriptional Activation Domain 
TAF: TBP Associated Factor 
TASPASE1: Threonine Aspartase 1 
TBP: TATA box Binding Protein 
TCA: Trichloroacetic Acid 
TEB: Tris-EDTA Boric acid buffer 
TPO: Thrombopoietin 
Trx: Trithorax 
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trxG: trithorax Group 
TSS: Transcription Start Site 
Ubx: Ultrabithorax 
UTX: Ubiquitously Transcribed TPR on X 
WBP7: WW Binding Protein 7 
WDR5: WD-Repeat protein-5 
X-ChIP: Cross-linking Chomatin Immunoprecipitation  
YY1: Yin Yang-1
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1. INTRODUCTION 
Almost every cells of a multi-cellular organism possesses the same genetic information asthe 
zygote from which it has developed, based on identical copies of the same DNA sequence. 
Upon differentiation cells must adopt a specific pattern of gene expression, which defines 
their function and identity. A pattern of gene expression is specific to individual cells and can 
vary in a dynamic manner through time, or in response to environmental influences (Jaenisch 
and Bird, 2003): genes can be selectively activated, repressed or maintained in their activity 
(Figure 1.1). These patterns of gene transcription are regulated via networks of activating or 
repressive transcription factors, but also by a range of  “epigenetic mechanisms”. Several 
definitions of “epigenetic” have been proposed (Berger et al., 2009; Bird, 2007; Probst et al. 
2009). Current definitions propose that epigenetic mechanisms correspond to changes in 
phenotype, or gene expression that occur without altering the DNA sequence (Berger et al., 
2009). In this study, the term “epigenetic mechanisms” is used to describe changes in the 
pattern of gene expression influenced by processes including nucleosome positioning, the 
distribution of histone post-translational modifications, and binding of chromatin-associated 
proteins and DNA methylation. Many of these mechanisms interact at specific genes, yet 
regulatory processes using histone modification play a central role as these are sensitive to 
intrinsic and environmental factors as these can impact on the activity of specialised histone 
modifying enzymes (Bird, 2007; Jaenisch and Bird, 2003). This has functional effects as 
histone modifications can either have direct effects on chromatin structure and/or be 
selectively recognised by “effector” proteins through functional domains (Jenuwein and 
Allis, 2007; Taverna, 2007), which subsequently act to govern gene activity (Campos and 
Reinberg, 2009) (Figure 1.2). The biological processes in which “epigenetic mechanisms” act 
are varied in both extent and duration, and range from the permanent chromosome-wide 
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Figure 1.1: Model of cell fate and gene activity (based on Jaenisch and Bird, 
Nature, 2003; Ng J.H. et al., Mutation research, 2008; and Lennartsson A. 
and Ekwall K., Biochim. Biophys Acta, 2009) 
Almost every cell possesses the same genetic information. However, their cell 
fate or phenotype is determined by the selective activation or repression of genes 
throughout  development, generating a pattern of gene expression which is 
transmitted through cell generations. The specialisation associated with the 
establishment of a pattern of gene expression is specific to individual cells, and 
can be governed by epigenetic mechanisms. 
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Figure 1.2 : Theoretical model of epigenetic regulation (based on Jaenisch 
R. and Bird A., Nature, 2003; and Imhof A., Briefings in functional 
genomics & proteomics, 2006) 
Epigenetic mechanisms are influenced by intrinsic and environmental factors, 
metabolic signals, or synthetic or naturally occuring small molecules. Modifying 
enzymes (Cofactors) are recruited by transcriptional activators or repressors (TF) 
and add or remove histone modifications (or histone “marks”), which are then 
recognised by specific effector proteins through recognition domains, leading to 
subsequent functional effects and the possible modulation of gene activity. 
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silencing associated with X-inactivation in mammals (Heard, 2004; Chow & Heard, 2009), to 
more gene- or cluster-specific regulation like the maintenance of homeotic gene expression 
(Lewis, 1978; Kundu & Peterson, 2009).  
1.1. Epigenetic modifications 
1.1.1. Chromatin organisation 
The human genetic information in every cell is contained in two metres of genomic DNA per 
cell. In order to be packed into the eukaryotic nucleus, DNA associates with small nuclear 
basic proteins termed histones, and folds into a series of higher order structures associated 
with increased levels of compaction (Figure 1.3). This highly organised structure is called 
chromatin. Histones are highly conserved proteins, being essentially identical in yeast and 
human, and assemble into nucleosomes, the fundamental unit of chromatin (Oudet et al., 
1975). The nucleosome is composed of the nucleosome core, the “linker DNA” and the 
linker histone H1 (Simpson, 1978).  
The nucleosome core particle is a structure composed of an octamer of core histones, around 
which wraps 147 base pairs of DNA in 1.75 turns. One nucleosome is composed of a H3-H4 
tetramer and two H2A-H2B dimers (Thomas and Kornberg, 1975). We understand the 
structure of the nucleosome due to high-resolution crystallography studies (e.g. Figure 1.4,!
Luger et al., 1997). Core histone proteins share a similar structural motif. Each histone 
displays a “U-shape” structure: the association of two of these structures in a “handshake” 
motif leads to the formation of a dimer, which are subsequently arranged to form “crescent-
shape” heterodimers (Luger et al., 1997). Each individual histone comprises a globular or 
“histone fold” domain, responsible for histone-histone interactions and histone-DNA 
interactions, and a “tail” domain, which are structurally undefined but highly evolutionarily
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Figure 1.3: Different levels of condensation of chromatin (from 
Felsenfeld,G. and Groudine, M. , Nature 2003) 
“Naked” DNA is first wrapped twice around nucleosomes, leading to the 
formation of a “beads on a string” structure. Then, nucleosomes are packed and 
the chromatin is condensed into higher order structures, which eventually fold 
into the structures associated with the mitotic chromosome, the highest 
condensed chromatin conformation. 
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Figure 1.4: Crystal structure of the nucleosome core particle (from Luger 
K. et al., Nature, 1997) 
Nucleosome core particles are composed of two H2A-H2B dimers and a H3-H4 
tetramer, and is associated with 1.75 turns of DNA. Each histone displays a “U-
shape” structure and associates with a partner to form a “crescent-shape” 
heterodimer. The figure shows the particle “face on” (left) or a side view (right) 
of a single nucleosome particle, with the two strands of 147 base pairs DNA 
indicated (green and orange), and the four core histones; H3 (Blue), H4 (Green), 
H2A (Yellow) and H2B (Red). Note the histone tails are not fully shown as 
these were not visible in this crystal structure. 
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conserved. The N-terminal tails of all the four core histones and the C-terminal tail of histone 
H2A are unstructured, highly basic domains (though they are thought to adopt a defined "-
helical conformation when binding within the chromatin fibre,! (Baneres et al., 1997), 
characterised by their high level of positively-charged residues, and protruding from the 
nucleosome, thus being exposed to chromatin-associated proteins (Vettese-Dadey et al., 
1996; Luger et al., 1997; Luger and Richmond, 1998; Zheng and Hayes, 2003). While the 
core histone is responsible for DNA binding, the histone tails have a role in the recruitment 
of specific protein factors, intervening either directly or indirectly in the modulation of higher 
order chromatin structures (Hansen, 2002; Hansen et al., 1989; Fletcher and Hansen, 1995; 
Luger, 2003). As such the histone tails are involved in the formation and modulation of 
higher order chromatin structures (Hansen, 2002; Hansen et al., 1998). It has been suggested 
that the assembly of chromatin can be transcriptionally repressive. In this model, the 
packaging of DNA in nucleosomes prevents the binding of DNA-binding factors (i.e. Lee et 
al, 1993), either due to the distortion of the highly constrained DNA, or because of steric 
occlusion generated by the core histones or histone H1 (Juan et al., 1997; Luger et al., 1997).  
Chromatin is typically packaged with nucleosomes at #200bp intervals, generating the 
intervening “linker DNA”!(Oudet et al., 1975). Thus, each nucleosome is linked to another 
by “linker DNA” and bound to a linker histone, such as H1, which influences and stabilises 
chromatin higher order structure (Hansen et al., 1989; Hansen, 2002). The association of 
about 160bp of DNA with the nucleosome, and associated with the linker histone H1, is 
termed the “chromatosome”!(Simpson, 1978). The linker histone H1 is positioned outside the 
core octamer, adjacent to the site of entrance and exit of the DNA from the nucleosome 
(Figure 1.5) (Travers, 1999). Chromatin depleted of histone H1 generates an 11-nm diameter 
fibre termed “beads-on-a-string” (Hansen, 2002). This structure can be subsequently further 
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compacted in a higher order 30-nm diameter fibre though the molecular details of this 
structure remain unresolved and controversial (Robinson and Rhodes, 2006). Two models of 
30-nm fibre structure have been proposed (Wu et al., 2007): a “one-start” stack of 
nucleosomes in which the 30-nm fibre is packaged as a solenoid, and constitutes a continuous 
helix of nucleosomes linked by bent “linker DNA”!(Finch and Klug, 1976), and a “two-start” 
stack of nucleosomes, composed of a helix arranged in a conformation where nucleosomes 
adopt a “zig-zag” conformation. In this model, the two stacks of nucleosomes are linked by 
linker DNA which can adopt two different orientations, corresponding to either a helical 
ribbon model (Worcel et al., 1981) or a crossed-linker model, depending on the linker DNA 
length (Williams et al., 1986) (Figure 1.6,!Dorigo et al., 2004). In addition, Richmond and 
colleagues recently proposed a “two-start” crossed-linker model comprising a four-
nucleosome “core”, but missing the linker histone (Schalch, et al., 2005). This structure was 
used as a model for 30-nm higher order chromatin compaction (Robinson and Rhodes, 2006). 
Though the “one-start” model was initially preferred because of its simplicity, some 
experimental data suggests that chromatin adopts a “two-start” stack conformation, as this 
correlates with the high degree of packaging observed with some fibres (Dorigo et al., 2004). 
In addition, the transition from the supercoiled helical structure to the relaxed crossed-ribbon 
structure is consistent with variable and reversible accessibility of chromatin (Turner, 2002; 
Margueron, Trojer et al., 2005; Wu et al., 2007). It was also proposed that higher order 
chromatin structure displays at least two levels of compaction, one “loose”, lacking histone 
H1, and a more compact structure containing the linker histone and corresponding to the 30-
nm fibre (Robinson and Rhodes, 2006). A more recent study by Routh et al. proposed that 
the degree of compaction of the 30-nm structure is also dependent on the nucleosome repeat 
length (Routh et al., 2008). Further compaction into higher order chromatin structures is
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Figure 1.5: Histone H1  
Schematic picture of a nucleosome linked to another by the linker DNA and is 
bound by  linker histone H1, which maintains chromatin higher order structure 
in a stable conformation (based on Travers A., Trends Biochem Sci, 1999). 
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Figure 1.6: Model proposed by Dorigo et al. for the 30-nm chromatin fibre 
(from Dorigo et al., Science, 2004) 
Nucleosome core particles can associate into a higher order structure, forming a 
30-nm chromatin fibre. Two models of the fibre were proposed: the solenoid 
helix conformation, comprising a “one-start” stack of nucleosomes, and in 
which the linker- DNA is bent (A), and the zig-zag helix conformation, 
comprising a “two-start” stack of nucleosomes, in which adjacent nucleosomes 
are linked by a straight linker DNA (B and C). This second model is consistent 
with two possibilities for the orientation of the linker DNA, which are associated 
with either an helical ribbon model (B), or a crossed- linker model (C). 
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necessary to enable the condensation of the chromatin into the structures seen as metaphase 
chromosomes, but this is not yet well understood. 
1.1.2.  Chromatin dynamics 
Linker histones are generally found in a 1:1 ratio with the core histones, and are thought to 
maintain the chromatin fibre in higher order structures (Thoma et al., 1979; Hansen et al., 
1989). However, it has been reported that the linker histone is only required for the 
stabilisation of this highly organised structure, while the core histones are involved in both 
the formation and the stabilisation of higher order chromatin structure (Schwarz and Hansen, 
1994). Indeed, H1-depleted chromatin can be folded into higher order structures at 
appropriate ionic conditions (Hansen et al., 1989), but the loss of the core histone tail 
domains (Garcia-Ramirez et al., 1992), notably the H4 tail prevent compaction (Dorigo et al., 
2003), even in the presence of the linker histone (Allan et al., 1982). This raises the question 
of if (or how) the histones contribute to the dynamic process(es) of chromatin folding. It is 
essential that the successive levels of chromatin structure are reversible in order to enable 
access for functional processes. This requirement for dynamic folding appears to be 
controlled by a combination of linker-histones, other chromatin-associated proteins (like the 
heterochromatin-associated protein HP1, Hiragami and Festenstein, 2005) and the post-
translational modifications of the N-terminal tails of the histones. For example, the degree of 
histone acetylation (Garcia-Ramirez et al., 1992), specifically at H4K16 (Robinson et al., 
2008) has been shown to modulate the folding of the chromatin fibre. Histone acetylation is a 
lysine amidation, in which the positive charge associated with this residue is neutralised, 
weakening its affinity for negatively charged DNA. This is thought to lead to the decrease of 
the interactions between histones and DNA involved in chromatin folding and stabilisation. 
A major effect of histone acetylation is on the linker DNA, leading to an extended 
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conformation of the chromatin between nucleosomes (Garcia-Ramirez et al., 1995). In 
addition to its role in the dynamics of chromatin organisation, the acetylation of the histones 
facilitates the accessibility of nucleosomal DNA to transcription factors (Lee et al., 1993; 
Utley et al., 1998) (Figure 1.7). This is thought to play a key role in transcriptional 
regulation, as the increased binding of transcription factors, correlates with an active state of 
gene expression.  
The functional links between histone modification and transcription were shown by Utley et 
al. (1998), who demonstrated that the yeast histone acetyl transferase complex SAGA was 
specifically recruited by a promoter-binding transcriptional activator, leading to nucleosomal 
acetylation, which stimulates active transcription (Utley et al., 1998). Inversely, the loss of 
histone acetylation leads to a stronger interaction of the histone tails with the DNA, which is 
thought to contribute to a compacted “inaccessible” chromatin structure. 
The structures (and regulators) of chromatin condensation remain unclear, but the suggestion 
that the initial stage(s) of chromatin compaction are determined by modification of the 
histone tails, represents a mechanism by which the cellular environment can impact on both 
chromatin structure and transcription (i.e. Murayama et al., 2008). Though histones and 
nucleosomes were initially acknowledged for their structural role in chromatin compaction, 
they are now recognised for their essential roles in regulating nuclear functions. The idea that 
histone post-translational acetylation may affect transcriptional activity (i.e. an increase of 
acetylation levels is associated with transcription activation) was suggested in 1964 by 
Allfrey et al.!(Allfrey et al., 1964). Subsequent studies showed that a high degree of histone 
acetylation (hyperacetylation) correlates with the active transcriptional state at the level of 
chromosomal domains (Turner, 1998) and individual genes (Hebbes et al., 1988) and has a 
causal role in facilitating transcription (Lee et al., 1993; Davie, 1997; Ura et al., 1997; Utley
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Figure 1.7: Histone acetylation and accessibility (from Schreiber, S., 
Cambridge, MA. 
http://www.broadinstitute.org/chembio/lab_schreiber/anims/animations/sm
dbHDAC.php) 
In the nucleosome, the N-terminal tails of histones are subject to acetylation. 
Histone acetylation (Left) results in the loss of histone-DNA contacts, resulting 
in the acquisition of an “open” chromatin conformation. This is more accessible 
to transcription factors, correlating with the active transcriptional state. In 
contrast, histone deacetylation (Right) results in the formation of a more 
compact chromatin conformation, which prevents access of transcription factors 
to the DNA and is associated with gene silencing. 
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et al., 1998). In contrast, incorporation of linker histone H1 represses transcription 
(Kamakaka and Thomas, 1990) and correlates with a restriction of the mobility of histones 
(Ura et al., 1997). 
Nucleosome assembly is essential in the structural organisation of chromatin. However, the 
recognition that the core histone tails can modulate the accessibility of the DNA to 
transcription factors and thereby regulate transcription factor access, and subsequent gene 
transcription, was important in the understanding of the functional role of chromatin (Bassett 
et al., 2009; Zheng and Hayes, 2003). These are also essential for maintaining both 
chromatin conformation and a dynamic chromatin structure through the action of ATP-
dependent chromatin remodelling complexes and associated factors (Clapier and Cairns, 
2009). Post-translational modifications may cause the tail to adopt new conformations and/or 
lead to new nucleosomal interactions, altering the properties of the chromatin. These 
remodelers have the capacity to modulate the composition of nucleosomes, therefore 
favoring DNA exposure to additional factors (Clapier and Cairns, 2009. Histone 
modifications on histone residues have also been shown to have a role as a binding platform 
for other non-histone proteins, leading to downstream functional events (Strahl and Allis, 
2000; Kurdistani and Grunstein, 2003). A wide variety of post-translational modifications are 
found on the histones and range from large and complex groups (i.e. sumoylation, 
ubiquitylation, ADP-ribosylation), which have been suggested to impact on chromatin 
structure, to small modifications, which have minimal charge effects (like lysine mono-
methylation) (Hansen, 2002; Ruthenburg et al., 2007; Turner, 2000). This suggests that for 
the majority of histone modifications, the role of modification-binding “effector” proteins is a 
key concept in their function and in the correlation between histone modifications and the 
transcriptional activity of genes (Jenuwein and Allis, 2001).  
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Specific post-translational histone modifications are also associated with different functional 
states of chromatin, depending on their level of enrichment and their distribution. As 
previously discussed, histone modifications are involved in modulating chromatin structure. 
Specific post-translational histone modifications are also associated with different functional 
states of chromatin, depending on their level of enrichment and their distribution. This has 
led to the concept that these modifications correspond to a “mark” that can be recognised or 
“read” by specific proteins, with subsequent functional consequences for the associated 
chromatin (Strahl and Allis, 2000; Jenuwein and Allis, 2001; Turner, 2000; Turner 2002). 
1.1.3.  Histone modifications and the histone code 
Following the hypothesis that that acetylation might be associated with functional effects on 
chromatin in Drosophila (Turner et al., 1992), the recognition that a range of histone 
modifications are found in chromatin, and play a role in regulating functional processes has 
recently led to the proposal of the “epigenetic” (Turner, 2000), or “histone code” hypothesis 
(Strahl and Allis, 2000). This suggests that one, or a combination of histone modifications 
generate an “epigenetic mark”, which is specifically recognised by proteins, with subsequent 
functional consequences for the underlying DNA (Strahl and Allis, 2000; Turner, 2000; 
Jenuwein and Allis, 2001; Turner, 2002). This concept is associated with a number of ideas 
that will be subsequently explored.  
1.1.4.  Histone post-translational modifications 
The N-terminal histone “tails” are subject to a broad range of post-translational modifications 
(including methylation, acetylation, phosphorylation, ubiquitination, biotinylation, 
glycosylation, carbonylation, ADP-ribosylation and sumoylation) (Figure 1.8). The 
functional consequences of many of these marks remain unclear, but lysine phosphorylation,
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Figure 1.8: Sites of post-translational modifications on histone tails (from 
Turner BM, Nature Structural and Molecular Biology, 2005) 
Histone tails are subject to post-translational modifications primarly on their N-
terminal tails. These are epigenetic marks. A wide range of marks on histone 
residues are shown, notably acetylation (Acetyl K), lysine and arginine 
methylation (Methyl K, Methyl R), serine phosphorylation (Phos. S) and lysine 
ubiquitylation (Ubiq. K). 
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lysine and arginine methylation and lysine acetylation (at specific residues) have been well 
studied. This has led to the concept that there are two classes of marks; particular histone 
modifications, termed “activating” marks, are enriched at sites of actively transcribed 
chromatin (i.e. H3 hyperacetylation, H3K4 methylation, etc.) whereas others, termed 
“repressive” marks, are predominantly found in silent chromatin (i.e. H3K9me, H3K27me), 
(Margueron et al., 2005; Turner, 2005). It should be noted that the functional role of these 
“marks” are highly modification and residue specific. The same modification at two different 
residues, or the deposition of two different modifications on the same residue typically has 
different functional effects, for example methylation of H3K4 (Santos-Rosa et al., 2002; 
Wysocka et al., 2006) typically has the opposite transcriptional consequences to H3K9 
methylation (Bannister et al., 2001) but this seems to be determined by the chromatin context 
(i.e. Shi et al., 2006). Furthermore, the number of methyl groups incorporated at a specific 
residue also impacts on the functional outcome of a “mark”; lysines can be mono, di or tri-
methylated (Santos-Rosa et al., 2002), whereas arginines can be mono or di-methylated 
(asymmetric or symmetric)!(Margueron et al., 2005; Kirmizis et al., 2009).  
1.1.5.  Spatial distribution of histone modifications 
Biochemical analysis of histone modifications, typically using chromatin 
immunoprecipitation (ChIP) approaches, has shown that different histone marks display 
distinct patterns in chromatin (Pokholok et al., 2005). Numerous studies have shown that 
promoter regions of active genes are associated with histone acetylation and H3K4 
methylation (Hebbes et al., 1988), whereas inactive genes are enriched with H3K27 
methylation (O'Neill et al., 2003). 
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More recent studies, using ChIP combined with gene microarray analysis (“ChIP-chip”), 
reveal consistent genome-wide patterns in both yeast and mammalian cell lines (Pokholok et 
al., 2005; Vakoc et al., 2006; Wang et al., 2008) (Figure 1.9). In active genes, modifications 
such as H3K4 methylation (H3K4me3) and H3K9 acetylation (H3K9ac) are enriched within 
the promoter regions, while some others are more abundant in the coding region. For 
example, in the yeast S. cerevisiae, the promoter and the 5’ end of genes are enriched with 
acetyl marks (H3K9ac), whereas the coding regions of actively transcribed genes are 
enriched with tri-methylation of H3K4, H3K36 and H3K79 (Pokholok et al., 2005; 
Kouzarides, 2007). Similarly, in mammals, mono, di and tri-methylation of H3K4 were 
found to be elevated at the transcription start sites (TSS) of active genes (Bernstein et al., 
2005; Barski et al., 2007). More specifically, where all H3K4me marks are enriched around 
the transcription start site, H3K4me1 and H3K4me2 typically display two major peaks of 
enrichment, on each side of the TSS, whereas the tri-methyl mark is closer to the 
transcription start site (Barski et al., 2007). In mammalian chromatin, there is also a high 
level of H3K79me3 near the transcription start site (TSS) of active genes (Vakoc et al., 
2006). In contrast, other marks present a clearly different distribution; H3K36me3, 
H3K9me3 and H3K79me3, and monomethylated H4K20 are enriched at the 3’ end of genes, 
and spread across the coding region. These marks also contribute to transcriptional repression 
(Vakoc et al., 2006).  
A similar pattern is seen with repressive modifications, with both TSS specific, and coding-
region-specific distributions. H3K27me3, a mark that correlates with gene repression, is 
slightly elevated in the promoter regions of transcriptionally inactive genes, and is associated 
with a broad distribution over the coding region, whereas this mark is decreased in active 
genes (Barski et al., 2007). Similarly, H3K9me2/3, a mark associated with gene repression 
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Figure 1.9: Distribution of histone marks on an “average” human active 
gene (based on Barski, A., et al., Cell, 2007)  
In active genes, histone marks show a characteristic pattern of distribution. For 
example, an histone mark associated with transcriptionally active gene, 
H3K4me3 is enriched at the transcription start site, whereas H3K4me2 and 
H3K4me1 are enriched in the proximity of the TSS, on each side. H4K20me1 is 
enriched at promoter of active genes. H3K27me3, a mark associated with gene 
repression, shows no enrichment on active genes. Note that the relative 
abundance of different marks cannot be compared. 
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and the formation of heterochromatin (Bannister et al., 2001), is increased around the 
transcription start site in silent genes (H3K9me2), and reduced in active genes (Barski et al., 
2007). Furthermore, the degree of modification adds another level of complexity: while 
H3K27me3 and H3K9me2 are associated with gene silencing, H3K27me1 and H3K9me1 are 
associated with actively transcribed genes, particularly surrounding the transcription start site 
(Barski et al., 2007). Similarly, where H3K4me3 is associated with gene activation only, 
high levels of mono and di H3K4me correlate with both active and inactive genes (Santos-
Rosa et al., 2002). The observation that different marks are associated with different 
functional states of genes and adopt distinct genomic locations suggests they have divergent 
functional effects, and achieve them in different ways. For example, it was proposed that the 
enrichment of repressive marks (such as H4K20me) within the transcribed region of genes, 
may be involved in the prevention of aberrant “adventitious activation” by RNA Polymerase 
II, as seen with H3K36me (Joshi and Struhl, 2005; Vakoc et al., 2006). 
Finally, interestingly, two functionally “opposite” marks, H3K4me3 and H3K27me3, are 
observed in the same region of key genes in the context of stem cell differentiation. These 
were termed “bivalent domains” and are proposed to enable the gene to adopt a different 
functional state (i.e. active to silent) as differentiation progresses, having the potential to be 
subsequently associated with either of these two marks (Bernstein et al., 2006; Azuara et al., 
2006). However, recent data suggests that bivalency at least partially reflects the pooling of 
functionally distinct populations of cells (Akkers et al., 2009). 
1.1.6.  “Cross-talk”, or the functional interaction of modifications 
The divergent distributions of histone modifications suggest their functional effects are via a 
number of mechanisms, but often these distributions overlap suggesting different marks act 
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in a co-ordinated manner. At a mechanistic level, this “cross-talk” implies that several marks 
act together to regulate processes, but it also suggests that some marks influence the 
deposition of other modifications, either in cis (on the same histone tail) or in trans (on 
different histone tails)! (Nightingale et al., 2006; Latham and Dent, 2007). The simplest 
examples are where one modification can affect the deposition of other modifications on the 
same residue, and thus are mutually exclusive; for example, H3K9 acetylation and H3K9 
methylation are marks with opposing transcriptional outcomes.  
Other interrelated modifications interact in trans, or between histones. For example, in the 
yeast S. cerevisiae, lysine 123 mono-ubiquitination of histone H2B precedes H3K4 and 
H3K79 trimethylation by the COMPASS and Dot1 methyl-transferases respectively (Briggs 
et al., 2002; Sun and Allis, 2002). In this case, deposition of the ubiquitin mark is catalysed 
by the ubiquitin-conjugating-enzyme Rad6/Bre1 (Sung et al., 1988; Robzyk et al., 2000), and 
leads to the direct or indirect recruitment of the histone methyl-transferase COMPASS 
(Complex of Proteins Associated with Set1)!(Dover et al., 2002; Nakanishi et al., 2009). This 
pathway is also conserved from yeast (through H2BK123Ub1) to human (through 
H2B120Ub1)!(Kim et al., 2009). As a crucial element in this cross-talk process, a study from 
Lee et al. showed that Swd2 is directly or indirectly recruited to the chromatin in a mono-
ubiquitination dependent manner, and that the subsequent association of Swd2 with 
COMPASS is essential for H3K4 trimethylation (Lee et al., 2007). However, this study 
contradicts other studies proposing that Swd2 is the key element in Set1 stability (Dichtl et 
al., 2004), but that H2B is not essential for Swd2 recruitment to the chromatin (Vitaliano-
Prunier et al., 2008). In this last study, it is proposed that Swd2 contributes to the unmodified 
H3-dependent recruitment of COMPASS to the chromatin. Ubiquitylation of both H2B and 
Swd2 would then favor the recruitment of the COMPASS subunit Spp1 contributing to H3K4 
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methylation (Dehe et al., 2006; Morillon et al., 2005; Vitaliano-Prunier et al., 2008). Swd2 
also binds to Dot1, and is required for H3K79 trimethylation (Lee et al., 2007). This H2B 
modification is transient though, as the mono-ubiquitination is then removed by a component 
of the Gcn5-containing SAGA complex, the ubiquitin protease Ubp8 (Dover et al., 2002; 
Henry et al., 2003; Margueron et al., 2005; Latham and Dent, 2007). Cross-talk can also 
occur between modifications on different residues on the same histone, in cis. A particularly 
well-studied example of cross-regulation involves H3K9ac, H3K14ac and H3S10p, where 
the phosphorylation of H3S10 is followed by acetylation of H3K14 (Cheung et al., 2000). 
This interrelation was also observed in yeast, where H3K14 acetylation is deposited by the 
Gcn5 acetyl-transferase (Lo et al., 2000). In addition, H3S10 phosphorylation prevents H3K9 
methylation (Rea et al., 2000), blocking the recruitment of HP1 to chromatin (Fischle et al., 
2005; Latham and Dent, 2007). Similarly, H3K4me3, H3K9ac and H3S10p are present on 
the same nucleosomes, on transcriptionally active genes in mouse (Clayton et al., 2000; 
Hazzalin and Mahadevan, 2005). These studies found histone H3 methylated at lysine 4 is 
subject to dynamic acetylation, whereas this was not observed with H3K9me. This was 
consistent with their findings that both H4K9ac and H3S10p were transient marks that 
correlated with gene activation, whereas H3K4me3 is present before gene activation and 
maintained for a few hours afterwards (Hazzalin and Mahadevan, 2005). 
The specific degree of histone modification seems to be determined by other adjacent 
modifications. Mass-spectroscopy (Churikov et al., 2004) and subsequent Western analysis 
showed that increased acetylation of histone H3 is associated with a high level of H3K4 
methylation (di and tri particularly) (Nightingale et al., 2007), whereas methylation at the 
residue H3R2 appears to inhibit H3K4 methylation (Kimizis et al., 2007). 
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H3K4 methylation can also influence other modifications in trans, and leads to the 
acetylation of histone H4 at lysine 16. This cross talk is the result of the association of two 
enzymes, the histone methyl-transferase MLL1 and the H4K16-specific histone acetyl-
transferase MOF (Dou et al., 2005). This is consistent with their “activating” roles; H4K16 
acetylation prevents higher order chromatin compaction (Robinson et al., 2008) and 
modulates the interaction of chromatin-associated proteins such as chromatin-remodelling 
enzymes (Shogren-Knaak et al., 2006; Shogren-Knaak and Peterson, 2006). In addition, 
H4K16 acetylation also contributes to the prevention of heterochromatin propagation 
associated with silencing in yeast (Shia et al., 2006). Similarly, in budding yeast, H3K4 and 
H3K36 methylation are required prior to H3K14 acetylation by the histone acetyl-transferase 
complex NuA3 (Martin et al., 2006). NuA3 is recruited to these marks through the PHD 
finger of its subunit Yng1p, which binds H3K4me (Martin et al., 2006). Modifications of 
these residues may also be required for H4K8 acetylation (Morillon et al., 2005; Latham and 
Dent, 2007).  
In many cases, the mechanistic basis of these interactions is unknown, but it is assumed that a 
combination of multiple marks generates a “platform” for the recognition and the recruitment 
of modification-recognising “effector” proteins, thus leading to the recruitment of other 
factors, or to chromatin rearrangement.  
1.2. Effector proteins 
Histone modification is a dynamic process which is influenced by the environment and is 
associated with a biological response. A modification can be deposited on a residue 
depending on the functional status of the chromatin, and then be removed or lost when this 
condition is changed (Nightingale et al., 2006; Vermilyea et al., 2009). Specific histone-
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modifying enzymes mediate the regulation of these modifications. Thus, histone modification 
acts as a platform for the recruitment of modification-specific “effector proteins”, which then 
influence the adjacent chromatin environment and its functional role (Jenuwein & Allis, 
2001). These subsequent effects can be both “activating” or “silencing”. Effector proteins are 
involved in the recruitment of specific enzyme activities to chromatin (e.g. HATs or 
chromatin remodelling complexes), but they can also maintain repressed genes or stabilize 
heterochromatin (e.g. HP1, or Polycomb-group proteins). This can favour the establishment 
of processes such as transcription, repair (Tsukada et al., 2005), replication (Goren et al., 
2008), and gene silencing. Complexes containing histone modification enzymes have been 
shown to associate with transcription factors as well, linking functional regulators and 
histone modification (Kuo et al., 1996; Spencer et al., 1997; Kouzarides, 2007). 
Effector proteins are recruited to specific marks via specialised domains that recognise both 
the residue, and the precise post-translational modification. These “domains” were 
historically recognised in many chromatin-binding proteins, via their high degree of 
conservation, and act to recruit both the protein, and its associated complex to specific loci. 
1.2.1. Bromodomain-containing proteins 
Acetylation was the first histone modification identified, and was proposed to play a role in 
transcription (Allfrey et al., 1964). Lysine histone marks can be identified and “read” by 
specialised protein domains called bromodomains, found in a wide range of chromatin-
associated proteins, in particular in histone acetyl-transferases (Dhalluin et al., 1999). The 
bromodomain was the first domain recognised to interact with histone modifications, being 
specific for lysine acetylation marks (Dhalluin et al., 1999). This conserved protein motif 
consists of around 110 amino acid residues and is found in a wide variety of chromatin-
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associated proteins, such as histone acetyl-transferases, chromatin remodelling complexes 
and transcription factors (Mizzen et al., 1996; Jacobson et al., 2000).  
The first histone-binding motif to be structurally characterised was the bromodomain of the 
p300/CBP-associated factor, PCAF (homologue of the S. cerevisiae histone acetyl-
transferase Gcn5p) (Dhalluin et al., 1999). Bromodomains display a conserved structure, 
constituted of a cluster of four helices, with a left-handed twist, and two interhelical loops at 
the end of the structure, forming a hydrophobic binding pocket, into which acetyl-lysine 
marks are inserted (Dhalluin et al., 1999; Zeng et al., 2008). This is kept in place in the 
binding pocket through a hydrogen bond, constituting an anchoring point to stabilise the 
interaction between the residue and the protein (Taverna et al., 2007; Zeng et al., 2008). 
However, despite the conservation of this structure, the amino acid composition of the loops 
is able to discriminate for the binding of specific residues (Mujtaba et al., 2007). Distinct 
bromodomain-containing proteins selectively bind acetyl lysine marks depending on the 
other residues surrounding the modified lysine (Mujtaba et al., 2007; Zeng et al., 2008; 
Zhang et al., 2010). Gcn5p recognises H4K16 acetylation (Owen et al., 2000), whereas 
PCAF (p300/CBP-associated factor) binds the acetylated lysine 50 residue of the HIV1 
(human immunodeficiency virus type 1) transactivator protein Tat (Mujtaba et al., 2002). 
Similarly, bromodomain-containing transcription complexes also bind selectively to specific 
acetylated residues. For example, the BRG1 subunit of the SWI/SNF complex binds H4K8ac, 
whereas TAF1 (TAFII250; Jacobson et al., 2000; Agalioti et al., 2002; Taverna et al., 2007), 
or the TAF1 homologue, Brdt (Moriniere et al., 2009), both of which contain two 
bromodomains, bind two adjacent acetylated marks. 
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1.2.2.  Chromodomain-containing proteins 
Chromodomains (for Chromatin Organisation Modifier) are highly conserved 50 amino-acid 
protein motifs, originally defined by regions of high sequence homology found within two 
Drosophila proteins, Pc and HP1 (Pearce et al., 1992). Chromodomains were then described 
in a variety of other proteins. In the mouse HP1-like protein, the chromodomain adopts a 
three-stranded anti-parallel ß-pleated sheet structure backing onto an "-helix. The domain is 
composed of a highly conserved hydrophobic core. Differences between chromodomains are 
mostly found in the bends connecting the sheets (Jones et al., 2000).  
H3K9 is a substrate for the SUV39H1 histone methyl-transferase (Suppressor of Variegation 
3-9 Homolog 1, or SuVar 3-9), which generates a mark (H3K9me3) recognised by a highly 
conserved chromodomain on heterochromatin-associated protein 1 (HP1) (Nielsen et al., 
2002; Lu et al., 2009). Recruitment of this factor favours heterochromatin formation and 
gene repression (Lachner et al., 2001). However, chromodomains are also specific for a 
number of methylated marks, for example the Polycomb (Pc) chromodomain recognises 
histone H3K27me3, a mark deposited by Enhancer of Zeste [E(Z)], and both proteins show 
some flexibility of binding as HP1 and Pc chromodomains target di- and tri-methyllysines 
(Lachner et al., 2001; Margueron et al., 2005; Taverna et al., 2007). Chromodomains are also 
found in histone acetyl-transferases. In the yeast SAGA (Spt-Ada-Gcn5-acetyltransferase) 
complex, the Chd1p (Chromo-ATPase/helicase-DNA binding domain 1) subunit contains 
two N-terminal chromodomains (Pray-Grant et al., 2005; Tran et al., 2000; Woodage et al., 
1997). In human CHD1, these two chromodomains are bridged by a two-helix linker 
element, forming a helix-turn-helix structure. This linker segment juxtaposes the two 
chromodomains, allowing them to cooperate by constituting a new recognition pocket to 
interact with H3K4me (Flanagan et al., 2005; Taverna et al., 2007). It should be noted that 
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the phosphorylation of the adjacent H3T3 residue weakens the binding of CHD1 for 
H3K4me (Flanagan et al., 2005). This is also seen in the Drosophila and human CHD1 
orthologues. Chd1p binds H3K4, with a preference for di and trimethylated residues, 
reflecting the specificity of one of its chromodomains (Pray-Grant et al., 2005). Interestingly, 
more divergent chromodomains are thought to bind RNA. In Drosophila, the histone acetyl-
transferase MOF interacts in vivo with RNA through its chromodomain, an interaction, which 
may contribute to the recruitment of MOF to the Dosage Compensation Complex (DCC) at 
the Drosophila male X chromosome (Akhtar et al., 2000). 
1.2.3.  Tudor domain-containing proteins 
Methyl-lysine marks are also recognised by proteins involved in their removal. In the JMJD2 
family, this recognition is mediated by the catalytic-core region, which comprises substrate 
binding sites and the JmjN and the JmjC catalytic domain (Chen et al., 2006). For example, 
H3K4me3 and H4K20me3 are individually targeted by the hybrid Tudor domains of the 
histone lysine demethylase JMJD2A! (Taverna et al., 2007; Adams-Cioaba and Min, 2009). 
This 50 amino-acid conserved motif was first identified in the Drosophila Tud protein 
(Boswell and Mahowald, 1985; Adams-Cioaba and Min, 2009). JMJD2A, which is a protein 
of the Jmjc histone demethylase superfamily, contains two Tudor domains. This double tudor 
domain binds methylated H3K4 and H4K20 (Huang et al., 2006; Kim et al., 2006) by 
adopting a two “lobed” structure, where only the second “lobe” can interact. This is a 
complex structure, requiring residues from both Tudor motifs to generate an “aromatic cage” 
binding pocket, used for the insertion of a trimethyl-lysine residue (Huang et al., 2006; 
Taverna et al., 2007).    
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1.2.4.  PHD finger-containing proteins 
Methyl-lysine marks can also be read by PHD-finger-containing proteins. Plant 
homeodomains (PHD) are constituted of around 60 amino acid residues, characterised by a 
motif consisting of four cysteines, one histidine, three cysteines (Cys4HisCys3). This motif 
binds two Zn2+ ions, coordinating the structure of the PHD finger. The PHD finger displays 
two flexible loops, the second loop being used to interact with specific nuclear proteins 
(Bienz, 2006). PHD fingers promote the recruitment of enzyme complexes by binding 
methylated marks, for example, the PHD fingers of BPTF and ING2 are composed of a 
H3K4me-binding pocket, containing two aromatic residues forming an aromatic cage 
(Taverna et al., 2007).  
PhD finger binding is now known to be highly specific; the human protein BPTF and its 
Drosophila orthologue NURF301, a subunit of the NURF chromatin-remodelling complex, 
contain a C-terminal PHD finger, which binds preferentially to H3K4me3, rather than the 
H3K4me2 mark. This is consistent with its ability to stimulate transcription in vitro (Li et al., 
2006), and the contribution of H3K4 methylation to transcription in S.cerevisiae (Santos-
Rosa et al., 2002; Pinskaya and Morillon, 2009). Moreover, the PHD finger domain is 
situated close to the C-terminal bromodomain, which suggests that these two domains may 
function in a cooperative manner in the recognition of histone marks (Wysocka et al., 2006; 
Taverna et al., 2007). In addition, the alternative splicing of the NURF301 subunit leads to 
the formation of two functionally distinct NURF complexes, one containing the full-length 
NURF301 protein, which recognises H3K4me3 as well as H4K16ac, and a complex 
containing a truncated form of NURF301, which cannot target these residues (Kwon et al., 
2009). In contrast, the human ING2 protein, a subunit of the histone acetyl-transferase 
complex Sin3 also interacts with H3K4me3, but is linked to gene repression (Pena et al., 
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2006; Shi et al., 2006; Taverna et al., 2007). More recent data confirms that PHD fingers can 
recognise the degree of methylation in a specific manner. For example, in contrast with 
BPTF and ING2, which bind preferentially to di- and tri-methylated H3K4, another PHD 
domain-containing protein binds specifically to non-methylated H3K4 (H3K4me0). The 
autoimmune regulator (AIRE) protein possesses two PHD fingers, through which the histone 
H3 is bound. The recruitment of AIRE to non-methylated H3K4 on the tissue-restricted 
antigen promoter then favours the recruitment of other factors, such as the histone acetyl-
transferase CBP and is associated with transcription activation (Musco and Peterson, 2008; 
Org et al., 2008).  
In addition to chromatin-remodelling complexes, PHD fingers are also used by transcription 
factors to recognise histone modifications. TAF subunits of the basal transcription factor 
TFIID bind post-translational histone marks through different motifs. TAF3 binds H3K4me3 
and H3K4me2 through its C-terminal PHD finger domain (Vermeulen et al., 2007). 
Interestingly, H3R2 dimethylation prevents TAF3 binding, by impairing H3K4 recognition, 
but does not impact on the binding of two other PHD-finger-containing proteins, ING2 and 
BPTF (Vermeulen et al., 2007). As discussed previously, TAF1 and its homologue Brdt, 
(Moriniere et al., 2009) contain a double bromodomain, suggesting that the cooperative 
recognition of multiple marks (H3K4me3 and H3 or H4 acetylation) by subunits of TFIID 
favours the interaction of the complex with transcriptionally active promoters (Vermeulen et 
al., 2007). 
1.2.5.  Phosphorylation-targeting proteins 
Histones can also be modified by the phosphorylation of serine and threonine residues, marks 
with a range of functional effects. For example, H3S10p is linked with early gene expression 
(Clayton et al., 2000; Soloaga et al., 2003), early transcription elongation (Ivaldi et al., 2007; 
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Zippo et al., 2009), and the onset of mitosis (Di Croce, 2005). Transient phosphorylation of 
H3S10 during early gene induction is mediated by mitogen-and stress-activated kinases 1 and 
2 (Msk1/2)!(Soloaga et al., 2003; Taverna et al., 2007). The H3S10p mark is recognised by 
conserved phosphoserine-binding modules, present in the mammalian 14-3-3 proteins 
(Bmh1p and Bmh2p in yeast) (Macdonald et al., 2005; Winter et al., 2008). Furthermore, the 
affinity of the binding is increased by adjacent acetylated H3K9 and H3K14 residues, 
suggesting that these acetylated marks stabilise the interaction (Winter et al., 2008). These 
proteins have the capacity to homo or heterodimerise, binding to at least two phosphoserine 
sites. 14-3-3 proteins also bind to H3S28p (Taverna et al., 2007).  
Thus to summarise, the interactions between histone modifications and specific effector 
proteins are complex. Specific histone residues are recognised by distinct domains. In 
addition, the degree of modification and the residues flanking a target histone mark influence 
this selective recognition, allowing specific functional proteins to be recruited. This 
specificity can be crucial when two proteins are competing to bind an adjacent modified 
residue. Modified residues can prevent the recruitment of some effectors and/or stimulate the 
recruitment of other proteins, potentially with diametrically opposite functional effects.  
1.3. Modifying enzymes 
The abundance of a specific histone modification at a locus is determined by the balance of 
activities of two classes of opposing enzymes - depositing and modification-removing 
enzymes. These are specific to particular classes of modification; for example, histone acetyl-
transferases catalyse the addition of acetyl marks, while histone methyl-transferases catalyse 
the addition of methyl marks. Other enzymes exist to catalyse the modification of other type 
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of histone marks. Furthermore, these marks can also be removed, in processes that involve 
other types of enzymes, histone deacetylases or histone demethylases (Figure 1.10).  
1.3.1.  Regulation of histone acetylation 
Histone acetyl-transferases (HATs) 
Histone acetylation is primarily at the histone tail (except the core-located H3K56 in yeast 
and Drosophila (Xu et al., 2005)) and is catalysed by Histone Acetyl Transferases (HATs) 
while its removal is catalysed by Histone Deacetylases (HDACs)! (Turner, 2002). Histone 
acetyl transferases catalyse the transfer of acetate groups from the cofactor acetyl Coenzyme 
A (acetyl CoA) to histones (Figure 1.11). Functionally it is involved in modulating chromatin 
structure. Early observations indicated that HATs were involved in transcriptional regulation, 
as actively transcribed regions of chromatin were found to be associated with 
hyperacetylation, while transcriptional silent regions were associated with hypoacetylation 
(Hebbes et al., 1988; Turner, 1991; Davie, 1997; Turner, 1998; Utley et al., 1998). This was 
more recently followed by the finding that transcription activators, like yeast Gcn5, acetylate 
histones (Kuo et al., 1996). Two processes were suggested to explain the link between 
histone acetylation and transcription regulation. An earlier hypothesis suggested that 
acetylation neutralises lysine’s positive charge, resulting in the reduction in histone - DNA 
interactions, thus leading to the formation of an accessible chromatin conformation. The 
second proposition proposes that histone modifications function as a platform for recognition 
by effector proteins. Experimental data suggests that both of these hypotheses are correct for 
histone acetylation.  
Histone acetyl-transferases constitute a diverse series of proteins that form five families: 
Gcn5-related acetyltransferases (GNATs), MYST-related HATs, p300/CBP HATs, general 
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Figure 1.10: A dynamic mechanism of post-translational modifications 
Histone and non-histone proteins can be post-translationally and reversibly 
modified. These modifications are highly dynamic: modifications can be added 
and then removed by specific enzymes. Three major mechanisms have been 
especially well-studied. Histone acetylation corresponds to the transfer of an 
acetyl group to a histone residue and is opposed to deacetylation. Histone lysine 
and arginine methylation correspond to the transfer of a methyl group from an S-
adenosyl cofactor to a lysine or arginine residue. This process is reversed by  
demethylation. Histone phosphorylation, in which the transfer of a phosphate 
requires ATP, is reversed by dephosphorylating phosphatase enzymes. 
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Figure 1.11: Acetylation and deacetylation mechanism 
Histone and non-histone proteins can be post-translationally and reversibly 
modified. Acetylation is catalysed by one of a broad family of structurally 
diverse histone acetyl-transferases (HATs), while histone deacetylation is 
catalysed by histone deacetylases (HDACs). Acetylation corresponds to the 
transfer of an acetate group from the cofactor acetyl-Coenzyme A to the protein. 
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transcription factors HATs and nuclear hormone-related HATs (Carrozza et al., 2003). The 
finding that a wide range of enzymes is involved in regulating essentially the same chemistry 
suggests that they act in different processes or at specific loci (Lee and Workman, 2007). 
Experimental data suggests that there is functional redundancy between some histone acetyl-
transferases.  
Most acetyl-transferases act as members of multiprotein complexes, whose members are 
essential in the selective targeting of genes (Berndsen and Denu, 2008). Thus, enzymes 
function in a cooperative manner to recognise specific histone modifications and generate an 
appropriately targeted, regulated effect. Acetyl-transferases can interact with histone methyl-
transferases, in order to cooperate in the regulation of gene transcription. For example MOF, 
a histone acetyl-transferase from the MYST family, catalyses the acetylation of a specific 
histone mark at H4K16 (Carrozza et al., 2003). MOF is also associated with the histone 
methyl-transferase MLL1 (Dou et al., 2005). Similarly, the broad specificity histone acetyl-
transferase, CBP, which catalyses the acetylation of multiple histone (Das et al., 2009; Tie et 
al., 2009) and non-histone proteins (Gu and Roeder, 1997), can also associate with MLL1 
(Ernst et al., 2001). 
Histone deacetylases (HDACs) 
Histone deacetylases (HDACs) (i.e. Figure 1.11) can be grouped into two families, the Silent 
Information Regulator Two (Sir2) family of NAD- dependent HDACs, or “sirtuins”, and the 
initial HDAC family. This second family is divided into class I (HDACs 1, 2, 3 and 8, 
Cunliffe, 2008) and class II (HDACs 4, 5, 6, 7 9, 10). In yeast, the principal deacetylases are 
Rpd3 and Hda1 (Kurdistani and Grunstein, 2003), where Rpd3 belongs to class I. Class I 
HDACs are principally found in the nucleus, while class II can transit in and out of the 
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nucleus (De Ruijter et al., 2003). As with histone acetyl-transferases; histone deacetylases are 
organised in complexes to mediate transcriptional silencing: e.g. the Sin3 complex (Zhang et 
al., 1997), the chromatin remodeller NuRD (Xue et al., 1998) and Co-REST (You et al., 
2001). Hos2, a HDAC that deacetylates histones H3 and H4, was shown to be associated 
with coding region of genes only during active transcription in yeast (Kurdistani and 
Grunstein, 2003). Acetyl-transferases and deacetylases also have other substrates. The first 
non-histone target for acetyl-transferase identified was p53 (Gu and Roeder, 1997), and is 
now known to be essential for its activation (Tang et al., 2008). Thus post-translational 
acetylation and deacetylation can affect diverse factors, such as transcription factors like 
YY1, cellular proteins like Hsp90 and tubulin, and viral proteins (Glozak et al., 2005). For 
example, some HATs and HDACs are associated with DNA binding proteins such as the 
transcription factor YY1 (Mokrani et al., 2006), whose regulation by acetylation and 
deacetylation influences its ability to bind DNA (Yao et al., 2001). The level of histone 
acetylation at specific loci in chromatin is generated by a balance of the activity between 
histone acetyl-transferases and histone deacetylases, modulating chromatin conformation and 
gene regulation. Other histone modifications are also involved in transcriptional regulation of 
genes including methylation and demethylation. 
1.3.2.  Regulation of methylation 
Histone methylation is catalysed by Histone Methyl Transferases (HMTs) on arginine and 
lysine residues. This reflects the activity of two families of Histone Methyl Transferases: the 
histone lysine methyl transferases (HKMTs), and a family of protein arginine methyl-
transferases (PRMTs, Krause et al., 2007). We will essentially focus on lysine modification.  
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Lysine histone methyl-transferases (KHMTs) 
Lysine methylation is the most studied process of methylation on the histone N-terminal tails.  
This process corresponds to the transfer of one to three methyl groups from the cofactor S-
adenosyl methionine (SAM) to lysine by a histone lysine N-methyl-transferase (Figure 1.12). 
This is catalysed by the SET domain (Rea et al., 2000). The evolutionarily conserved SET 
domain was initially identified in modifier of PEV (Position Effect of Variegation) as a 
region of homology to the C-terminal regions of three proteins; Drosophila histone Su(var)3-
9, Enhancer of zeste [E(z)] and Trithorax (Trx)!(Tschiersch et al., 1994). Human SUV39H1 
and S. pombe Clr4, were the first histone methyl-transferases identified containing a SET 
domain, suggesting that other proteins containing this domain might have histone methyl-
transferase activity (Rea et al., 2000). These HMTs catalyse methylation of H3K9. More 
recently, other HMTs have been identified, like Drosophila Ash1, which catalyse 
methylation of H3K4,K9 and H4K20 (Beisel et al., 2002), and the human histone H3K9-
specific methyl-transferases G9a (Tachibana et al., 2001) GLP, Suv39H2 and PRDM2 (Wu 
et al., 2010), though there are indications that these protieins are not all specific to core 
histone substrates (Huang et al., 2010; Trojer et al., 2009). This domain of homology was 
also identified in the human homologue of TRX, ALL1/MLL (Tschiersch et al., 1994).  
Studies in the yeast S. cerevisiae indicate broad similarities between mammalian and yeast 
histone methyl-transferases. Sequence alignment identified six genes containing SET 
domains, termed set1-6 in S.cerevisiae (Pijnappel et al., 2001). In particular, the protein Set1 
was found to display similarities with the SET domain of Trx. Set1 is part of a multi-protein 
complex, the Set1 complex (Set1C) or COMPASS (Complex Proteins Associated with Set1), 
which has histone methyl-transferase activity, specifically catalysing the deposition of methyl 
groups on H3K4 (Miller et al., 2001; Roguev et al., 2001). Subunits of COMPASS are 
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Figure 1.12: Methylation by HMTs  
Histones  can be post-translationally and reversely  methylated on their lysine 
residues. Lysine mono, di and tri-methylation is catalysed by histone lysine 
methyl-transferases (KHMTs). This process corresponds to the transfer of one to 
three methyl group(s) from the cofactor S-adenosyl Methionine (SAM) to the 
lysine of a histone. Methyl groups can be removed by one, or more lysine 
demethylases (KHDMs), through mechanisms described in the following 
figures. 
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similar to Trithorax associated proteins (Miller et al., 2001) and include a H3 binding subunit 
Swd2 (Vitaliano-Prunier et al., 2008), and Wdr82, which is required for the recognition of 
ubiquitinated H2B in chromatin (Wu et al., 2008). SET domain-containing proteins present 
some structural differences though: the SET domain of Drosophila SUVH9H1 possesses a 
cysteine-rich motif in its N-terminal region (Rea et al., 2000), which is required for histone 
methyl-transferase activity, whereas this “pre-SET” domain is not essential in Set1 (Roguev 
et al., 2001). Similar to COMPASS, these characteristics and specific enzymatic activity can 
be found in the MLL complex, which will be discussed later. 
Histone demethylases (HKDMs) 
Until recently, histone methylation was thought to be irreversible, although histone 
demethylase activities were detected in whole cell extracts in the early 1970’s (Paik and Kim, 
1973). Two families of proteins displaying histone lysine demethylase activity (HKDM) have 
been identified: LSD1 (Shi et al., 2004), and the JMJC class, JHDM1!(Tsukada et al., 2006). 
These proteins are structurally and functionally distinct, using different chemistries to act on 
distinct histone modifications (Marmorstein and Trievel, 2009). LSD1 induces lysine 4 
demethylation on histone H3 via an amine oxidation that removes methyl groups (Shi et al., 
2004), while JHDM1 is implicated in H3K36 demethylation via a hydroxylation mechanism 
(Tsukada et al., 2006).  
LSD1 specifically demethylates histone marks associated with active transcription, such as 
H3K4me but not H3K9me and it was first proposed that flanking residues can modulate 
substrate specificity (Shi et al., 2004). However, subsequent experiments showed that 
residue-specificity can also be modified by proteins associated with LSD1, for example, the 
association of LSD1 with the androgen receptor leads to the removal of methyl marks on 
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H3K9, and to the derepression of target genes (Metzger et al., 2005). Furthermore, this 
histone demethylase also discrimates between di- and tri-methylation. LSD1 can demethylate 
mono- or di-methylated histones, but not tri-methylated histone residues. This reflects its 
amine oxidase activity; LSD1 would need a protonated nitrogen to demethylate tri-methyl 
residues (Shi et al., 2004). LSD1 is a flavin-containing protein, which can bind the cofactor 
FAD in order to catalyse the amine oxidation reaction (Shi et al., 2004) (Figure 1.13). Recent 
biochemical characterisation indicates that LSD1 is a component of the NuRD chromatin 
remodelling and deacetylase complex (Wang et al., 2009). 
The JmjC domain is evolutionarily conserved and more than 100 proteins containing this 
domain have been identified (Tian and Fang, 2007). Demethylation involves binding to 
Fe(II) and "-ketoglutarate cofactors through its JmjC domain, and demethylation via 
hydroxylation leads to the formation of succinate and formaldehyde (Figure 1.14)!(Tsukada 
et al., 2006). Ongoing biochemical characterisation indicates that these proteins are specific 
for a wide variety of residues - JHDM1A preferentially demethylates H3K36me2 (Tsukada et 
al., 2006), whereas JHDM2A, can specifically demethylate mono- and di-methylated H3K9 
(Yamane et al., 2006), JMJD3 is specific for H3K27me (Burgold et al., 2007) and GASC-1 
was shown to demethylate di- and tri-methylated H3K9, to form mono-methylated H3K9 
(Cloos et al., 2006). Similarly, JHDM3A (or JMJD2A) is necessary for the demethylation of 
trimethylated H3K9 and H3K36 (Klose et al., 2006). Perhaps not surprisingly, JMJD2 
proteins are also found to demethylate residues on linker histones (Trojer et al., 2009). 
In summary, transcriptional regulation is modulated by distinct processes, involving a diverse 
range of proteins depositing or removing histone methyl or acetyl groups. These specific 
enzymes modify residues selectively, depending on their degree of modification, and with a 
specificity determined by enzyme-associated subunits. Thus, the association of catalytic 
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Figure 1.13: Demethylation by LSD1 (based on Shi Y. et al., Cell, 2004) 
Mechanism of LSD1-catalysed demethylation of a monomethylated lysine. 
Amine oxidation is catalysed by the flavin-containing amine oxidase LSD1 and 
the cofactor FAD, generating an imine intermediate. This substrate is then 
hydrolysed to form an amine and an aldehyde (HCHO). For simplicity, the 
mechanism is represented for demethylation of monomethylated lysine, but the 
same mechanism is used for  dimethylated residues. 
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Figure 1.14: Demethylation by JHDM1A (based on Tsukada Y. et al., 
Nature, 2006) 
Mechanism of JHDM1A-catalysed demethylation of a monomethylated lysine. 
The amine oxidation is catalysed by JHDM1A and the cofactors Fe(II) and 
alpha-ketoglutarate (!-KC), generating an imine intermediate. This substrate is 
then hydrolysed to form an amine and an aldehyde (HCHO). For simplicity, the 
mechanism is represented for demethylation of monomethylated lysine, but the 
same mechanism is used for dimethylated residues. 
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enzymes with other factors into a multiprotein complex constitutes an essential and complex 
means of regulating chromatin remodelling and gene regulation.  
1.4. The MLL family of histone methyl transferases  
1.4.1.  MLL1 protein (KMT2A) 
Mixed Lineage Leukaemia (MLL1 or ALL1, HRX) is the archetypal protein of the family of 
MLL histone methyl-transferases. MLL was originally identified at the site of reciprocal 
chromosomal translocation frequently observed in 10% of human acute myeloid (AML) and 
acute lymphoid (ALL) leukaemias, as well as in therapy-induced secondary leukaemia 
treated with DNA topoisomerase II inhibitors. This gene was found to span the 11q23 region, 
a chromosomal breakpoint involved in leukaemia (Ziemin-Van Der Poel et al., 1991). These 
rearrangements involving MLL1 result in the generation of oncogenic fusion proteins, 
corresponding to the expression of the N-terminal region of MLL fused to one of over 50 
partners. As such the catalytic C-terminal region is lost. Chromosomal translocations can also 
lead to the generation of partial genomic tandem duplication of MLL1 (PTD), corresponding 
to the association of an additional MLL1 N-terminal region to MLL1 (Slany, 2009). 
At a protein level, MLL1 is a histone methyl-transferase (HMT) belonging to the MLL 
family. MLL is the mammalian homologue of Drosophila Trithorax (TRX), a positive 
regulator of gene expression, especially the homeotic Hox genes (Gu et al., 1992; Tkachuk et 
al., 1992). TRX is one of a group of proteins involved in “cellular memory”, acting to 
maintain pre-established transcription patterns during development (Kundu and Peterson, 
2009). MLL encodes for a large protein of 3,969 residues with an expected mass of about 
430kDa. This large protein is post-translationally cleaved in the cytoplasm into a large 
320kDa N-terminal protein (MLLN) and a small 180kDa C-terminal protein (MLLC), which 
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is achieved by a specialized threonine-aspartase endopeptidase TASPASE1 (Hsieh et al., 
2003) (Figure 1.15a). The two polypeptides then non-covalently associate in the nucleus, 
forming an active heterodimeric complex (Nakamura et al., 2002; Hsieh et al., 2003; Slany, 
2005a), and stabilising each other (Hsieh et al., 2003). Interestingly MLLC and MLLN have 
antagonistic transcriptional properties (Yokoyama et al., 2002).  
MLL bears multiple conserved domains with enzymatic activities (Figure 1.15b), with 
several domains identified in the MLLC fragment involved in epigenetic modification of 
chromatin. MLLN contains three AT hook motifs involved in DNA binding (Tkachuk et al., 
1992), a bromodomain, three PHD zinc finger domains (Fair et al., 2001) and a region with 
homology to DNA methyltransferase (CxxC), while MLLC contains the SET domain 
involved in the methylation of H3K4 (Milne et al., 2002; Nakamura et al., 2002), a binding 
site for the histone acetyltransferase CBP and a domain with transcriptional activation 
capacity (TAD) (Slany, 2005b). The structure of the SET domain of MLL1 has evolved to 
optimise association with both the target lysine and the SAM cofactor, and thereby enables 
the optimal methyl-transferase activity of MLL1. The domain comprises three distinct 
regions, SET-N, SET-I and SET-C, whose residues form a channel holding the target lysine 
residue in position for the efficient transfer of the methyl group (Southall et al., 2009). 
Among these regions, the orientation of SET-I is essential for the proper association with the 
substrate, modulating the accessibility of the channel, and optimising MLL1 activity, though 
it is thought that this modulation requires the intervention of other factors (Southall et al., 
2009). 
In mice, double knockout (Mll -/-) is embryonic lethal at 10.5 day post coitum, this being 
associated with defects in yolk sac (where blood cells are first detected during 
embryogenesis), foetal liver haematopoiesis, and segmental identity (Hess et al., 1997), 
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Figure 1.15: MLL1 and MLL complex (adapted from Slany RK, 2005) 
a) MLL1 is post-translationally cleaved by a specific threonine aspartase 
enzyme, Taspase 1, into a large N-terminal fragment (MLLN) and a small C-
terminal fragment (MLLC). MLL contains several functional domains, the most 
important being the SET domain involved in the methylation of lysine 4 on 
histone 3. MLL1 also contains a TA domain that binds CBP, an AT hook 
domain that binds DNA, a PHD domain that may be involved in protein-protein 
interactions, and a CxxC domain that selectively binds non-methyl-CpG DNA. 
The two polypeptides MLLC and MLL-N are then non-covalently bound in an 
active heterodimeric complex.  
b) MLL is associated with 29 other proteins in a large complex. Among them are 
found Histone Acetyl-Transferase (HAT) proteins such as MOF and CBP, 
proteins involved in DNA binding such as menin and proteins involved in 
histone modification or the recognition of histone marks. WDR5 is implicated in 
complex stabilisation, as well as the direct contact with the H3 substrate. 
/P,!
HP,!
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whereas heterozygous Mll-/+ mice are characterised by retarded growth, homeotic 
transformations of the body axis and defects in haematopoiesis (Yu et al., 1995). This 
highlights the central role of MLL1 in development, and as with TRX, MLL is now known to 
act at the Hox genes (Yu et al., 1998). 
The histone methyl-transferase MLL associates with transcriptionally active genes, such as 
the active promoters of Hox genes (such as Hoxa9), in a cell-type!and differentiation-stage 
dependent manner (Milne et al., 2002; Milne et al., 2005), and contributes to their regulation 
(Milne et al., 2002). Enzymatic H3K4 methyltransferase activity was first described in S. 
Cerevisiae, where a protein with MLL homology, Set1 was shown to deposit H3K4 
methylation in the promoter and the coding region of genes (Briggs et al., 2001). More recent 
studies have shown that Set1 is a component of the COMPASS complex, which is capable of 
generating mono-, di-, and tri-methyl H3K4 marks (Schneider et al., 2005), and this has 
functional effects by recruiting HDAC activities to the 5’ transcribed regions of genes (Kim 
and Buratowski, 2009). The nature of the mark deposited is key as H3K4 di-methylation is 
associated with both active and inactive genes, while the tri-methyl mark is associated with 
active genes (Santos-Rosa et al., 2002). A similar study showed that MLL1 binds at the 
transcription start site and on 5’ regions of actively transcribed genes, correlating with an 
enrichment of H3K4 trimethylation (Guenther et al., 2005). H3K4 specific methyl-
transferase activity was then further confirmed by Milne et al. (Milne et al., 2002). Despite 
its diverse functional domains, MLL1 acts in a large complex, requiring the association of 
other factors to function optimally. 
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1.4.2.  The MLL1 histone methyl-transferase complex 
As with yeast COMPASS, MLL is part of a multi-protein complex including many factors 
involved in chromatin modification and gene transcription (Nakamura et al., 2002; Dou et 
al., 2005). A MLL-containing complex purified by Yokoyama et al., called MLL/HCP 
complex, was composed of eight polypeptides displaying similarities with the proteins of the 
Set1 complex, including proteins such as WDR5, ASH2L, and RBBP5 (Yokoyama et al., 
2004) (Figure 1.16). These MLL1-associated polypeptides appear to assemble in a stable 
subcomplex interacting with MLLC through its SET domain (Yokoyama et al., 2004). This 
MLL “core complex” is similar to the SET1 family members of histone methyl-transferase 
complexes.  
Of the core complex, the WDR5 subunit is essential for the maintenance of MLL1 complex 
stability at promoters and facilitates the interaction of SET domain with the H3K4me2 
substrate (Wysocka et al., 2005). This activity reflects WDR5’s ability to associate with 
methylated histone H3, and increase the conversion from di to trimethylation of H3K4 by 
MLL1 (Wysocka et al., 2005). WDR5 possesses a specific WD40-repeat motif, constituted 
of seven ß-propeller “blades”, each composed of four anti-parallel ß-sheets, which interact 
with the N-terminal of histone H3, at the motif Ala1-Arg2-Thr3-Lys4 of histone H3 through 
an association of hydrogen bond and van der Waals contacts (Couture et al., 2006; 
Ruthenburg et al., 2006). Post-translational modification of H3R2 and H3T3 prevent binding 
of histone H3K4me2 by WDR5 (Couture et al., 2006). Both methylation of H3R2 and 
phosphorylation of H3T3 disrupt WDR5 binding histone H3, by either disrupting hydrogen 
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Figure 1.16: MLL1 complex and associated proteins  
MLL1 is associated with diverse factors in a multi-protein complex. Some are 
associated either with the MLL N-terminal region (like menin, or LEDGF 
through menin), or with the C-terminal region. Specifically, the acetyl-
transferase CBP is associated with the transcriptional activation domain, or TA 
of MLL, whereas the histone acetyl-transferase MOF, WDR5, RbBP5 and 
Ash2L interact with the SET domain. 
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bond or ionic interactions or sterically blocking the WDR5 T3 binding pocket (Couture et al., 
2006). Furthermore, two independent studies have shown that the N-SET region of MLL1 
binds the WDR5 binding pocket through a histone H3-like motif (ARAEVHLRKSAFD) 
(Song and Kingston, 2008), also called WDR5 interaction or “Win” motif 
(GSARAEVHLRKS)!(Patel et al., 2008; Patel et al., 2008), which is conserved among SET1 
family members. The WDR5 binding pocket that binds this MLL1 specific motif is also 
required to bind histone H3, so both compete for WDR5 binding (Patel et al., 2008; Song and 
Kingston, 2008).  
In association with WDR5, RbBP5, another WD40–repeat protein, is required to stabilise 
MLLC’s interaction with the core complex. WDR5 and RbBP5’s interaction with MLL 
depends on the SET domain (Yokoyama et al., 2004). RbBP5 is also required for the 
association of AshL2 with the core complex, and the activity of both proteins is required for 
the di and trimethylation of H3K4 (Dou et al., 2006). In particular, Ash2L regulates H3K4 
trimethylation activity at the 5’ end of genes in human cells (Steward et al., 2006). However, 
in contrast with MLL1 methylation processes already described in the literature, another 
process of methylation involving MLL1 and the core complex has recently been described. 
Patel et al. (2009) proposed that the isolated MLL1 SET domain is a H3K4 monomethyl-
transferase, which can then acquire H3K4 dimethyl-transferase activity in the presence of the 
core complex; this is consistent with observation that MLL1 efficiency is impaired without 
additional factors, like Ash2L, RbBP5 or WDR5 (Southall et al., 2009).  
Biochemical analysis showed that the presence of a phenylalanine at position 3,942 of MLL1 
modulates its histone methyl-transferase activity, allowing it to act as a trimethyl-transferase. 
It was proposed that MLL1 trimethyl-transferase activity could be generated by the 
interaction of MLL1 with other proteins, which act to influence the position of the tyrosine 
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residue in the SET domain (Patel et al., 2009). This was reinforced by Dou et al. (2005), who 
proposed that MLL1 needs association with another component to be fully active (Dou et al., 
2005).  
Altogether, WDR5, ASHL2 and RbBP5 form a structurally independent complex, which 
constitutes a common platform for catalytic HMTs (Dou et al., 2006; Steward et al., 2006). 
In addition to this initial subcomplex, another protein, DPY-30, was proposed to be part of 
the core complex (Miller et al., 2001; Patel et al., 2009). This protein is involved in the 
recruitment of factors to the dosage compensation machinery in C. elegans (Hsu et al., 1995). 
MLL1 is also associated with histone acetyl-transferases such as MOF and CBP, and these 
are also known to contribute to MLL function. MOF is an acetyl-transferase catalysing 
H4K16 acetylation. This enzyme is associated with the MLL1 SET domain through its zinc 
finger (Dou et al., 2005), suggesting that both proteins function in a coordinated manner for 
the activation of transcription. A model was proposed, in which the MLL1 complex is 
recruited to target genes either following the binding of WDR5 to H3K4me-marked 
nucleosomes, or through the binding of the MLL1 bromodomain to H4K16ac-marked 
nucleosomes (Dou et al., 2005). This does not make clear how these marks are originally 
deposited though. CBP binds to the MLL1 activation domain, corresponding to MLL amino 
acids 2,829 to 2,883, through a “KIX”, or CREB-binding domain (Ernst et al., 2001). This 
interaction is essential for transcriptional activation by MLL1 (Ernst et al., 2001), 
presumably reflecting CBP’s ability to acetylate a wide range of non-histone proteins. In 
addition, it has recently been shown that CBP mediates the acetylation of residues such as 
H3K56 (Das et al., 2009). CBP also mediates acetylation of H3K27 in Drosophila, thereby 
preventing the methylation of the same residue by TRX, the MLL1 orthologue (Tie et al., 
2009). 
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The N-terminal fragment of MLL1 is associated with menin, a tumor suppressor protein, 
which can bind DNA (La et al., 2004), interacts with several transcription factors such as 
NF-!B (Heppner et al., 2001) and is proposed to contribute to DNA recruitment of the MLL 
complex (Yokoyama et al., 2004). Menin is essential for maintaining Hoxa9 expression 
suggesting that it could influence MLL1 function (Yokoyama et al., 2004; Popovic and 
Zeleznik-Le, 2005; Slany, 2005b). Interestingly, menin interacts with both wild type MLL1 
and MLL-fusion proteins (Yokoyama et al., 2004) (see later), suggesting it interacts with the 
N-terminal region (MLLN).  
Purification of the MLL-ENL fusion/menin complex identified a 75kDa subunit called 
LEDGF (Yokoyama and Cleary, 2008). LEDGF is implicated in transcriptional coactivation 
(Ge et al., 1998), and colocalises with MLL target genes, including Hoxa9 (Yokoyama and 
Cleary, 2008), associating with transcriptionally active chromatin through its conserved 
PWWP domain (Turlure et al., 2006). This motif is related to “royal family” domains, having 
similarities with Tudor domains. It is thought that menin is only required to recruit or 
stabilise LEDGF in the MLL1 complex, which thereby allows MLL1 to target 
transcriptionally active chromatin through (Yokoyama and Cleary, 2008).  
To summarise, it is clear that the MLL1 complex requires cofactors and associated proteins 
to be recruited to chromatin on target genes and be fully active. Furthermore, the proper 
association of both MLLC and MLLN, which have transcriptionally antagonistic properties, is 
essential in the balanced function of MLL1. It is perhaps not surprising that the disruption of 
this balance would thus have consequences for downstream regulation. Indeed, the 
generation of MLL-fusion proteins leads to the disregulation of gene expression. 
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1.4.3.  MLL-Fusion proteins 
A leading reason why MLL1 is a focus of widespread research is the finding that 
chromosomal translocations are able to generate MLL fusion proteins that disrupt the proper 
regulation of genes, notably the Hox genes. These translocations typically result in the loss of 
the C-terminal region of the MLL protein, including the PHD domains (Fair et al., 2001), the 
transactivation domain and the SET domain, which are replaced by one of 54 translocation 
partners fused to MLLN (Slany, 2009). Early papers suggest that the loss of PHD domains 
prevents the recruitment of corepressors (Fair et al., 2001), however, this may also impact on 
MLL-chromatin interactions. Importantly, it is thought that the novel properties characteristic 
of MLL-fusion proteins explain the resulting gene disregulation: cell transformation by MLL 
fusions necessitates the loss of the PHD domains (Chen et al., 2008), whose presence would 
reduce association with Hoxa9 and impair Hoxa9 up-regulation (Muntean et al., 2008), but 
requires the CxxC domain to associate to non-methylated CpG DNA sites (Ayton et al., 
2004). Furthermore, menin remains associated with the N-terminal region of MLL-fusion 
proteins (Yokoyama et al., 2004), and still acts to recruit LEDGF to MLL-fusion proteins 
(Yokoyama and Cleary, 2008). Thus, the composition of the “remaining MLL” after 
translocation is critical for leukaemic transformation. Furthermore, MLL fusion partner 
proteins are essential for transformation; these are mostly transcription factors, like AF4 (Gu 
et al., 1992), AF9 (Dobson et al., 1999) and ENL (Tkachuk et al., 1992), where the 
generation of “MLL-transcription factors fusions” is associated with a gain-of-function on 
gene expression (Lavau et al., 1997). MLL can also, but rarely, fuse with proteins normally 
found in the MLL complex, such as CBP, which is also sufficient for transformation 
(Yokoyama and Cleary, 2008). The fusion of the chimeric MLL1 with an acetyl-transferase, 
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and the permanent recruitment of this protein lead to the hyperacetylation of MLL target 
genes and thus aberrant up-regulation (Slany, 2009). 
The process of MLL fusion generates a truncated MLL molecule, which loses a number of 
regulatory domains, but gains a range of activating factors, resulting in novel functions due to 
the constitutive activation of MLL. Thus it is proposed that MLL translocation partners act to 
change MLL into a permanent transcriptional activator (Zeisig et al., 2003), though recent 
analysis of MLL target genes suggest that the pattern of histone modification brought to 
MLL target genes by fusion proteins may lead to deregulation (Guenther et al., 2008; 
Krivtsov et al., 2008) 
Other MLL proteins are present in metazoans: four other MLL’s have been described in 
human, and three in mouse, but they remain poorly characterised. Members of the MLL 
family share a high degree of homology within the same species, but MLL proteins from 
human and mouse also share a high degree of homology (Figure 1.17). This is typically 
focused on the conserved domains (Figure 1.18). 
1.4.4.  MLL4 (KMT2D) 
Human MLL4 (MLL2, WBP7, HRX2, TRX2) was initially named MLL2, and is the second 
human homologue to the Drosophila trithorax gene to be described. The gene is located on 
the region 19q13.1 in human (Fitzgerald and Diaz, 1999) and displays a high degree of 
homology with MLL1 and contains the same conserved domains observed in MLL1 
(Huntsman, Chin et al., 1999). The observation that both proteins interact with similar 
factors, suggests there are overlapping functions between the two proteins (Huntsman, Chin 
et al., 1999). Human MLL4 is a 2,715 residue protein and like MLL1 contains three AT-hook 
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Figure 1.17: Human MLL HMTs  
Cladogram showing sequence alignment of human MLL proteins (alignment 
software: ClustalW2). Proteins with links to leukaemia (  ) and solid tumours (   ) 
are indicated. The equivalent mouse MLL homologues and their overall 
sequence conservation are indicated (http://services.uniprot.org). 
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Figure 1.18: MLL family 
proteins in human and 
mouse 
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domains, one CxxC motif, three PHD domains and a SET domain (Huntsman et al., 1999). In 
addition, the mouse protein contains a HMG binding motif, a domain found in a number of 
DNA and chromatin binding proteins. MLL4 is part of a similar protein complex to MLL1 
(including ASH2, RbBP5, and WDR5) (Hughes et al., 2004; Yokoyama, Wang et al., 2004), 
and also associates with menin (Hughes et al., 2004).  
In mouse, Mll4 knockdown leads to a reduction of cell growth and an increase of apoptosis in 
Mll4-/- ES cells, possibly because MLL4 contributes to Bcl2 expression, an anti-apoptotic 
gene (Lubitz et al., 2007). Furthermore, differentiation is delayed in Mll4-/- cells (Lubitz et al, 
2007). This suggests that Mll4 and Mll1 are involved in distinct mechanisms of development, 
and act to regulate different genes (Glaser et al., 2006). 
1.4.5.  Other MLL family members 
In total, five MLL family members have been identified in human (four in mouse) such that, 
in addition to MLL1 and MLL4, the MLL family is composed of MLL2, MLL3 and MLL5 
(MLL3 and MLL5 in mouse). All of these proteins share high sequence homologies, notably 
in shared specific motifs. In particular, all MLL family members display a SET domain 
located in their C-terminal region, except for MLL5, which has a N-terminal SET domain. 
MLL2 (or ALR) is a 5,262 residue protein containing a SET domain, PHD fingers and a 
HMG domain. The MLL2 gene maps to chromosome 12q12-13 (Prasad et al., 1997). MLL2 
knockdown experiments in Hela cells have been used to identify its target genes, many of 
which are implicated in development, cell adhesion, cytoskeleton organisation and 
transcriptional regulation. This is consistent with findings that MLL2 knockdown leads to a 
reduction of the migration capacity of HeLa cells (Issaeva et al., 2007).  
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The MLL3 gene maps to chromosome band 7q36, a region whose deletion is commonly 
found in malignant myeloid disorders (Ruault et al., 2002), and encodes for a predicted 
protein of 4,911 residues. As with MLL1, MLL3 is characterised by conserved protein 
domains, including; (1) the N-terminal domain carrying six PHD fingers, divided into two 
groups, (2) an HMG box, and (3) a C-terminal SET domain (Ruault et al., 2002; Brun, Gasca 
et al., 2006). 
MLL5 remains the least well-characterized MLL family member. The Mll5 gene was located  
to chromosome band 7q22 in a screen for candidate myeloid leukaemia tumor suppressor 
genes within this region in a mouse model (Emerling et al., 2002). Mll5 is highly conserved 
in mouse and human, and a small 1,858 residue protein, containing (1) a single PHD domain, 
and (2) a SET domain located in the N-terminal region of the protein, rather than at the C-
terminal as in MLL1. In contrast, it does not contain AT hooks (which suggests that MLL5 
might not bind DNA) nor a methyl-transferase homology domain, unlike other MLL family 
proteins. These domains are involved in the transforming ability of MLL fusion proteins 
(Slany et al., 1998; Deng et al., 2004), suggesting that MLL5 does not regulate transcription 
directly. It has been suggested that the MLL5 gene could contribute to leukemogenesis by 
haplo-insufficiency, as a single functional copy of MLL5 is not sufficient to maintain a wild-
type condition (Emerling et al., 2002). MLL5 has a role in haematopoiesis in mice, as mice 
deficient in Mll5 have more megakaryocyte-erythrocyte progenitors than granulocyte-
macrophage progenitors (Zhang et al., 2009). It has also been shown that a MLL5 over-
expression induces growth arrest in G1 phase (Deng et al., 2004).  
Thus, MLL histone methyl-transferases regulate gene transcription through multiple and 
cooperative mechanisms. To date, research has focused on MLL1 because of its role in the 
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disregulation of genes in leukaemia, but also for its involvement in Hox gene regulation 
during development. 
1.5. The contribution of Hox genes to differentiation 
1.5.1.  Hox genes  
Cell differentiation and organ development need to be tightly regulated and coordinated, and 
are controlled by a group of master regulatory genes. These genes, described as homeobox 
(Hox) genes, are highly conserved through evolution and encode DNA-binding transcription 
factors. Hox genes were first identified following observations made in mutants of the fruit 
fly Drosophila melanogaster (Lewis, 1978). For example, mutation of one of the ANT-C 
genes, Antennapedia (Antp), which is responsible for the identity of the second thoracic 
segment, leads to gross changes in body morphology. Failure to express this Hox gene 
properly results in the development of antennae instead of legs in the second thoracic 
segment, whereas its inappropriate expression in the eye-antennal imaginal disc leads to the 
production of legs instead of antennae (Struhl, 1981; Gehring, 1987). Similarly, mutants of 
the Hox gene Ultrabithorax (Ubx) are associated with the development of wings instead of 
halteres in the third thoracic segment. These changes were described as “homeotic 
tranformations”, and are associated with the conversion of a body segment to another one. In 
Drosophila, Hox genes are organised in two complexes of genes, associated with segments of 
the body axis: the first complex, called the Antennapedia complex (ANT-C), is constituted of 
five homeobox genes, labial (lab), Proboscipedia (Pb), Deformed (Dfd), Sex comb reduced 
(Scr) and Antennapedia (Antp). These genes are responsible for the establishment of the head 
and the first thoracic segment. The second complex, the Bithorax complex (BX-C)! (Lewis, 
1978), is composed of the genes Ultrabithorax (Ubx), abdominal-A (abd-A) and Abdominal-
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B (Abd-B), and are involved in the development of the second and third thoracic segments, 
and the abdominal segments.  
In mammals, Hox genes are composed of 39 genes, which are organised into four clusters (A-
D) (Figure 1.19) located on distinct chromosomes: on chromosomes 7, 17, 12 and 2 in human 
and on chromosomes 6, 11, 15 and 2 in the mouse, respectively. Each cluster is constituted of 
nine to eleven individual genes, corresponding to 13 paralogous groups: each cluster is 
composed of a specific combination of these genes, with none of them containing a complete 
set of paralogues. These clusters can be aligned with each other on the basis of sequence 
homology, as with the Drosophila HOM-C cluster.  
One of the more interesting observations on these gene clusters is the relationship between 
the relative position of Hox genes on chromosomes and the spatial gradient of Hox gene 
expression along the body axis; Hox genes positioned at the 3’ end of the locus are expressed 
earlier than Hox genes situated at the 5’ end (Krumlauf, 1994). In addition, in limb 
development, expression of Hox genes at the 3’ end of the locus was observed the proximal 
regions, while expression of Hox genes from the 5’ end was observed in distal regions 
(Lappin, Grier et al., 2006). Therefore, Hox gene arrangement follows a co-linear pattern, 
where expression of these key regulator genes shows a spatio-temporal pattern along the 
anterior-posterior body axis in mammals and insects during development (Lewis, 1978; 
Krumlauf, 1994; Lappin et al., 2006). These genes express transcription factors, and contain 
a highly conserved domain, the homeobox, which determines their DNA binding activity.  
1.5.2.  Long-term regulation of Hox genes 
Gene regulation is thought to be determined by a range of genetic and epigenetic mechanisms 
(Jaenisch and Bird, 2003; Jenuwein and Allis, 2001; Li, 2002). Histone modifications are 
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Figure 1.19: Hox gene clusters in Drosophila melanogaster and mouse 
(adapted from Carroll S. B., 1995) 
 In Drosophila, Hox genes are gouped in two clusters: the Antennapedia (ANT-
C) and the Bithorax (BX-C) complexes, Corresponding Hox genes are organised 
in four clusters in mammals (Hoxa, b, c and d), constituted of 13 paralogous 
groups. Hox genes are expressed following a spatio-temporal gradient along the 
anterior-posterior body axis, which is mirrored by their position on the 
chromosome. 
!!!
!!!!
?D!
involved in the ongoing regulation of gene transcription (Jenuwein and Allis, 2001) as part of 
the mechanism of short term regulation. However, another level of regulation ensures the 
long-term maintenance of gene expression, and ultimately its transmission through to the 
next generation of cells (Probst et al. 2009). These mechanisms include DNA methylation 
(Bird, 2002; Jaenisch and Bird, 2003) and the action of Trithorax and Polycomb group 
proteins, which appear to be key to Hox cluster regulation (Orlando and Paro, 1995; 
Soshinikova and Duboule, 2008). 
DNA methylation 
The mammalian mechanism of long-term cellular memory of gene expression pattern can be 
determined by DNA methylation (Sen et al., 2010), which corresponds to the addition of a 
methyl group to CpG dinucleotides in DNA. Vertebrate genomes are characterised by the 
presence of GC-rich regions with a high density of CpG dinucleotides at the promoter 
sequences of many genes (about 60% in human genes), termed CpG islands. During 
development, some CpG islands showed increased levels of methylation 
(“hypermethylation”), which is associated with promoter silencing. This methylation is, for 
example, involved in the process of X chromosome inactivation that occurs in the early 
embryo (Courtier et al., 1995). X-inactivation in female mammals can be mediated partly 
through DNA methylation of X-chromosome (Li, 2002). DNA methylation is also required 
for spematogenesis and has been suggested to regulate chromosome architecture (Li, 2002; 
Trasler, 2009). CpG islands can also in certain cases become hypermethylated in specific 
tissues, in permanent cell lines and in abnormal cells such as transformed cells (Bird, 2002).  
DNA methylation is maintained during replication by copying the parental-strand 
methylation in a semi-conservative mechanism (Li, 2002). This is performed by DNA 
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methyltransferase 1 (DNMT1) (Li, 2002). However, DNA methylation can be established de 
novo by two enzymes: DNMT3A and DNMT3B, in a mechanism which is linked to the 
deposition of H4R3 methylation, a mark involved in gene silencing (Zhao et al., 2009). This 
occurs mostly in early embryonic cells (Okano et al., 1999).  
It has been suggested that DNA methylation is a secondary event, acting to stabilise 
transcriptional repression on genes that are already silenced by other means, rather than 
acting to silence active promoters. Nevertheless, transcription repression by DNA 
methylation depends on the location and density of methyl-CpGs relative to the promoter. 
Typically it is associated with long-term repression, but methylation can also be reversed 
(Barreto et al., 2007). It has been proposed that histone modification, as determined by gene 
transcriptional activity, influences the level of DNA methylation. Thus, methyl-CpG sites 
could either prevent the binding of factors required for gene activation, or favour the 
recruitment of transcriptional repressor complexes containing HDAC activities (Bird, 2002; 
Fuks, 2005). For example, it has been shown that the PcG (Polycomb Group) protein EZH2 
leads to EZH2-target promoter methylation by recruiting DNA methyl-transferases (Vire et 
al., 2006). This is driven by complexes containing DNA methyl-binding proteins, the 
archetypal protein being MeCP2, which binds methyl CpG sites (Nan et al., 1993) and 
recruits histone deacetylases, such as Sin3/histone deacetylase co-repressor complex to 
targeted promoters, thereby mediating transcriptional silencing (Nan et al., 1998; Ng and 
Bird, 1999).  
Polycomb and Trithorax groups 
The long-term maintenance of gene expression can also be regulated by a specific group of 
proteins, which act to maintain genes in a transcriptional state once the initiating signals are 
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lost. These regulators are highly evolutionarily conserved, and form the polycomb (PcG) and 
trithorax group (trxG) families of proteins. These regulators were first identified in 
Drosophila, and constitute multiprotein complexes, which bind chromatin to modulate its 
conformation (Ringrose and Paro, 2004). PcG proteins maintain transcriptional repression, 
whereas trxG proteins maintain transcriptional activation through generations of cells 
(Ringrose and Paro, 2004). In Drosophila, two PcG complexes have been identified, PRC1 
and PRC2. PRC2 core complex is composed of the histone methyl-transferase E(Z) 
(Enhancer of zeste), SU(Z) (Suppressor of zeste) and ESC (Extra Sex Combs) (Muller et al., 
2002). PRC1 is primarly composed of four subunits; PC (Polycomb), PSC (Posterior Sex 
Combs), PH (Polyhomeotic), and dRing (an ubiquitin ligase) (Francis et al., 2001). 
Methylation of H3K27 is catalysed by the enzymatic subunit E(Z) of PRC2 (Muller et al., 
2002). This histone modification is then recognised by the PC chromodomain, which leads to 
the recruitment of PRC1 to chromatin (Cao et al., 2002). TrxG proteins have also been 
identified, like Brahma (BRM, corresponding to yeast SWI/SNF nucleosome-remodelling 
complex), and TAC1 (Trithorax Activating Complex 1). The BRM complex contains 
Brahma, Moira and OSA, whereas TAC1 contains TRX, CBP and an antiphosphatase Sbf1 
(Ringrose and Paro, 2004). These proteins have human homologues, like MLL1, which play 
similar regulatory roles. 
  
These two modes of transmission of gene expression patterns are essential in regulating Hox 
genes. They thus play a critical role in the correct regulation of genes and the generation of 
downstream mechanisms, such as cell differentiation. 
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1.5.3.  The Hox genes: Developmental role and regulation 
In addition to their role in the regulation of the anterior-posterior body axis of embryos, Hox 
genes are essential for the regulation of haematopoiesis. Haematopoietic stem cells (HSC) are 
multipotent cells, which have the capacity of self-renewal, but also to differentiate into 
different cell lineages (Iwasaki and Akashi, 2007). During haematopoiesis, stem cells can 
generate myeloid (granulocytes, monocytes, macrophages, erythrocytes, megakaryocytes and 
mast cells) or lymphoid (T, B and Natural killer cells) lineages, first giving rise to specific 
progenitor cells, which then develop into a variety of differentiated cell types (Iwasaki and 
Akashi, 2007) (Figure 1.20). Progenitor cells are grouped into distinct populations: common 
myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs), megakaryocyte-
erythrocyte progenitors (MEPs), common lymphoid progenitors (CLPs), and pro-T and pro-B 
cells (Terskikh et al., 2003). The cell fate decisions of HSC’s are dependent on a broad 
variety of factors, including the Hox genes. In mammals, Hox genes of the a, b and c clusters 
are expressed in subpopulations of haematopoietic cells (Sauvageau et al., 1994; Pineault et 
al., 2002). Loss of Hox genes (for example Hoxa5 (Fuller et al., 1999) or Hoxa9 (Izon et al., 
1998)) leads to defects of haematopoiesis. Interestingly, Hox genes are co-linearly down-
regulated upon differentiation, with Hox genes at the 3’ end of clusters being preferentially 
down-regulated at early stages, whereas Hox genes located in the 5’ region of clusters being 
down-regulated in later stages (Sauvageau et al., 1994).  
In addition to playing a role in global differentiation, specific Hox genes are key regulators of 
cell type determination. Indeed, expression of distinct Hoxa genes is specifically associated 
with cell type specific expression and with the stage of cell maturation. For example, HOXA5 
expression is proposed to influence cell identity: reduction of HOXA5 favours the generation 
or proliferation of erythroid progenitor cells (megakaryocytes and erythrocytes), whereas it is  
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Figure 1.20: Haematopoiesis and the different cell lineages (from Qasim W., 
Expert Reviews in Molecular Medicine, 2004) 
Bone marrow is composed of a range of cell types including haematopoietic 
stem cells (hSC) that can differentiate into different cell lineages. Multipotent 
hSCs can either self-renew or become common lymphoid or myeloid progenitor 
cells. The lymphoid lineage produces T cells, B cells, and NK cells (natural 
killer). The myeloid lineage produces erythrocytes, mast cells, megakaryocytes, 
neutrophils, monocytes and osteoclasts. 
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required for maturation and proliferation of myeloid progenitor cells (granulocytes and 
monocytes)! (Crooks et al., 1999; Fuller et al., 1999). Determination of cell fate is then 
maintained in the long-term by the DNA methylation of individual genes. In adult 
haematopoietic cells (but not in embryonic cells), HOXA5 CpG islands are hypermethylated, 
correlating with a loss of gene expression (Strathdee et al., 2007b). This observation was also 
made with Hoxa5 in mouse (Hershko et al., 2003). Hoxa4 has also been described as a gene 
required for cell type specificity. Hypermethylation of promoter CpG islands of Hoxa4 and 
Hoxa5 leads to repression of gene expression, and is associated with the progression of 
leukaemia (Strathdee et al., 2007a).  
Hoxa cluster regulation: Role of transcription factors 
Specific factors are involved in tissue- and developmental-specific gene regulation in order to 
determine cell-fate upon differentiation. Genes are thought to be mainly regulated at the 
transcriptional level, by the “basal” transcription machinery. The association of this complex 
with a specific gene requires the recruitment of a diversity of sequence-specific DNA-
binding transcription factors, transcriptional co-activators such as ATP-dependant chromatin 
remodellers (Clapier and Cairns, 2009), and the basal transcription machinery, which 
includes RNA polymerases (Campos and Reinberg, 2009; Martinez, 2001). ATP-dependent 
chromatinremodelling complexes such as SWI/SNF also contribute to the accessibility of 
chromatin to other factors (Mellor, 2005).  
This indicates that epigenetic factors, including Polycomb and Trithorax family members (as 
discussed), histone variants such as macroH2A (Buschbeck et al., 2009), and microRNAs 
contribute to the co-linear regulation observed on Hox gene clusters (Lemons and McGinnis, 
2006). However, the transcription factors contributing to this regulation remain relatively 
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unclear. Hox regulation appears to be determined by both inter-genic and “global” enhancers, 
which respond to a range of developmental signals (Dubole, 1998).  Retinoic acid response 
elements (RAREs) are found in many Hox genes, and exogenous retinoic acid addition is 
known to induce genes in the Hoxb cluster  (Roelen et al., 2002). These are found to regulate 
Hoxa1  (Dupe et al., 1997), as are estrogen response elements found to regulate HOXA10 in 
some cell types (Akbas et al., 2004).  Similarly YY1 (Hoxa11; Luke et al., 2006) and NF-!B 
(HOXA9; Trivedi et al., 2009) are known to mediate extracellular signals on multiple Hox 
genes, and are known to contribute to the regulation of individual HOXA genes. Interestingly, 
NF-kB has been found to interact with the H3S10p-specific histone kinase Msk1 (Reber et 
al., 2009), suggesting a potential mechanism to recruit this modification to these MLL target 
genes.  
Hoxa Regulation: Role of the MLL complex 
Consistent with the central role of Trithorax family members on Hox gene regulation (Yu et 
al., 1995), MLL1 is also required for haematopoiesis (Hess et al., 1997; Ernst et al., 2002), 
for the proper regulation of body segment identity and the positive regulation of Hox gene 
expression (Guenther et al., 2005). MLL1 is required for the maintenance of gene activity on 
some Hox genes, like Hoxa7, Hoxc8 (Yu et al., 1998) and Hoxa9, Hoxa10 (Ernst et al., 
2004b) but not for the initiation of these genes (Yu et al., 1998). Furthermore, Mll-/- cells are 
associated with a reduction of expression of some Hox genes and defects in haematopoiesis, 
which can be “rescued” by the re-expression of Hox genes (Ernst et al., 2004b). The MLL1-
dependent regulation of Hox genes was also described for some Hoxb and Hoxc cluster genes 
(Ernst et al., 2004b; Feinberg et al., 2006). In addition, Hox gene expression is abolished in 
Mll-/- embryos and over-expressed in leukemogenic cells (Yu et al., 1995; Milne et al., 2002; 
Ayton and Cleary, 2003). This arises as in normal cells haematopoiesis is associated with the 
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down-regulation of Hox genes, whereas in leukaemia, MLL1 is transformed into a permanent 
transcriptional activator, associated with the up-regulation of MLL target gene expression 
(Figure 1.21). For example, MLL fusion proteins induce disregulation of the HOXA9 gene by 
preventing its down regulation in differentiation.  
Altogether, this shows the critical interrelation between MLL and Hox gene regulation during 
haematopoiesis. The disregulation of these processes can lead to the development of 
abnormal cells. 
1.5.4.  MLL fusion proteins and acute myeloid leukaemia (AML) 
Metastatic cancers typically develop from normal cells via benign tumors. This process is 
typically associated with an accumulation of mutations in growth regulating genes leading to 
their aberrant expression. However, epigenetic mutations also play a central role in 
carcinogenesis: cancer cells are typically globally hypomethylated (Feinberg et al., 2006), 
but also show hypermethylation at tumor suppressor gene promoters associated with 
silencing and hypomethylation of oncogene promoters associated with inappropriate over-
expression of gene (Feinberg et al., 2006; Kristensen et al., 2009). A number of type of 
leukaemia are typically associated with specific chromosomal rearrangements, e.g. Acute 
Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML)! (Feinberg et al., 
2006). Frequently these translocations involve the mixed lineage leukaemia (MLL) gene on 
chromosome band 11q23, and the corresponding MLL rearrangements are present in almost 
all types of haematologic malignancies (Slany, 2005a). It has been shown that the 
translocation event, involving the splitting of the MLL coding region, alters the nature of the 
MLL transcript, in which the DNA sequence is either partly lost or is ligated to new material 
(Ziemin-Van Der Poel et al., 1991). Thus chromosomal rearrangements lead to the 
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Figure 1.21: Hox gene expression in normal cells and leukaemic cells 
In normal cells (a), differentiation is associated with the down regulation of the 
Hox genes and Meis1 expression, while in acute myeloid leukaemia (AML) (b) 
this down regulation is prevented by MLL fusion proteins. The cells do not 
differentiate and continue unregulated self-renewal. 
/P,!
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generation of novel oncogenic proteins, called fusion proteins, containing the amino-terminus 
of MLL fused with one of the 54 partner proteins (Gu et al., 1992; Tkachuk et al., 1992; 
Slany, 2009). Partners are diverse and include transcription factors like AF4 (Gu et al., 1992) 
and AF9 (Dobson et al., 1999), or histone acetyl-transferases such as CBP (Yokoyama and 
Cleary, 2008). MLL can also associate with another N-terminal region of MLL, generating 
MLL dimers (Slany, 2009). MLL fusion proteins lack the SET domain, the CBP-binding 
domain and the PHD finger domains, and compromise the balance between transcriptional 
activation and repression. Several genes are upregulated by MLL fusion proteins, including 
HOXA9 and the Hox co-factor MEIS1, found to be over-expressed in human leukaemias with 
MLL rearrangements (Zeisig et al., 2004; Feinberg, Ohlsson et al., 2006).  
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1.6. Aim of the study 
The aim of this study was to examine and understand how the histone methyl-transferase 
MLL1 and its core complex regulate gene expression. In order to assess the dynamic 
processes involved, we have developed a differentiation model to examine MLL target gene 
regulation at genes that show differentiation-induced changes in transcriptional activity.  
Our initial studies characterise “epigenetic” events on MLL target genes during 
differentiation. MLL1 targets a broad number of genes, but we chose to characterise histone 
modifications on the Hoxa cluster genes as these are well studied due to their key 
contribution to differentiation process. Then, we aimed to understand the underlying 
regulation of these events by characterising the binding of the proteins associated with 
depositing of these histone modifications, and thus contributing to the regulation of Hoxa 
genes activity upon differentiation.  
Finally we aimed to assess the contribution of the MLL complex to these events by using 
siRNA technology to induce a MLL knockdown, to characterise the changes in histone 
modification in the absence of the MLL complex.  
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2. MATERIALS AND METHODS 
2.1. Cell culture 
2.1.1.  HPC-7 cells 
As a model, HPC-7, an immortalised Mouse Embryonic Stem Cell (ESC-like) line was used. 
This cell line was generated by expressing the LIM-homeobox gene Lhx2 in Haematopoietic 
Progenitor Cells (HPCs), derived from embryonic stem cells differentiated in vitro, and was 
established by the Carlsson Lab (Karolinska Institute, Sweden)!(Pinto Do et al., 1998; Pinto 
Do et al., 2002; Richter et al., 2006). Lhx2 is a transcription factor involved in asymmetric 
cell division, tissue specification and differentiation of specific cell types. HPC-7 cells have 
the capacity to differentiate into several different cell types, notably into megakaryocytes, 
using thrombopoietin.  
Cells were grown in “HPC-7 Growth Medium”. Cells were maintained at 1x106 per ml in 
growth medium with 1/10 CHO/SCF conditioned medium. Cells were split every two days. 
The CHO/SCF conditioned medium was obtained from cultivated CHO cells.  
HPC-7 Growth Medium: Invitrogen StemPro-34 SFM medium, supplemented with 
StemPro-34 Nutrient Supplement (Invitrogen), 1/100 penicillin (10,000 U/ml)/ streptomycin 
(10,000 !l/ml), 1/100 L-glutamine (200 mM) (Invitrogen) and 1/10 CHO/SCF conditioned 
medium 
2.1.2.  CHO cells and CHO conditioned medium 
CHO (Chinese Hamster Ovary) cells were kept in DMEM, 10% FBS (Foetal Bovine Serum), 
1/100 penicillin/streptomycin (Invitrogen), and 1/100 L-glutamine (Invitrogen), until 
confluence. Cells were expanded three-fold as follows: CHO cells were washed with DMEM 
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and then resuspended with 5ml 0.05% Trypsin-EDTA (Invitrogen). After five minutes at 
37°C, trypsination was stopped by adding 25ml of DMEM, 10% FBS. Cells were split into 
three flasks, and the same volume of DMEM, 10% FBS medium with supplements was 
added. CHO cells were maintained at 37°C until confluence, then left for two more days at 
37°C. The cells were then pelleted and resuspended in StemPro-34, 0.5% FBS, 1/100 
penicillin/streptomycin, 1/100 L-glutamine final concentrations, which was repeated the 
following day. The cells were then left for two days at 37°C before the medium was 
collected, filtered (0.45!m filter) and aliquoted. The medium collected is subsequently called 
“CHO/SCF conditioned medium”. Aliquots were kept at -20°C. 
2.1.3.  HPC-7 cells differentiation to megakaryocytes 
HPC-7 cells differentiate into megakaryocytes in the presence of thrombopoietin (TPO) over 
six days. The differentiation was achieved in 75 cm3 flasks, with 20x106 cells in 20ml HPC-7 
Growth Medium seeded per flask. On the initial day, 1/50 CHO/SCF conditioned medium 
and 100ng/ml murine rTPO (recombinant ThromboPOietin) (PrePro Tech) were added. Cells 
were expanded two-fold on day two. On day three, the medium was changed to HPC-7 
Growth Medium, 1/100 CHO/SCF conditioned medium and 100 ng/ml rTPO. On day five, 
the medium was changed to HPC-7 Growth Medium, 1/200 CHO/SCF conditioned medium 
and 100ng/ml rTPO. The cells were collected on day six, washed twice with cold Phosphate 
Buffer Saline (PBS), including the histone deacetylase inhibitor (HDACi) sodium butyrate 
(0.5mM), and the phosphatase inhibitor okadaic acid (100!M) where cells were used to 
examine histone marks. A first Bovine Serum Albumin (BSA) gradient (3% BSA overlaid 
with 1.5% BSA) was prepared to separate the megakaryocytes (bigger and heavier than 
undifferentiated HPC-7 cells) from undifferentiated cells. Again, the PBS/BSA gradient was 
supplemented with 0.5mM sodium butyrate and 100!M okadaic acid to prevent the loss of 
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histone marks. The separation in the BSA gradient was performed on ice for two hours. 
Then, the bottom 1ml was pelleted and washed with cold PBS, or cold PBS/butyrate/okadaic 
Acid before performing a second BSA gradient separation to ensure only megakaryocytes are 
retained. The cells were finally washed with cold PBS or cold PBS/butyrate/okadaic Acid 
and used or stored at -80°C. 
2.1.4.  SL2 cells 
Carrier chromatin immunoprecipitation requires a cell type from a species different to HPC-7 
as a carrier. Drosophila SL2 (Schneider line-2) cells were cultured in Schneider’s medium 
supplemented with 8% foetal calf serum (FCS, Gibco) and antibiotics (1/100 
penicillin/streptomycin, Gibco). Drosophila cells were kept incubated at 26°C. Cells were 
washed, pelleted and kept frozen at -80°C for subsequent C-ChIP experiments.  
2.2. Protein analysis 
2.2.1.  Isolation of proteins from HPC-7 cells 
Proteins were extracted from HPC-7 cells (2x107) using a whole cell extract lysis buffer. 
Cells were washed three times with ice-cold PBS and pelleted. 75!l Lysis buffer was added 
per ependorf tube for 30 minutes, with the tubes kept on ice. Cells were then spun down at 
13,000 rpm for 10 minutes at 4°C. The protein concentration was quantified using Coomassie 
Plus ™ Protein Assay Reagent (Thermo Scientific) at 595 nm.  
Whole Cell Lysis Buffer: 20mM Tris-HCl pH7.4, 100mM EDTA, 10mM NaCl, 1% Triton 
X-100, 1mM NaF, 1 mM ß-glycerophosphate, 1mM EGTA, 5mM sodium pyrophosphate, 
Protease cocktail inhibitors (Roche) 
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2.2.2. Isolation of histones from HPC-7 cells 
Changes in histone modifications in undifferentiated HPC-7 cells and megakaryocytes were 
assessed using histone extraction. Cells from both cell types were pelleted and washed twice 
with cold PBS containing a final concentration of 5mM sodium "-butyrate and 100!M 
okadaic Acid.  
Megakaryocytes were separated from undifferentiated HPC7 cells on two BSA gradients 
(1.5-3% BSA in cold PBS with 5mM butyrate and 100!M okadaic Acid). The usual method 
to isolate histones is to perform an acid extraction. 
• Histone extraction with 0.4M HCl 
HPC-7 cells were washed into cold PBS/5 mM butyrate/100 !M okadaic Acid and then 
pelleted. Then megakaryocytes pellets were resuspended in 1ml Triton Extraction Buffer 
(TEB) whilst pellets from undifferentiated HPC-7 cells were resuspended in 4ml of the same 
buffer and incubated for 10 minutes on ice. Samples were spun at 2,000 rpm for 10 minutes. 
The pellets were subsequently resuspended in half the initial volume of TEB and then spun 
again at 2,000 rpm for another 10 minutes. 500!l of 0.4M HCl was finally added per tubes, 
which were left for three hours on ice. After extraction, the tubes were centrifuged at 4°C and 
supernatants were retained. 
TEB: 4mM Na-"-butyrate, 0.5% Triton X-100, 2mM PMSF, 0.02% Na-Azide in PBS 
• Extraction with 5% perchloric acid (PCA) (Linker histone extraction)  
Linker histones were extracted from cell pellets according to the protocol developed by 
Paulson et al. (Paulson, Ciesielski et al., 1994). Cells were chilled on ice, pelleted, washed 
with cold PBS/5mM butyrate. 300!l of 5% Perchloric Acid was used to resuspend the 
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pellets, which were left 15 minutes on ice in order to extract linker histones. After an initial 
centrifugation for 10 minutes at 13,000 rpm (4°C), 100!l of 100% Trichloroacetic Acid 
(TCA) was added to the supernatant, to precipitate the proteins extracted. This was 
performed on ice for 35 minutes. The extracts were pelleted (13,000 rpm of centrifugation at 
4°C for 10 minutes) and finally washed gently and briefly twice with acetone. The pellets 
were dried and resuspended into 50 !l of 1mM HCl.  
Once the proteins have been quantified, half a volume of 2x Sodium Dodecyl Sulfate (SDS) 
loading buffer was added. The proteins were denatured by adding the tubes at 95°C for 5 
minutes. The samples were loaded on a 15% SDS gel to visualize them.  
2.2.3.  Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and gel 
transfer 
Proteins were separated according to size following the method developed by Laemmli 
(Laemmli, 1970). The samples were loaded on an acrylamide gel whose concentration 
depends on the size of the proteins to be separated. A 15% SDS gel is prepared for separating 
histones (9-15 kDa) while a 7% SDS gel is prepared to examine MLL (The C-terminal 
domain of MLL1 is 180 kDa). The resolving gel was overlaid with a few drops of water-
saturated isobutanol to prevent evaporation during polymerisation. Isobutanol was 
thoroughly washed away with distilled water before addition of the stacking gel. Protein 
samples were incubated at 95°C for 5 minutes and loaded onto the gel through SDS reservoir 
buffer. The gel was electrophoresed at 400V, 40mA and 20W, for three to five hours 
depending on the size of the proteins of interest, in a standard vertical electrophoresis unit 
(Hoefer “SE 600 Ruby”, Amersham).  
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Proteins separated were then transferred (as described (Towbin et al., 1979) onto a Hybond C 
nitrocellulose membranes (Amersham) for three hours (180V/300mA/20W) in a Bio-Rad 
TransBlot Cell through transfer buffer. The efficiency of transfer was checked by soaking the 
membrane in Ponceau Red. The membrane was then incubated for one hour or overnight at 
4˚C in a Blocking Buffer in order to prevent non-specific antibody binding. The membrane 
can also be stored in PBS/0.1% Tween.  
Resolving gel for histones (15%): 15% Bis-acrylamide (30% Acrylamide-0.8% Bis), 250!M 
Tris-HCl pH8.8, 300!l 10%SDS, 100!l 10% APS (Ammonium Persulfate) and 30!l 
TEMED made up to 30ml with distilled water 
Stacking gel: 1ml 30% Acrylamide-1.6% Bis, 250!l Tris-HCl pH6.8, 100 !l 10% SDS, 
100!l 10% APS and 10!l TEMED made up to 10ml with distilled water 
SDS reservoir buffer: 50mM Tris, 0.384M glycine, 0.1% SDS 
Blocking buffer: 10% dried milk powder, PBS/0.1% Tween-20 
Transfer buffer: 25mM Tris, 192mM glycine, 20% methanol 
2.2.4.  Western blotting 
Antibodies were obtained from commercial and in-house sources. The membrane was then 
incubated with a first antibody (rabbit or mouse) diluted in PBS-0.1%Tween, with 5% milk: 
H3K4me1 (204) 1/400-fold dilution, H3K4me2 (R148) 1/400-fold dilution, H3K4me3 (612) 
1/2,000-fold dilution, H3S10p (Ab12181, AbCam) 1/1,000-fold dilution, H4K8ac (R228) 
1/1,000-fold dilution, H4K16ac (R252) 1/1,000-fold dilution, H3T3p (Ab17352, AbCam) 
1/20-fold dilution, rabbit polyclonal ß-actin (Ab8227, AbCam), Msk1 (Ab32190, AbCam) 
1/750-fold dilution, KAT3A/CBP (Ab3652, AbCam) 1/200 fold dilution, NF!B/p65 
(Ab7970, AbCam) 1/1,000 fold dilution, menin (Ab2605, AbCam) 1/2,000-fold dilution for 
1-2 hours or overnight at 4°C, and the mouse monoclonal MLLC/HRX (clone 9-12, Upstate) 
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1/200-fold dilution, H3K4me3 (184) 1/400-fold dilution, H3K9me3 (Ab8898-100, AbCam) 
1/500-fold dilution overnight at 4˚C. The membrane was washed twice with PBS/0.1% 
Tween and once with PBS/0.1%Tween/5% dried milk (15 minutes each). The secondary 
antibody (Anti-rabbit, Li-cor 1/5,000-fold dilution or goat anti-mouse HRP IgG peroxidase 
conjugate, A4416, Sigma, 1/2,000-fold dilution) was then added. The membrane was washed 
twice (10 minutes each) with PBS/0.1% Tween. Binding was either visualised by using the 
“Odyssey” (Li-cor) imaging system, or by ECL western Blotting detection reagents 
(Amersham) and then exposing the membrane to autoradiography film (Amersham) for 30 
seconds to 30 minutes. Histone loading was typically normalised using an antibody raised 
against the C-terminal of histone H3 (AbCam), a domain with no known histone 
modifications. 
2.2.5.  Validation of antibody specificity 
All histone-modification specific antibodies were assessed for specificity prior to use. In-
house generated antibodies (i.e. H3K4me1, me2, and me3, H4K8ac) were assessed by 
competitive ELISA assays, in which the antibody of interest was bound to immobilised 
tissue-culture derived histones, and the interaction challenged by histone peptides containing 
or lacking the appropriate modifications. These assays were performed by first coating a 
microtitre plate with 50!l histones (10!g/mL) per well, which were left overnight to bind. 
These were removed, the wells washed with 2x PBS, and blocked with 1% BSA/PBS 
(“blocker”, 4°C, 60 min.), prior to washing with 1x PBS. Peptide dilutions are prepared with 
PBS and 0.2mM 2mercaptoethanol (fresh). A serial dilution of the test antibody is generated 
with blocker buffer (in the range 10!g/ml to 0.31!g/ml), and 50!l/well incubated at 4°C (60 
min.). In each well are deposited either the blocker, 100!l of antibody completed with 100!l 
of blocker or 100!l of appropriate peptide dilution completed with 100!l of antibody. The 
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well is subsequently washed twice with PBS/1M NaCl, PBS-Tween (0.1%) and PBS. The 
secondary antibody (1/1000) is then applied at 50!l/well, and incubated for 60 minutes at 
room temperature, prior to washing twice with PBS and four times with ddH2O, before 
applying the substrate (100!l/well) and left for 10 minutes. The reaction is terminated by 
addition of 5% H2SO4 (100µl/well). The plate is then read. 
In contrast commercial histone modification specific antibodies were screened using two 
approaches. We initially ascertained that the antibodies recognised the correct histone by 
Western blotting when probing tissue culture cell-derived histones (K. Nightingale, personal 
communication). A second screen used an in-house generated histone peptide microarray, in 
which 183 modified histone peptides are spotted on glass slides, including a range of peptides 
containing H3K27me, H3K9acS10p, and peptides containing multiple adjacent modifications 
(i.e H3K9ac, H3S10p etc.). This substate is probed by standard Western blotting conditions 
(with the exception that wash steps are higher stringency than required in Western blotting 
(1x PBS, 0.1% Tween, 1M NaCl). Primary antibody binding was detected by fluorescent-
labelled anti-mouse IgG (800nm, Licor), using an “Oddyssey” scanner (Licor). Antibodies 
against non-histone proteins (i.e. Menin, MLL-C, etc) were assessed by Western blotting of 
HPC-7 - derived nuclear extracts, to ensure a single band of the correct molecular weight was 
detected.   
2.2.6.  Acid-Urea-Triton (AUT) polyacrylamide electrophoresis 
In order to characterise the degree of modification of histones, proteins were separated on an 
AUT-PAGE according to their charge, as described (Bonner et al., 1980). Gel solutions were 
degassed before addition of 500!l Triton X-100, 150!l TEMED and 2ml 0.0004% riboflavin 
per 30ml gel solution and photopolymerised in front of a 2 X 15 W light source. The 
resolving gel was overlaid with a few drops of water-saturated isobutanol to prevent 
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evaporation during polymerisation. Isobutanol was washed off the resolving gel thoroughly 
with distilled water before addition of the stacking gel. It was degassed before addition of 
100!l TEMED and 700!l 0.0004% riboflavin per 10ml gel solution. Photo-polymerisation 
was carried out as for the resolving gel.  
Resolving gel: 12% acrylamide, 0.32% N,N-bis-acrylamide, 8M urea, 1M glacial acetic acid 
and 0.05M ammonia 
Stacking gel: 4% acrylamide, 0.21% bis-acrylamide, 8M urea, 1M glacial acetic acid and 
0.15M ammonia 
Protein samples were prepared for AUT-PAGE as following: 
1 volume of protein sample (20-50!g) was mixed with 2 volumes of AUT-loading buffer, 
vortexed and spun down at 13,000 rpm for 15 minutes, before loading through AUT reservoir 
buffer. Gels were run for 15 hours at 150V, 30mA, 10W at 10°C using reversed polarity. 
AUT-loading buffer: 8M urea, 5% ß-mercaptoethanol, 1M glacial acetic acid, completed 
with a few drops of tracking dye pyroninY 
AUT-reservoir buffer: 1M glycine, 0.1M glacial acetic acid 
2.2.7.  Coomassie blue and silver staining 
Proteins were revealed by staining the gel with Coomassie brilliant blue, for half an hour. 
After destaining in several baths of 30% methanol/ 10% acetic acid, the gel was soaked in 
50% methanol overnight to remove all of the remaining Coomassie blue stain. A more 
accurate and sensitive method to detect proteins is silver staining, achieved after overnight 
incubation with 50% methanol.  
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A first “Solution A” was prepared with 0.4g of silver nitrate in 2ml of water. 10.5ml of 
0.36% sodium hydroxide (NaOH) was mixed with 800µl of 14.8M ammonium hydroxide 
(NH4OH), which constitutes Solution B. Solution A was added to Solution A drop by drop 
with constant mixing. The silver nitrate must be totally dissolved. Then the solution was 
made up to 50ml with water. The gel was stained in this final solution for 15 minutes with 
gentle agitation, and then washed 5 minutes with water. The developing solution (2.5ml citric 
acid, 50µl 38% formaldehyde made up to 500 ml water) was added until bands were visible. 
After washing the gel with water, the reaction was stopped with 45% methanol/10% acetic 
acid solution. The gel was finally stored in 50% methanol.  
2.2.8.  Immuno-microscopy of histone distributions 
The distribution of histone modifications in undifferentiated HPC-7 cells, HPC-7-derived 
megakaryocytes, and mouse bone-marrow-derived megakaryocytes (a gift from Dr. S. 
Watson, University of Birmingham) were examined by immunofluorescence microscopy 
using a standard protocol including a crosslinking/fixing step.  
Briefly, cells are harvested at 1,000rpm (10 min, 4°C), and washed twice with PBS. 2x105 
cells/ml are resuspended in 0.1M KCl and incubated for 10 minutes at room temperature. 
Cells were mounted on glass slides (VWR 1.0-1.2mm thick, ethanol washed) with a Shandon 
Cytospin 4. 4x104 cells are added per chamber and spun down at 1,500 rpm, 10 min. The 
location of cells weas marked and the slide immersed in KCM buffer (10 min, RT). Primary 
antibodies were made up in KCM/0.1% BSA and 50!l applied per slide, this was covered 
with Parafilm, and incubated (60 min) in a humid chamber at 4°C. Slides are washed twice 
with KCM for 10 minutes. 50!l FITC-conjugated secondary antibody (Goat anti-rabbit FITC 
x50 dilution, Sigma) is applied and incubated for one hour at 4°C in a humid chamber. Slides 
were washed twice with KCM (10 min.), fixed in 4% (v/v) formaldehyde/KCM (10 min.), 
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briefly washed with distilled water, and mounted in 7.25!l DAPI (1!g/ml, Sigma) in 
Vectorshield (Vector Labs) prior to analysis. 
In-house generated antibodies have been examined for their specificity in the procedure by 
competition using histone tail peptides either containing or lacking the appropriate 
modification (Dr. L.O’Neill, Uni. Birmingham, personal communication).  
2.3. Native and Carrier chromatin immunoprecipitation (Amended by 
Turner’s group) 
To examine the pattern of epigenetic marks on specific genes, in undifferentiated cells and 
megakaryocytes, two different chromatin immunoprecipitation protocols were used. Because 
of the limited amount of cells, the examination of histone marks in differentiated HPC-7 cells 
used the Carrier-Chromatin Immunoprecipitation (C-ChIP) protocol (Figure 2.1)!(O'Neill et 
al., 2006), while the examination of histone marks in undifferentiated cells used the Native-
Chromatin immunoprecipitation (N-ChIP) protocol. 
2.3.1.  Chromatin isolation from SL2/HPC-7 cells 
For the carrier chromatin immunoprecipitation (C-ChIP) procedure, HPC-7 cells were mixed 
with Drosophila SL2 cells. Drosophila SL2 cells were pelleted and washed three times with 
ice-cold PBS, 5mM butyrate. Cells were resuspended to 5x107 cells/ml and a 1ml aliquot was 
mixed with 105 megakaryocytes.  
2.3.2.  Chromatin preparation for C-ChIP 
HPC-7 cells (8 flasks of 20ml, generating about 105 cells) were differentiated before use in 
the C-ChIP following the differentiation protocol (see paragraph 2.1.3 above). The cell pellet 
was resuspended into 400µl of NB buffer and 100µl was added to each aliquot (4) of frozen 
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Figure 2.1: Carrier Chromatin Immunoprecipitation  
 Cartoon of step in C-ChIP protocol. 
!!!
!!!!
JF!
SL2 cells (5x107). Then each fraction (about 2.5x104 cells) was made up to 1ml with NB 
buffer. The cells (HPC-7 / SL2 / NB buffer) were then transferred into 7ml bijou tubes 
containing 1mL of NB buffer/1%, tween 40 and kept on ice. 10µl of PMSF was added prior 
to stirring the samples on ice for 15 minutes. Each sample was kept separated and put into a 
different ice-cold Dounce homogeniser. Five strokes were given with a tight pestle (“A”), 
twice. In should be noted that chromatin release could not be checked by microscopy at this 
stage, due to the high amount of debris generated by frozen SL2 cells. However, the yield of 
chromatin obtained was subsequently checked and optimised by carefully following this 
protocol. Then, the samples were transferred to 50ml Falcon tubes and spun down for 15 
minutes, at 800g, 4˚C. The supernatant was removed and the pellets were dislodged before 
being resuspended in 10mL of 5% sucrose/ NB buffer. At this step, the nuclei (pellet) must be 
white and a thin layer. The pellets were spun down at 3,000 rpm, for 10 minutes at 4˚C, 
dislodged and then resuspended into 2 ml of digestion buffer. The quantity of chromatin was 
checked by spectrophotometer (260nm, 280nm and 260/280 ratio) (Ultrospec 2100 pro 
UV/Visible) by adding 20µl of each sample to 300µl of 0.1% SDS. The chromatin pellets 
were spun down at 2,000 rpm for 10 minutes at 4˚C, and resuspended in digestion buffer in 
order to obtain a final concentration of 500µg chromatin per ml. 1ml of each sample was 
digested with 50U (10U/µl) of Micrococcal nuclease (Amersham Biosciences), at 28˚C for 5 
minutes. The reaction was then stopped on ice by adding 0.1M EDTA. The samples were 
spun down at 13,000 rpm for 10 minutes at 4˚C. The supernatants were collected (S1 
fraction) and kept in the fridge. The pellets were resuspended into 500µl of lysis buffer. 
Samples were put into dialysis membrane (Dialysis Tubing Cellulose Membrane, Sigma-
Aldrich), and dialysed into Lysis buffer overnight. Each sample were transferred into 
individual ependorf tubes and spun down at 13,000 rpm, for 10 minutes at 4˚C. Supernatants 
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were kept (S2 fractions). The pellets were dislodged and resuspended into 200µl of lysis 
buffer. The quality of the chromatin was checked again with the spectrometer as before and 
by running a 1.2% agarose gel with 2µg of each sample. The S1 and S2 fractions were then 
pooled.  
NB Buffer: 15mM Tris-HCl pH 7.4, 60mM KCl, 15mM NaCl, 5mM MgCl2, 0.1mM EGTA, 
0.5mM ß-mercaptoethanol, 0.1 mM PMSF, 5mM Na-Butyrate 
Digestion Buffer: 0.32M Sucrose, 50mM Tris-HCl pH 7.4, 4mM MgCl2, 1mM CaCl2, 
0.1mM PMSF, 5mM Na-Butyrate 
Lysis Buffer: 1mM Tris-HCl pH7.4, 0.2mM EDTA, 5mM Na-Butyrate, 0.2mM PMSF, 
protease cocktail inhibitors (Roche) 
2.3.3.  Chromatin preparation for N-ChIP 
The N-ChIP protocol was used on undifferentiated HPC-7 cells. This protocol is similar to 
the C-ChIP protocol.  
1x108 cells were harvested and washed three times with ice-cold PBS, 5mM Na-Butyrate. 
The cell pellet was then resuspended into 5ml ice-cold TBS with 0.02mM PMSF. 5 ml of 1% 
ice-cold Tween 40 / TBS, protease inhibitors (Roche) and PMSF, was added. The samples 
were stirred on ice for 25 minutes. The lysate was transferred into an ice-cold Dounce 
homogeniser. Homogenisation was performed by giving 5 strokes with the tight “A” Pestle. 
Nuclei release was checked under microscope before carrying on with the preparation. 
Homogenates were pooled and centrifuged at 2,000 rpm for 20 minutes at 4˚C. A white pellet 
was obtained, corresponding to the nuclei. Pellets were first dislodged, and then washed in 10 
ml 25% sucrose / TBS and centrifuged at 3,000 rpm for 10 minutes at 4˚C. Pellets were then 
resuspended in 5ml of Digestion Buffer (see before: C-ChIP), quantified by optical density 
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(260 nm) and then centrifuged at 2,000 rpm for 10 minutes at 4˚C. Pellets were dislodged and 
resuspended in Digestion Buffer in order to obtain a 0.5mg/ml final chromatin concentration. 
As with the C-ChIP protocol, the quality of the chromatin was checked with the spectrometer 
as before and by running a 1.2% agarose gel with 2 µg of each sample (Figure 2.2). From this 
point, the protocol follows the C-ChIP protocol. After DNA precipitation, the pellets were 
resuspended in 250µl of water.  
TBS Buffer: 15mM NaCl, 10mM Tris-HCl pH7.5, 3mM CaCl2, 2mM MgCl2, 5mM Na-
butyrate 
2.3.4.  Chromatin immunoprecipitation and DNA extraction 
Immunoprecipitations were performed with about 75µg of chromatin in a volume of up to 
1.3ml of antibody and incubation buffer or (15µl) Pre-Immune serum and incubation buffer. 
(Antibodies used: 100µl of H3K4me3 (Lab 612), H3K9me2 (616), H3K9ac (607), H4K16ac 
(252), or 15µl of H3K27me3 (07-449, Upstate), H3K9acS10p (Ab12181, AbCam)). The 
immunoprecipitation was performed at 4˚C overnight on a rotating wheel. 200µl of protein A 
Sepharose$ CL-4B (GE Healthcare) was added to each ependorf containing samples. Then 
the tubes were put on a high speed rotating wheel for three hours at room temperature. From 
this step, only siliconised tubes and pipettes were used. 15ml siliconised tubes were prepared 
with 9ml of buffer B. After incubation with the beads, the samples were spun down at 13,000 
rpm for 10 minutes. The supernatants were kept (and labelled “Unbound Fraction”) and 
transferred to siliconised tubes for protein extraction. The beads were resuspended into 1mL 
of buffer B and transferred into siliconised tubes with the 9ml of buffer B. The beads were 
spun down at 2,000 rpm for 10 minutes at 4˚C, then washed with 10ml of buffer C, then with 
10mL of buffer C*. The beads were finally resuspended into 1ml of buffer C* and transferred
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Figure 2.2: Chromatin analysis prior to N-ChIP 
The chromatin extracted was treated with miccrococcal nuclease in order to 
obtain fragments of an appropriate size (mono, di, tri nucleosomes, etc) before 
performing the immunoprecipitation. S1 is the supernatant generated after 
centrifugation of digested chromatin (see Materials and methods), whereas S2 is 
the supernatant of pelleted chromatin after over-night dialysis. The quality of the 
chromatin was examined on a 1.2% agarose gel and visualised with ethidium 
bromide. S1 (lane 1-3) and S2 (lane 5-7) 
MW= a molecular weigh marker 
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into a 1.5ml siliconised ependorf tubes and spun down at 13,000 rpm for 10 minutes. The 
beads were resuspended into 250µl of incubation buffer / SDS 1% left for 15 minutes on a 
high speed rotating wheel at room temperature, before being spun down at 13,000 rpm for 10 
minutes. Supernatants were kept in siliconised tubes while the chromatin was again eluted 
from the beads in the same way. Supernatants from these two elutions were then pooled. 
500µl of incubation buffer was added to each pool and transferred into 5ml siliconised tubes 
(labelled “Unbound fractions”). A Phenol-Chloroform extraction was then performed on the 
Bound and Unbound fractions to extract the DNA. DNA was precipitated with 5µl glycogen 
(Roche), 80µl of 5M LiCl and cold ethanol up to 4ml in a polypropylene tube. Proteins were 
precipitated with 4µl of 10 M H2SO4, 20µl of 1mg/mL BSA and cold acetone up to 4ml. 
Precipitations were performed overnight at -20˚C. DNA from Bound and Unbound fractions 
was spun down at 3,000 rpm 20 minutes at 4˚C, and the supernatants discarded. The pellets 
were dried and resuspended into 120µl of water. DNA was quantified using a Nanodrop® 
ND-1000 spectrometer.  
Incubation Buffer: 75mM NaCl, 20mM Tris-HCl pH7.5, 20mM Na-Butyrate, 5mM 
Na2EDTA, 0.1mM PMSF fresh 
Buffer B: 50mM Tris-HCl pH7.5, 10mM EDTA, 100mM NaCl, 5mM Butyrate 
Buffer C: 50mM Tris-HCl pH7.5, 10mM EDTA, 150mM NaCl, 5mM Butyrate 
Buffer C*: 50mM Tris-HCl pH7.5, 10mM EDTA, 175mM NaCl, 5mM Butyrate 
PCR analysis of immunoprecipitated material was performed with 10ng of DNA, on 384-
well plates, on the ABI-7900 PCR machine. Only bound fractions were used for analysis. In 
order to normalise the data, Bound fractions obtained after immunoprecipitation of the 
chromatin with the pre-immune IgG, were used as an input. A new input was made for every 
ChIP.  
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2.4. Formaldehyde Cross-linking Chromatin Immunoprecipitation 
In order to detect the distribution of MLL complex components on loci in the Hoxa gene 
cluster and other target genes, X-ChIP (Cross-linked Chromatin Immuno-Precipitation) was 
performed. This protocol has been adapted from an AbCam protocol, initially used in the 
Kouzaride lab (Cambridge University) (Figure 2.3). 
2.4.1.  Chromatin preparation 
5x106 undifferentiated cells were pelleted and resuspended in a final concentration of 0.75% 
formaldehyde was immediately added for 10 minutes at room temperature and gently mixed. 
Cross-linking was stopped by the addition of glycine (1 M) to a 0.125 M final concentration. 
The cells were then washed twice with ice-cold PBS, and spun down at 1,200 rpm, 5 min at 
4˚C. A final wash was performed with 1ml PBS per 107 cells. The cells were split into 
siliconised ependorf tubes, with 107 cells per tube. They were then resuspended in 1ml of 
lysis buffer, and divided into three siliconised ependorf tubes. The samples were sonicated at 
medium power for 8 min with 30 seconds On-Off (Bioruptor, Diagenode), and then quickly 
centrifuged at 13,000 rpm. The supernatant fractions were pooled, and 50µl samples were 
kept (labelled “Input”). 400µl of lysis buffer and 5 µl of proteinase K (20 mg/ml) were added 
to the input. The crosslinking was reversed by incubation at 65˚C overnight, while the 
remaining chromatin was kept at 4˚C. DNA from the input was then extracted by phenol-
chloroform and quantified. The sonicated chromatin was checked by loading 10 µl of the 
input on a 1.2 % agarose gel (Figure 2.4).  
Lysis Buffer: 1% SDS, 10mM EDTA, 50mM Tris-HCl pH8, protease cocktail inhibitors 
(Roche
!!!
!!!!
JK!
 
 
 
 
Figure 2.3: Cross-Linking Chromatin Immunoprecipitation  
 Cartoon of steps in X-ChIP protocol. 
!!!
!!!!
KD!
 
 
 
 
Figure 2.4: Assessment of cross-linked chromatin 
The chromatin extracted was sonicated in order to obtain fragments of the 
appropriate size (between 200 and 700 bp) before performing the 
immunoprecipitation. The quality of the chromatin was examined on a 1.2% 
agarose gel, and visualised by ethidium bromide. MW= molecular weigh 
markers, Ch= chromatin. 
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2.4.2.  Chromatin Immunoprecipitation 
The chromatin was prepared with the dilution buffer up to 1 ml into a siliconised ependorf 
tube. Each fraction contains 25µg chromatin. Two controls were prepared: a fraction with no 
antibody and another one containing 10µl of Pre-Immune serum. Antibodies were added to 
the fractions: H3 C-terminal (Ab1791, AbCam) 1/100 as a positive control, the mouse 
monoclonal MLLC/HRX (clone 9-12, Upstate) 1/50, menin (Ab2605, AbCam) 1/50, MLL-N 
(L. Ringrose Group, University of Vienna, Austria), RNA Pol2 (Ab24758, AbCam), Msk1 
[PhosphoS376] (Ab32190, AbCam), KAT3A/CBP[AC238] (Ab3652, AbCam), MLL4 
(Ab39267, AbCam). The fractions were immunoprecipitated at 4˚C on rotating wheel 
overnight. 40µl of protein A agarose beads supplemented with salmon sperm DNA (1 mg/5 
ml) (Salmon Sperm DNA/Protein A Agarose, Millipore/Upstate) was added and the fractions 
were incubated two hours at room temperature on a wheel with fast rotation. After 
centrifugation at 8,000 rpm, for one minute at room temperature, the beads were washed 
three times with a low salt buffer. The final wash was done with a high salt buffer. The DNA 
was eluted by adding 450µl of elution buffer (1% SDS, 100mM NaHCO3) incubated 15 
minutes at room temperature with rotation. After 1 minute of centrifugation at 8,000 rpm, the 
supernatant was removed with siliconised tips and kept into a siliconised ependorf tube. 5µl 
of proteinase K (20 mg/ml) was added to deproteinise the sample whilst reversing the cross-
links at 65˚C overnight. The DNA was extracted by phenol-chloroform extraction, and 
resuspended into 50µl of water.   
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Dilution buffer: 2% Triton X-100, 0.1% SDS, 2mM EDTA, 150mM NaCl, 20mM Tris-HCl 
pH8, protease cocktail inhibitors (Roche) 
Low Salt buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 150mM NaCl, 20mM Tris-HCl 
pH8 
High Salt Buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 500mM NaCl, 20mM Tris-
HCl pH8 
2.5. Gene expression analysis 
2.5.1.  RNA extraction (Stratagene Kit or Qiagen Kit) 
Total RNA was isolated from HPC-7 cells using either QIAGEN (QIAshredder$, RNase 
Free DNase Set and RNeasy% Minikit) or Stratagene (Absolutely RNA% Miniprep) Kits 
according to the manufacturer’s instructions. RNA was quantified using an UV/visible 
spectrophotometer (260 nm, 280 nm) (Ultraspec 2100 pro).  
Subsequently, the RNA could either be used directly to perform a one step RT-PCR (for 
Reverse-Transcriptase Polymerase Chain Reaction), or be reverse transcribed in order to use 
the cDNA obtained in a semi-quantitative hot PCR. The aim of this reaction was to amplify 
the cDNA using primers specific to genes of interest. The first experiments were done with 
the latter method, before I switched to RTQ-PCR (Real-Time Quantitative PCR).  
2.5.2.  Reverse transcription and semi-quantitative PCR 
SuperScript$ III RNase H - Reverse Transcriptase kit (Invitrogen) was used according to 
manufacturer’s instructions. 1µg of RNA was denatured at 65˚C for 5 minutes along with 
2pmol of each primer (either primer specific cDNA synthesis, or 1µl of a random Oligo(dT)20 
primer (50µM) Invitrogen), 1µl of dNTP mix (100mM) (Invitrogen) and made up to 13µl 
with RNase free water. The mix was then kept on ice for around 1 minute to stop the reaction 
!!!
!!!!
KF!
and avoid non-specific annealing. The mix was then completed with 4µl of 5X First Strand 
Buffer, 1µl of 0.1M dithiothreitol (DTT), 1µl of Protector RNase Inhibitor (40 U/µl) (Roche) 
and 1µl of SuperScript™ III Reverse Transcriptase (200 U/µl) (Invitrogen). The synthesis 
was performed by incubation at 55˚C for 1 hour, and the reaction stopped by heating the mix 
at 75˚C for 15 minutes. cDNA was stored at -20°C. 
To quantify the expression of Mll genes, I first performed several semi-quantitative hot PCR 
by adding ["-32P]-dATP in the reaction, which allowed the sensitive detection of the 
products. Each reaction contained 45 !l of ReddyMix PCR MasterMix (1,1x) (ABgene), 1!l 
of each primer (10!M), 2!l of DNase-free water and 1!l of cDNA template. 0.1!l of ["-
32P]-dATP (Amersham) was added to each reaction. The number of cycles required differs 
according to the primers. The programme was set as follows: a first step in which the samples 
were heated 2 minutes at 95° permitting to activate the Taq-polymerase. This first 
initialization step was also essential to ensure that most of the cDNA template and the 
primers were denatured. The amplification was then performed in three steps: (1) 
denaturation of the double-strand cDNA at 95°C for 30 seconds, (2) annealing at 54°C for 30 
seconds (the temperature of annealing depends of the set of primers), (3) elongation and 
synthesis of the new strand at 72°C for 30 seconds (this corresponds to the optimum 
temperature for the polymerase activity). The time of extension depended on the length of the 
cDNA fragment. These three steps were performed for about 30 cycles depending on the 
primers. A final elongation step at 72°C for 10 minutes was performed to ensure that any 
remaining single-stranded cDNA was extended. The samples were stored at 4°C. The 
samples were then loaded on a 6% polyacrylamide gel. After drying the gel, it was exposed 
on a Phospho-Imager cassette from 1 hour to overnight, and subsequently scanned with the 
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Typhoon™ 9200 scanner (Amersham). The products obtained were quantified by using the 
software ImageQuant™ v2003.01 (Amersham biosciences).  
2.5.3.  Real-Time Quantitative PCR (or RTQ-PCR) with Reverse Transcription 
In order to obtain more accurate results, the next cDNA amplification used RTQ-PCR. This 
allowed simultaneous RNA reverse transcription and cDNA amplification in one step, and 
was performed according to manufacturer’s instructions. The reaction was achieved with 
commercial primers in the case of the genes Hoxa9, Meis1 and ß-actin. The mix per tube 
contained the following: 12.5!l of QuantiTech™ Sybr& Green Mix (Qiagen), 0.25!l of 
Rtmix (Qiagen), 1.25!l of each primers for the Mll genes, or 2.5!l of the commercial 
primers, diluted to 24!l with DNase free water. Another kit, Brilliant%II SYBR% Green QRT-
PCR Master Mix 1-Step kit from Stratagene was also used, according to the manufacturer’s 
instructions. Three analyses were performed for each sample. A control was performed 
without Rtmix, also in triplicate, in order to ensure the non-contamination of the products. 
1!l of cDNA (100 ng/!l) was added to each mix (2!l, i.e. 200 ng/!l in the case of Hoxa9).  
The samples were loaded in a 96-well optical reaction plate with barcode (ABI PRISM™, 
Applied Biosystems). The RTQ-PCR was performed on the 7500 Real Time PCR System 
(Applied Biosystems) or the MxPro-Mx3000P (Stratagene) machine. The programme was set 
up as following: reverse transcription was achieved by heating the samples at 50°C for 30 
minutes. The samples were then heated at 95°C for 15 minutes (10 minutes for Stratagene), 
94°C for 15 seconds for the denaturation (95°C for 30 minutes for Stratagene), 54°C for 30 
seconds for the annealing (55-60°C for 1 minute for Stratagene), 72°C for 40 seconds for the 
elongation (30 seconds for Stratagene). These three last steps were performed 40-42 times. 
The real time PCR employed the characteristics of a fluorescent dye, SYBR& Green, which 
binds to double-strand DNA. PCR products are thus visualized and quantified after each 
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cycle of amplification, due to the emission of fluorescence by the SYBR& Green. The results 
were analysed and quantified either with the 7500 System SDS Software (Applied Biosystem) 
or the Stratagene Software. 
2.5.4.  Real Time PCR 
N-ChIPs and the C-ChIP results were analysed by Real-Time PCR, using 384 well plates on 
the ABI-PRISM 7900HT Sequence Detection System PCR machine from Applied 
Biosystems. The mix per tube was constituted as following: 5µl of SYBR® Green 2x 
(QuantiTect™ SYBR® Green kit (200) from Qiagen), 0.5µl of each primer, 10ng of DNA and 
DNase free water up to 10µl.  The programme was set up as following: (1) the samples were 
first heated at 95°C for 15 minutes, (2) then at 94°C for 15 seconds for the denaturation, (3) 
at 58°C for 30 seconds for the annealing, (4) and at 72°C for 30 seconds for the elongation. 
These three last steps were performed 45 times. The efficiency of the reaction was checked 
by examining the standard curve generated from a gradient of concentration (generated from 
successive dilutions of the product of interest), for a specific primer set (Figure 2.5). A 
dissociation curve step was added at the end, in order to check the specificity of the product 
amplified (Figure 2.6). A single product will generate a single peak, corresponding to the 
melting temperature for a specific amplified fragment. The results were analysed and 
quantified with the SDS 2.2.2 Software (Applied Biosystem). The ChIP results are displayed 
as the ratio of the amount of DNA in bound fractions and normalised to the input (amount of 
DNA in the bound fraction performed with the pre-immune IgG). 
2.6. Co-Immnunoprecipitation 
10x108 HPC-7 cells were harvested and washed twice with ice-cold PBS, 5mM butyrate, 
before to being resuspended in 300!l of NP40 150mM NaCl buffer supplemented with 
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Figure 2.5: Assessing the efficiency of primer sets 
Analysis of transcript abundance was performed using Real-Time PCR (and 
QRT-PCR). The quality of primer sets designed is checked by ensuring the 
standard curve generated from a gradient of different concentrations of a product 
displays a correct slope (-3.3) and a high percentage of efficiency. 
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Figure 2.6: Assessing the quality of the QRT-PCR analysis 
Analysis of transcript abundance was performed using Real-Time PCR (and 
QRT-PCR). The specificity of primer sets designed is checked by ensuring a 
single species is generated in the dissociation curve (Left panel) and generates 
smooth, consistent amplification curves, with an appropriate Ct threshold (Right 
panel). 
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PMSF and protease cocktail inhibitors (Roche). The cells were well vortexed and left for 20 
minutes on ice to lyse. The lysate was then spun down at 13,000 rpm for 20 minutes. The 
supernatant was kept.  
Protein A agarose beads were washed beforehand with NP40 150mM buffer. The lysate was 
then pre-cleared, by adjusting its volume up to 400!l with NP40 150mM buffer, 
supplemented with PMSF and protease cocktail inhibitors (Roche). Subsequently, 40!l of 
pre-washed agarose beads were added onto the lysate for 30 minutes at 4°C, on a rotating 
wheel. It is then spun down by centrifugation at 13,000 rpm for one minute, and the 
supernatant was kept. 5!g of the appropriate antibody was added to the pre-cleared lysate, 
and left overnight at 4°C. 40!l of protein A agarose was then added and left on the wheel for 
three hours before being spun down for three minutes at 3,000 rpm, 4°C. The supernatant 
was then kept (labelled “S1”). Beads were washed three times with NP40 150mM buffer 
(supplemented with PMSF and protease cocktail inhibitors), and once with NP40 200mM 
buffer (supplemented with PMSF and protease cocktail inhibitor). Samples were finally 
resuspended into 40!l Laemmli buffer.  
NP40 150mM NaCl: 1% Nonidet P40, 10% glycerol, 50mM Tris pH7.5, 0.1% Sodium 
Azide, 150mM NaCl 
NP40 200mM NaCl: 1% Nonidet P40, 10% glycerol, 50mM Tris pH7.5, 0.1% Sodium 
Azide, 200mM NaCl 
Laemmli 4X: 200mM Tris-HCl pH6.8, 8% SDS, 40% glycerol, 2.4M ß-mercaptoethanol, 
Bromophenol blue 
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2.7. siRNA: cloning and DNA preparation 
Primers were designed and to generate siRNA in order to perform Mll knockdowns for the 
mouse Mll1, Mll2, Mll3 and Mll5 genes (Figure 2.7).  
The short hairpins RNA (Mll3 and Mll5) used for the knockdown were designed (sequence 
identification using InvivoGen’s siRNA Wizard$ program, “http://www.sirnawizard.com/”) 
and cloned using a BLOCK-IT™ U6 RNAi Entry Vector Kit (Invitrogen). For each gene, six 
different single-stranded DNA oligos have been designed (three top strand oligos and three 
bottom strand oligos). Once the oligos are synthesized, double-stranded oligos are generated, 
by annealing equal amounts of each single-strand oligo. The reaction (5µl “Top strand” DNA 
oligo 200µM, 5µl “Bottom strand” DNA oligo 200µM, 2µl 10X Oligo Annealing Buffer 
(Invitrogen), 8µl DNase/RNase-free water) was incubated at 95˚C for 4 minutes. The reaction 
was cooled for 10 minutes at room-temperature, and then centrifuged briefly. A 100-fold 
dilution was made with RNase/DNase-free water, then another dilution (1/100) was made 
with 1/10 10X oligo Annealing buffer in RNase/DNase-free water to obtain a 5nM double-
stranded products.  
The double-stranded oligo was then cloned (ligation reaction) into the pENTR™/U6 vector. 
Ligation requires: 4µl of 5X ligation buffer, 2µl of pENTR™/U6 (0.5 ng/µl), 1µl of ds oligo 
(5nM), 12µl of DNase/RNase free water and 1µl of T4 DNA ligase (1 U/µl) were mixed and 
incubated 30 minutes at room-temperature, and then placed on ice. The ligation reaction was 
then transformed into One Shot® TOP10 chemically Competent E.coli. 20µl of TOP10 
(Invitrogen) are added to 2µl of ligation reaction. The mix was left 5 minutes on ice, heat 
shocked for 30 seconds at 42˚C and then incubated for 1 minute again on ice. 200µl of LB 
(10 g Bacto-tryptone / 5g yeast extract / 10g NaCl for 1 litre) were added to the bacteria,
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Figure 2.7: Establishing siRNA knockdown protocols 
Three vectors were designed to knockdown Mll3 or Mll5 gene expression using 
Block-It pENTR/U6 vector kit (Invitrogen). Double strand fragments were 
generated then cloned in the pENTR/U6 vector. Clones were selected by 
kanamycin resistance.  
The sequence of clones was checked and a higher amount of DNA was 
subsequently generated to be used for cell transfection. Three vectors have been 
cloned for each target. Each vector has then been tested for its efficiency. 
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 which were shaken (300 rpm) for 1 hour at 37˚C. Finally, 50µl and 150µl of TOP10 were 
spread onto LB-agar-kanamycin (50 µl/ml) plates (Mll3 and 5) or LB-agar-ampicillin (100 
µl/ml) plates (Mll1 and 2) and incubated at 37˚C overnight. The day after, colonies were 
picked to prepare the plasmid according to a classical alkaline lysis technique. Once 
extracted from the bacteria, the DNA was sequenced (Functional Genomics and Proteomics 
Laboratory, University of Birmingham) to check if the double-stranded oligo has been 
correctly integrated. Correct vectors were then transformed again into TOP10 E. Coli to 
produce a high quantity of DNA. The DNA obtained was used to transfect HPC-7 cells and 
inactivate selective gene expression.  
Other Mll (Mll1, Mll2 and Mll5) double-stranded oligo pre-designed products were also used:  
Mouse GIPZ lentiviral shRNAmir clones [Open Biosystems]. (Clone Id: Mll2 
V2LMM_193085 and V2LMM_151544; Mll1 V2LMM_96426 and V2LMM_96428; Mll5 
V2LMM_107211). These clones were spread onto LB-agar-carbenicillin (100 µg/mL) plates 
and incubated at 37˚C overnight. DNA was isolated from the colonies picked as above. 
pGIPZ vectors express TurboGFP allowing measurement of transfection efficiency.  
2.8. Transfection of HPC-7 cells 
Knockdown vectors were transfected into HPC-7 cells using a commercial procedure (Cell 
Line Nucleofector® Kit L, Amaxa Biosystems). A 12-well plate was prepared with 1 ml of 
2x HPC-7 Growth Medium (for 11ml final: 7.8 ml StemPro-34, 572µl StemPro-34 Nutrient 
Supplement, 1/50 penicillin/ streptomycin, 1/50 glutamine, 2.2ml CHO/SCF conditioned 
medium) and 400 µl unsupplemented StemPro medium per well. 2x106 cells were required 
per nucleofection and per well. An Amaxa biosystems Cell line nucleofector% kit L was used 
according to manufacturer’s instructions. Cells were centrifuged at 90 rcf for 10 minutes at 
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room temperature (RT), and resuspended in 100µl of Nucleofector Solution L. 2µg of DNA 
was added per cell suspension (DNA from siRNA clones or a plasmid expressing GFP was 
used as a control). The cell suspension was transferred into an appropriate cuvette for 
transfection with the Amaxa Biosystems Nucleofector™ II (programme X-001). 500µl of 
pre-warmed RPMI 1640 medium [Gibco] were immediately added after transfection. The 
cells were then transferred into an eppendorf tube and left 30 minutes to an hour at 37˚C for 
recover. The cells were finally transferred into pre-warmed 12-well plate and incubated for 
the required time period. 
2.9. Flow Cytometry Analysis 
After transformation, the cells were incubated overnight to allow them to revive before cell 
sorting, and preparation for Flow Cytometry analysis (FACS: Fluorescence-Activated Cell 
Sorting). The cells are harvested, spun at 850 rpm (90g) for five minutes. The pellet is 
resuspended in StemPro-34 media (Invitrogen), plus supplements (300 µl per 10x106 cells) 
with no FCS. The cells are filtered through a cell strainer immediately before sorting.  The 
filter is placed on top of a FACS tube. Cells are sorted in collection tubes (one per sample) 
containing 250µl Stem Pro media plus supplements.  
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3. RESULTS - CHARACTERISATION OF THE HAEMATOPOIETIC 
STEM CELL DIFFERENTIATION MODEL 
A differentiation model was established using Haematopoietic Progenitor Cells (HPC-7), an 
immortalised mouse embryonic stem cell line derived from haematopoietic stem cells 
transformed with the transcription factor Lhx2 (Pinto d’O et al., 1998). HPC7 cells have the 
capacity to differentiate into a variety of haematopoietic cell lineages, including monocytes 
and megakaryocytes the lineage we focus on in this work.  
3.1. Generating megakaryocytes 
HPC-7 cells present several advantages for this study, notably that they can differentiate 
under controlled conditions to megakaryocytes, which are then easily purified from 
undifferentiated cells. Haematopoietic stem cells were maintained in the presence of steel 
factor (conditioned media), and self-renewed until differentiation was induced by adding a 
unique cytokine, thrombopoietin (TPO), involved in megakaryopoiesis and thrombopoiesis. 
Differentiated cell morphology differs from the undifferentiated stem cells: megakaryocytes 
become substantially larger, with an increase in ploidy (Figure 3.1a). Megakaryocytes were 
separated from the small undifferentiated cells using two consecutive BSA gradients. The 
purity of differentiated cell populations was checked by FACS analysis: a homologous 
population of megakaryocytes can be isolated as characterised by the number of cells 
containing greater than 8N (the majority are 16 and 32N) (Figure 3.1b). Moreover, the 
differentiation process was characterised by changes in gene expression, notably at Hoxa9 
and Meis1, genes dysregulated in leukaemia. Relative expression for these particular genes 
was assessed after three and six days of TPO-induced differentiation: Hoxa9 gene expression 
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Figure 3.1: Our model for differentiation: HPC-7 cells 
Cells were differentiated for six days in the presence of thrombopoietin. 
Megakaryocytes were isolated by fractionation on BSA gradients. a) Cell 
morphology of undifferentiated  HPC-7 cells (left panel) and after 6 days 
exposure to TPO (right panel). Morphology was assessed by Diff-Quick staining 
of cytospin preparations. b) FACS analysis of undifferentiated cells (Undiff) and 
megakaryocytes (Megs). c) Real-time PCR analyses of relative gene expression 
in differentiating HPC-7 cells were performed with samples taken at different 
points in the differentiation process (Undifferentiated cells, Day 3 and Day 6). 
RNA samples were analysed in triplicate, and gene expression expressed relative 
to ß-actin expression (Dr. F. Tavner). 
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displays a substantial decrease (95%) whereas Meis1 gene expression is slightly reduced 
(40%) (Figure 3.1c, data from Dr. F. Tavner).   
3.2. Characterising megakaryocyte maturity 
Previous data (Figure 3.1b) showed that a pure fraction of differentiated cells could be 
obtained using this differentiation protocol with HPC-7 cells. However, expression of 
particular control genes was assessed in order to confirm that the cells produced were fully 
mature megakaryocytes. Three genes involved at specific stages of development were used as 
controls. PU.1 is the product of the Spi-1/Sfp-1 gene and a haematopoietic transcription factor 
required in early development. Only a few mature haematopoietic cells express PU.1, 
including monocytes, macrophages, lymphocytes B, mast cells and neutrophils (Valledor et 
al., 1998). PU.1 expression in mature megakaryocytes is therefore not expected, and as can 
be observed, Sfpi-1 is four-fold down regulated in our megakaryocyte populations (Figure 
3.2a). Another gene, whose expression was checked, is Gata-1, which encodes GATA 
binding Protein 1, present in progenitor cells. Gata-1 expression is increased 18-fold in 
megakaryocytes (Figure 3.2b). GATA-1 drives the transcription of the Gp6 gene. GP6 
(Glycoprotein VI) is a platelet receptor exclusively expressed in the megakaryocyte lineage 
(Jandrot-Perrus et al., 2000; Holmes et al., 2002). Gp6 gene expression considerably 
increased during HPC-7 differentiation (#3500-fold), indicating that the cells obtained are 
mature megakaryocytes (Figure 3.2c).  
3.3. Changes in Hoxa gene activity during differentiation 
Haematopoiesis is associated with the controlled regulation of particular genes by protein 
complexes, such as the MLL complex. Key genes in the differentiation of haematopoietic 
cells are the Hoxa genes. These genes encode transcription factors essential to determine the 
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Figure 3.2: Expression of control genes in generated megakaryocyte cell 
population 
To assess the quality of our model, control genes (Sfpi1, Gp6 and Gata-1) were 
used to evaluate megakaryocytes maturity. PU.1, encoded by the gene Sfpi1 (a), 
is down-regulated in megakaryocytes whereas Gata-1 is expressed in 
megakaryocytes (b). Gp6 is exclusively expressed in mature megakaryocytes 
(c). RNA was extracted from undifferentiated HPC-7 cells (Undiff) and 
megakaryocytes (Megs), and analysed in triplicate using Gapdh as a control. 
PCR was performed in triplicate from one experiment. 
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identity of regions of the embryonic anterior-posterior body axis during development 
(Krumlauf, 1994). These genes are distributed in a co-linear organisation, and are temporally 
expressed according to this spatial organisation (Figure 3.3a). We examined the changes of 
the Hoxa cluster (Hoxa1-13) gene expression during differentiation by assessing changes in 
transcript abundance in undifferentiated HPC-7 cells and megakaryocytes. In the first 
instance, Ct (Cycle threshold) values were examined along the Hoxa cluster gene (Hoxa1-
13), reflecting transcript abundance (Figure 3.3b). It should be noted that Gapdh transcript 
abundance does not change during differentiation. Apart from genes at the edge of the cluster 
(Hoxa1 and Hoxa13), there is a global increase of Ct values, indicating a reduction in 
transcript abundance at these genes during differentiation from undifferentiated HPC-7 cells 
to megakaryocytes. This is clearest for Hoxa5, which shows three cycles of difference 
between undifferentiated HPC-7 cells and megakaryocytes indicating a six-fold decrease in 
transcript abundance. Then, Hoxa gene expression normalised with Gapdh transcript 
abundance was examined. This alternative way of presenting this information (Figure 3.3c) 
shows a broad reduction of Hoxa gene expression on the Hoxa cluster in megakaryocytes. 
However, it must be noted that the transcript abundance of the genes at the edges of the 
cluster (Hoxa1 and Hoxa13) display wide variations, while other genes, especially Hoxa5 
and Hoxa6, show a consistent reduction in expression. It should be noted that Hoxa5 and 
Hoxa6 Ct values are low (around 23 for Hoxa5 in undifferentiated cells) in comparison with 
other Hoxa genes (around 34 for Hoxa13 in undifferentiated cells), reflecting the relatively 
high abundance of these transcripts in the cells. Similarly, the change of Ct value is bigger 
for Hoxa5 (going from 23 to 25) than for Hoxa13 (going from 34.74 to 34.44, Supplementary 
data). Therefore, assuming equivalent primer efficiency, the biggest changes were observed 
at Hoxa5 and Hoxa6.  
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Figure 3.3: Hoxa gene cluster transcript levels in undifferentiated HPC-7 
cells and megakaryocytes 
Quantification by Real-Time PCR of levels of gene transcripts (normalised with 
Gapdh) along the Hoxa cluster in undifferentiated HPC-7 cells (blue) and 
megakaryocytes (orange). 
a) Figure of Hoxa cluster, showing the positions of Hoxa genes.  
b) Changes in transcript abundance (Ct values) in undifferentiated HPC-7 cells 
(blue) and megakaryocytes (orange). It should be noted that Gapdh abundance 
does not change. (**p<0.01, *p<0.05, °p<0.5, student test, comparing CT values 
in undiff. HPC-7 and megakaryocytes samples). 
c) Changes in Hoxa gene expression upon differentiation, with the level of 
transcripts in undifferentiated cells set at 1.0. It should be noted that the 
transcript abundance of the genes at the edges of the cluster (Hoxa1 and 
Hoxa13) display wide variations, reflected by wide error bars. qRT-PCR was 
performed in triplicate from more than two biological experiments. 
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It should also be noted that the decrease of the abundance of Hoxa gene transcripts is lower 
than expected. Transcript stability was next examined in order to assess if this could impact 
on RNA abundance.  
3.4. Degree of stability of Hoxa gene transcripts 
The stability of Hoxa gene transcripts was assessed by exposing undifferentiated HPC-7 cells 
to the toxin "-amanitin, which is an inhibitor of the RNA Polymerase II (Figure 3.4). Cells 
were treated for 8, 16, 24 and 48 hours before being washed and harvested. RNA was 
extracted, and RT-QPCR performed with the QIAGEN QuantiTect SYBR Green RT-PCR 
Kit©. Values correspond to the relative abundance of specific Hoxa genes (Hoxa3, Hoxa4 and 
Hoxa5), normalised to the control Gapdh gene. Presentation of transcript abundance data 
indicate that the abundance of these transcripts is maintained until 24 hours of treatment, and 
is even slightly increased for Hoxa3 and Hoxa5 transcripts, before starting to decrease 
following 48 hours treatment. Therefore, transcripts of Hoxa genes are still detectable in cells 
48 hours after the cessation of polymerase activity, suggesting that Hoxa gene transcripts are 
stable for extended periods. This stability could explain the apparently limited down-
regulation of the Hoxa genes (i.e. Hoxa1-4, Hoxa7, 11 and 13) observed in megakaryocytes 
(i.e. Figure 3.3). Subsequent analysis of both MLL complex (i.e. Figure 5.2) histone 
modifications (i.e. Figure 4.3), and RNA polymerase II (i.e. Figure 5.6) give conflicting 
indications of the changes that are occurring on these genes upon differentiation (Discussed 
later).  
3.5. General distribution of epigenetic marks on cells 
These data established that there is a global down regulation of Hoxa gene expression during 
differentiation, and therefore a substantial difference in gene expression between 
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Figure 3.4: Time exposure to !-amanitin in undifferentiated HPC-7 cells 
Undifferentiated HPC-7 cells were treated with alpha-amanitin for 8, 16, 24 and 
48 hours. PCR was performed with primer sets corresponding to  the coding 
region of Hoxa3, Hoxa4 and Hoxa5, and was performed in triplicate from two 
experiments. Error bars represent the standard error of the mean. 
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undifferentiated HPC-7 cells and megakaryocytes. We next examined whether these changes 
in transcriptional activity reflected global changes in histone modifications, using 
immunofluorescence microscopy (Figure 3.5). Both undifferentiated HPC-7 cells (Upper 
panels) and megakaryocytes (Lower panels) were stained with histone modification-specific 
antibodies and compared to DAPI-stained nuclei. In megakaryocytes, cells are polyploid (as 
described previously), which are characterised by nuclear “lobes”. One potential issue arises 
from our use of megakaryocytes; that is whether all copies of the Hoxa genes are equally 
regulated, in the whole genome, particularly as ChIP experiments assume that all copies of 
Hoxa genes are assembled into equivalent chromatin. Antibodies against activating marks 
(H3K4me3, H3K9ac) (Figure 3.5, a and b) and antibodies against repressive marks 
(H3K9me2, H3K27me3) (Figure 3.5, c and d) were used. As expected in undifferentiated 
cells, the histone marks are uniformly spread throughout the nucleus, though H3K9me2 
staining shows a punctate distribution (c). It should be also noted that this mark is 
concentrated in the centromeres of metaphase chromosomes. In contrast, in megakaryocytes, 
histone marks are distributed overall, but highly concentrated regions of histone marks are 
associated with what could correspond to the “lobes”, or structures “budding off” from the 
nucleus, as well as what appear to be “vacuoles”. A similar distribution was observed for 
activating marks (H3K4me3, H3K9ac) (a and b) and repressive marks (H3K9me2, 
H3K27me3) (c and d) with the exception of H3K9me2, which shows punctate distribution as 
in undifferentiated cells.  
These images were unexpected, but do not appear to reflect a technical artefact: we observed 
similar uneven distributions of histone modifications in cells, which were cross-linked either 
before or after incubation with antibodies. It was then essential to investigate whether this 
distribution reflected the histones in primary haematopoietic Stem Cells (hSC), as this could 
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Figure 3.5 a & b: Staining with H3K4me3 (a) and H3K9ac (b) antibodies 
and revelation by immunofluorescence  
Undifferentiated HPC-7 cells (Upper panels) and megakaryocytes (Lower 
panels) have been stained with DAPI alone to highlight the DNA (Right panels) 
or with the antibody of interest on top of it (Left panels). Magnification X400, 
Megs; X600, Undiff. 
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Figure 3.5 c & d: Staining with H3K9me2 (c) and H3K27me3 (d) antibodies 
and revelation by immunofluorescence  
Undifferentiated HPC-7 cells (Upper panels) and megakaryocytes (Lower 
panels) have been stained with DAPI alone to highlight the DNA (Right panels) 
or with the antibody of interest on top of it (Left panels). Interphase and 
metaphase cells are indicated (c). Magnification X400, Megs; X600, Undiff. 
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reflect a HPC-7 specific anomaly. These cells were generated, and treated in a similar way to 
the HPC-7 cells and megakaryocytes, in order to confirm that they both are characterised by 
the same distribution of epigenetic marks. The morphology of undifferentiated hSC and 
differentiated hSC after five days of treatment with thrombopoietin was first examined 
(Figure 3.6). Undifferentiated primary hSC are small and round cells, while TPO-induced 
megakaryocytes appear similar to the cells produced from HPC-7 cells (Figure 3.6a). Histone 
marks display a similar distribution of H3K9me2 and H3K27me3, showing punctate 
(H3K9me2) and “all over” staining with concentrations in “vacuoles” (Figure 3.6b). This 
suggests that our previous observations in HPC-7 do not seem to reflect a cell-specific 
artefact, as undifferentiated cells stain as expected and most antibodies give the same 
distribution. These “lobe/vacuole” structures could thus either reflect areas where genome is 
replicating, or correspond to the processes that lead to the break down of cells to generate 
platelets. The latter seems unlikely though, as these “lobe/vacuole” structures were also 
observed in nuclei of smaller non-mature megakaryocytes.  
3.6. Global chromatin changes during differentiation 
The previous immunofluorescence studies indicate that the histone modifications examined 
are present in both undifferentiated HPC-7 cells and megakaryocytes, but these studies 
cannot give insight into the abundance of histone marks in these two cell types. Previous 
studies have detected changes in global histone modifications upon differentiation, notably in 
histone acetylation (Marin-Husstege et al., 2002; Lee et al., 2004; Wu and Sun, 2006). This 
is why global changes in histone modifications were then examined during differentiation.  
We initially examined the histone proteins in both undifferentiated HPC-7 cells and 
megakaryocytes to assess if large changes occurred in histone isoform variants. Histones 
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Figure 3.6: Characterising primary haematopoietic Stem Cells (hSCs)  
a) Cell morphology of undifferentiated  primary hSC and after five days 
exposure to TPO. Morphology was assessed by microscope observation, 
magnification (X20).  
b) Undifferentiated haematopoietic Stem Cells (Lower panels) were stained with 
DAPI alone to highlight the DNA (Right panels) or with the antibody of interest 
(H3K9me2 or H3K27me3) (Left panels). Magnification (X400). 
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were isolated by acid (HCl) extraction, monitored for degradation by SDS gel (Figure 3.7) 
and the loading adjusted by Western blotting with an H3 C-terminal antibody (Data not 
shown). This is an ideal control, as the C-terminal region of the histone H3 contains no 
known modifications. No substantial changes are observed in histone abundance, though a 
novel high molecular weight band is observed only in differentiated HPC-7 cells (Figure 3.7, 
“?”). However, this novel protein is not extracted with perchloric acid (PCA), using the 
standard protocol for extracting linker histones, suggesting that it is not a linker histone. 
A 2-dimentional SDS-AUT gel was performed in order to identify potential general changes 
in the histones occurring between undifferentiated HPC-7 cells and megakaryocytes (Figure 
3.8). Histones were first separated according to their degree of acetylation, by migration on 
an AUT (Acid-Urea-Triton) resolving gel. This gel also allows the separation of modified 
histone variants and subtypes of histones on the basis of their charge and mass. Then, 
histones were separated according to their size, on a SDS denaturing gel. Comparing the two 
gels (a and b) shows no substantial changes in the distribution of the variant histones H3.1, 
H3.2 and H3.3, in spite of the fact that they appear to be smeared in megakaryocytes, which 
could be due to the acquisition of a phosphate. Furthermore, no noticeable changes in the 
degree of histone acetylation were shown, with the exception of a novel band revealed in 
undifferentiated HPC-7 cells (arrowed). The proximity of this new band with that of histone 
H2B, and its reduced mobility in the TAU dimension suggests that this probably reflects the 
acetylation of H2B. Subsequent mass spectroscopic analysis of this histone “spot” has shown 
that this contains a number of histone acetyl - methyl isoforms, including modifications at 
novel sites (K. Nightingale, H. Cooper, Personal communication).  
Subsequently, different histone marks were more specifically examined by Western blot. 
These include marks associated with both the active (H3K4me1,2,3, H4K8ac and H4K16ac), 
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Figure 3.7: Changes in histone proteins between undifferentiated HPC-7 
cells and megakaryocytes 
Histone proteins were examined in undifferentiated HPC-7 cells (Undiff) and 
megakaryocytes (Megs). Histones were acid extracted (HCl) and then examined 
by silver staining. An unknown protein (?) is observed in megakaryocytes. This 
is not observed in Perchloric Acid (PCA) extracted samples (Right panel). 
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Figure 3.8: 2D gel identifying histone changes in undifferentiated HPC-7 
cells and megakaryocytes 
Histones from undifferentiated HPC-7 (a) and megakaryocytes (b) were first 
separated on a SDS denaturing gel, depending on their molecular weight. Then 
the proteins separated a second time on a TAU (Triton-Acid-Urea) gel, on the 
base of the charge and mass, according to their degree of acetylation. In 
undifferentiated HPC-7 cells (a), it should be noted the presence of a novel band 
(arrow), that is not observable in megakaryocytes (b). 
!!!
!!!!
""K!
and repressive (H3K9me2) states of gene expression and a mitotic chromatin (H3S10p) 
(Figure 3.9a). Quantification was normalised using an antibody against the H3 C-Terminal. 
Quantification of the abundance of these histone marks in megakaryocytes is shown relative 
to the abundance in undifferentiated HPC-7 cells, which was set at 1 (Figure 3.9b). Broadly 
most marks do not show substantial changes: H3K4me1 and H3K4me2 and H3K9me3 are 
slightly increased in megakaryocytes, whereas H3K4me3 and H4K16ac show small 
reductions, but these data need to be reproduced. No difference is observed with the 
acetylated H4K8 mark. In contrast, the most significant difference is observed with the 
phosphorylated H3S10 mark, which is increased by three-fold in megakaryocytes. This is 
consistent with the increase in mitotic activity in the polyploid megakaryocytes.  
3.7. Changes in the MLL1 Histone Methyl-Transferase distribution during 
differentiation 
Our previous studies assessing the abundance and distribution of histone modifications in 
undifferentiated HPC-7 cells and megakaryocytes showed that differentiation is not 
associated with large changes in histone modifications. This raised the question whether this 
could reflect a change in the abundance of specific histone methyl-transferase enzymes. The 
MLL family of histone methyl-transferases possesses a SET domain, which gives these 
enzymes the capacity to methylate H3K4. Moreover, the archetypal MLL protein, MLL1, 
plays an important role in haematopoiesis (Ernst et al., 2002; Ernst et al., 2004a). Mll1 gene 
expression was therefore examined in undifferentiated HPC-7 cells and megakaryocytes 
(Figure 3.10a). The four MLL family members are expressed in HPC-7 cells. Mll1, Mll4, 
Mll3 and Mll5 transcript abundance was initially quantified by semi-quantitative PCR using 
["-32P]-dATP labelled nucleotide incorporation, and normalised with ß-actin gene expression 
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Figure 3.9: Changes in global histone modification between undifferentiated 
HPC-7 cells and megakaryocytes 
Histone marks were examined in undifferentiated HPC-7 cells (Undiff) and 
megakaryocytes (Megs). H3K4 mono, di and trimethylation (H3K4me1,2,3 
respectively), H3K9 trimethylation (H3K9me3), H4K8 acetylation (H4K8ac), 
H4K16 acetylation (H4K16ac) and H3K9acS10 phosphorylation (H3K9S10p) 
were examined. 
a) Histone mark modification was examined at a protein level by Western 
blot in undifferentiated cells (Undiff) and megakaryocytes (Megs). The 
protein level was normalised with the H3 C-Terminal antibody.  
b) Histones were normalised to the H3 C-Terminal. This chart displays 
histone mark abundance in megakaryocytes (Megs) relative to 
undifferentiated HPC-7 cells (Undiff), which are set at 1. Values are the 
mean of one or two experiments. Error bars represent the standard error 
of the mean. 
!!!
!!!!
"0"!
 (Figure 3.10a). According to this first experiment, only Mll1 gene expression displayed a 
change between the cell types, showing a three-fold increase in megakaryocytes (Figure 
3.9b). Otherwise, no significant differences were observed for the other Mll genes. These first 
results were confirmed by quantitative PCR (Real-time QRT-PCR) (Figure 3.10c). This 
result initially seems to be incompatible with the global changes in H3K4me3 during 
differentiation; this will be addressed in the following chapter. 
3.8. Summary: Establishing a model of differentiation 
In this model, TPO-induced differentiation of HPC-7 cells generates a clear morphologically 
distinct cell type: megakaryocytes. Their degree of maturity was validated by an increase in 
ploidy, and the detection of specific control genes, such as Gp6, which are exclusively 
expressed in mature megakaryocytes. Differentiation is associated with down regulation of 
MLL-target genes in the Hoxa gene cluster, as well as the key leukogenic gene Meis1. These 
changes are associated with only small changes in the global abundance of histone 
modifications, suggesting that targeted changes at individual loci, rather than genome-wide 
effects determine gene activity upon differentiation. Together, these observations suggest that 
this is an appropriate model to study regulation at MLL1 target genes.  
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Figure 3.10: Mll family members transcript levels in undifferentiated HPC-
7 cells and in megakaryocytes 
a) Gene expression (Mll1, Mll4 Mll3, Mll5) was quantified in 
undifferentiated cells (Undiff) and in megakaryocytes (Megs) by semi-
quantitative PCR, by adding alpha-32P in the reaction. 
b) Abundance of Mll family members in undifferentiated cells (Undiff) and 
megakaryocytes (Megs). Mll transcript abundance is set at 1 in 
undifferentiated HPC-7 cells. The quantification was normalised using ß-
actin gene expression as a control. 
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Figure 3.10 c: Mll family member gene transcript abundance in 
undifferentiated HPC-7 cells and in megakaryocytes 
Quantification by real-time PCR of Mll family member transcript abundance 
(normalised  with Gapdh). Transcript abundance in undifferentiated HPC-7 is set 
at 1. 
!!!
!!!!
"0/!
4. CHARACTERISING HISTONE MODIFICATIONS ON MLL-
TARGET GENES 
In the previous chapter, a model system of differentiation was established to analyse MLL1 
complex-driven changes on MLL target genes. It was established that genes of the Hoxa 
cluster, and the leukaemic gene Meis1 are down regulated upon differentiation. Also, no 
global changes in histone modifications were observed, and previous results were unlikely to 
reflect changes in MLL1 abundance.  
This chapter focussed on changes at the Hoxa4 and Hoxa5. Hoxa5 gene showed a substantial 
and reproducible fall in transcript abundance upon differentiation, suggesting an efficient 
silencing process. These genes are also implicated in haematopoiesis (Fuller et al., 1999; 
Strathdee et al., 2006). Notably, Hoxa4 was described to be the most 3’ gene involved in 
haematopoiesis (Sauvageau et al., 1994). We examined epigenetic changes associated with 
specific Hoxa genes and control genes. This investigation focussed on number of activating 
and repressive marks, using Native chromatin immunoprecipitation (N-ChIP) in 
undifferentiated HPC-7 cells and Carrier chromatin immunoprecipitation (C-ChIP) in 
megakaryocytes, where material is more limiting. In the experiments performed, the 
housekeeping gene Gapdh was used as a control. 
4.1. How is the Hoxa gene cluster globally regulated? 
To assess the contribution of epigenetic regulations, histone modifications were examined on 
the Hoxa4 and Hoxa5 genes in undifferentiated HPC-7 cells when the genes are active, and 
in megakaryocytes when they are repressed. Specific primer sets were designed in order to 
assess the distribution of epigenetic marks at specific sites along these genes (Figure 4.1). 
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Figure 4.1: Representation of the distribution of primer sets used for PCR 
analysis over the Gapdh, Hoxa4 and Hoxa5 genes 
The localisation of specific regions of the gene amplified by primer sets are 
represented below the name of each primer set. The arrow corresponds to the 
transcription start site (TSS), and boxes indicate exons. Promoter region is 
indicated with red bar and deduced from region of high homology in mammals. 
A TATA box could not be found on Hoxa4 and Hoxa5. 
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Sites were located in the upstream “promoter” region of the genes, as well as at the 
transcription start sites (TSS), in some coding regions and downstream of these genes. The 
distribution of histone marks was assessed in undifferentiated HPC-7 cells using unfixed 
chromatin, performing Native Chromatin Immunoprecipitation (N-ChIP). However, the low 
number of megakaryocytes available (#105 cells) required a different procedure, in which the 
initial Native Chromatin Immunoprecipitation protocol was performed using Drosophila SL2 
cells as a carrier. This method, developed by the Turner group (Birmingham University, UK) 
and called C-ChIP (O'Neill et al., 2006), was used on megakaryocytes. These two methods 
differ in the way of preparing the chromatin. Because of this first different step, it was 
important to assess whether the data obtained from these two distinct cell types, and by 
different procedures, could be compared quantitatively. In order to validate that these two 
methods can be compared, histone modifications were first examined on the control, 
housekeeping gene Gapdh and then compared in undifferentiated HPC-7 cells and 
megakaryocytes.  
4.1.1.  Examination of histone distributions on Gapdh 
It is essential to notice that Gapdh transcript abundance does not change significantly  (1% 
down/up regulation) between undifferentiated HPC-7 cells and megakaryocytes (Cf. Figure 
3.3b and Supplementary data). This particular gene is therefore ideal to assess if the two 
methods can be compared.  
Histone modifications associated with an active state of gene expression (H3K4me3), and 
one characterising a repressive aspect of gene expression (H3K27me3) were chosen to 
evaluate the results. The results are displayed as the amount of DNA bound, where a value 
corresponding to non-specific binding (derived from pre-immune binding) is subtracted. This 
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approach reflects the technical difficulties of adapting ChIP to real-time PCR. Whilst our 
group is typically using a Bound/Unbound ratio to quantify binding, we used this approach as 
we found the material in unbound C-ChIP fractions could not be quantified by real-time 
PCR. This may reflect the large excess of Drosophila DNA to mouse DNA, which generates 
a high background, but Real-Time PCR also appears to be more sensitive to this problem 
than conventional PCR. The locations of the primer sets used are presented above the graphs 
(Figure 4.2). Both undifferentiated HPC-7 cells (Figure 4.2, Left upper panel) and 
megakaryocytes (Left lower panel) display a peak of trimethylated H3K4 at the transcription 
start site (TSS) of Gapdh, consistent with numerous studies of this mark present at 
transcriptionally active genes (Margueron et al., 2005). These show similar levels of 
enhancement, but the peak in megakaryocytes is broader, with the mark also being detected 
upstream in megakaryocytes (Gapdh/1; Fig. 4.2) when it is absent in undifferentiated cells. 
This apparent broader peak of modification in megakaryocytes is likely to reflect the reduced 
extent of digestion and lower resolution of the chromatin obtained from these cells - we note 
that the Gapdh/1 and Gapdh/2 primers sets are separated by only #200 base pairs. 
H3K27me3 was also monitored (Figure 4.2, Right panels). Its pattern along the Gapdh gene 
in megakaryocytes suggests that there are no significant changes during differentiation.  
This experiment was important to establish that similar data could be obtained from what 
should be a similarly-regulated housekeeping gene in two cell types. This was first confirmed 
qualitatively, as similar patterns of distribution were observed in the two cell types. This is 
also consistent with what was previously described: peaks of active marks are typically 
associated with the “promoter” region (Liu et al., 2005; Pan et al., 2007). Furthermore, 
values from bound (specific – non specific) are quantitatively similar, suggesting that the two 
cell types can be compared using the two ChIP approaches. The difference of detection at 
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Figure 4.2: Distribution of H3K4me3 and H3K27me3 histone modifications 
on the Gapdh control gene in undifferentiated HPC-7 cells and 
megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibodies against H3K4me3 and H3K27me3. The 
graphs display the relative enrichment [Bound (specific) - Bound (pre-immune)], 
where non-specific binding (ns) obtained from pre-immune bound is subtracted. 
PCR was performed with primer sets corresponding to specific sites on the 
Gapdh gene and was   performed in triplicate from one or two ChIP 
experiments. Error bars represent the standard error of the mean. 
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Gapdh1 with H3K4me3 suggests that chromatin from megakaryocytes may be lower 
resolution than from the undifferentiated cells.  
4.1.2. What histone marks are up and down-regulated on Hoxa4 and Hoxa5 genes? 
Once the legitimacy of comparing N-ChIP and C-ChIP data in these two cell types had been 
established, histone modifications on genes of interest (Hoxa4 and Hoxa5) were then 
examined. In particular, two histone marks related to an active transcription state (H3K4me3, 
H3K9ac) and two marks corresponding to the repressive transcription state (H3K27me3, 
H3K9me2), were assessed for their distribution at defined sites along these genes.  
H3K4me3 was first examined (Figure 4.3). In undifferentiated HPC-7 cells, a peak of this 
activating mark was observed close to the transcription start site of Hoxa4 (Figure 4.3, Left 
panels), and shows a high abundance when compared to the regions surrounding this site. In 
contrast, there is a clear decrease (12-fold) of this histone enrichment in megakaryocytes. 
Similarly, an enrichment of H3K4me3 was observed over the transcription start site of Hoxa5 
(Figure 4.3, Right panels), which is then substantially decreased in megakaryocytes (20-fold 
decrease). Hoxa5 displays a similar pattern of modification as Hoxa4: a substantial decrease 
of H3K4me3 at the transcription start of these genes in megakaryocytes. The reduction of 
H3K4me3 abundance in megakaryocytes suggests the requirement of a histone H3K4 
demethylase, or histone turn-over. 
Another “activating” mark, H3K9ac, was then examined (Figure 4.4). This particular histone 
mark is deposited by a number of HATs, including Gcn5 as part of the SAGA complex 
(Grant et al., 1999), but it is also a mark of replication-coupled chromatin assembly (Kuo et 
al., 1996). Once again, a peak of acetylation is observed over the transcription start site of 
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Figure 4.3: Distribution of H3K4me3 histone modifications on the Hoxa4 
and Hoxa5 genes in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against H3K4me3. The graphs display the 
relative enrichment [Bound (specific) - Bound (pre-immune)], where non-
specific binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes and was performed in triplicate from two or three ChIP 
experiments. Error bars represent the standard error of the mean. (**p<0.001, 
*p<0.02, Student test, comparing Hoxa4/1 and Hoxa4/2, Left panel. Comparing 
Hoxa5/2 and  Hoxa5/3, Right panel). 
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Hoxa4 in undifferentiated cells (Figure 4.4, Left Upper panel). This enrichment is not as 
substantial as with H3K4me3 though, when compared with adjacent regions.  
Interestingly, this mark spreads throughout the coding region of the gene after differentiation 
(Figure 4.4, Lower panel). Similarly, H3K9ac shows an enrichment at the TSS of Hoxa5 in 
undifferentiated HPC-7 cells (Figure 4.4, Right upper panel). This is lost in megakaryocytes 
but we observed a broad enrichment of this mark throughout the locus (Figure 4.4 Lower 
panel). In contrast to H3K4me3, the distribution of H3K9ac is counter-intuitive, as this mark 
appears to increase in megakaryocytes with substantial increases in this mark in both the 
promoter and the coding regions. This is variable, as the increased errors bars indicate. An 
alternative interpretation of these data is that the distinct peak at the TSS seen in 
undifferentiated HPC-7 cells is lost, and replaced by a generalised distribution of the acetyl 
mark on silent genes.  
The distribution of an additional “activating mark” was examined on Hoxa4: H4K16ac 
(Figure 4.5). H4K16ac is a mark deposited by another member of the MLL complex, the 
histone acetyl-transferase MOF. In undifferentiated cells, a slight enrichment of H4K16 
acetylation is observed over the TSS of Hoxa4 (Hoxa4/2) (Figure 4.5, Upper panel). This 
mark is reduced by about three-fold in megakaryocytes (Figure 4.5, Lower panel). This result 
reinforces the idea of the MLL complex involvement in the regulation of Hoxa genes. 
Interestingly, all these “activating” marks examined display a similar pattern of distribution 
on Hoxa4 in undifferentiated cells. So far, an enrichment of active histone marks, associated 
with the TSS of active genes, was observed in undifferentiated HPC-7 cells, which was 
substantially decreased after differentiation into megakaryocytes. This pattern of histone 
modification correlates with the global down-regulation of Hoxa gene expression during 
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Figure 4.4: Distribution of H3K9ac histone modifications on the Hoxa4 and 
Hoxa5 in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against H3K9ac. The graphs display the 
relative enrichment [Bound (specific) - Bound (pre-immune)], where non-
specific binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes and was  performed in triplicate from two ChIP experiments. Error 
bars represent the standard error of the mean. (*p<0.1, student test, comparing 
binding at Hoxa5/2 and Hoxa5/3) 
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Figure 4.5: Distribution of H4K16ac histone modifications on the Hoxa4 
gene in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panel) were differentiated into 
megakaryocytes (Megs, Lower panel). Chromatin was extracted and 
immunoprecipitated with antibody against H4K16ac. The graphs display the 
relative enrichment [Bound (specific) - Bound (pre-immune)], where non-
specific binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 gene 
and was performed in triplicate from one or two ChIP experiments. Error bars 
represent the standard error of the mean. 
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differentiation (i.e. Figure 3.3). We next asked whether “repressive” histone marks, typically 
associated with silent genes, show corresponding increases upon gene silencing. 
In order to check repressive histone marks, the distribution of H3K27me3 was first assessed 
(Figure 4.6). In undifferentiated HPC-7 cells, this mark shows a low level, or “background” 
level, of abundance with no particular pattern on Hoxa4 (Figure 4.6, Left panels). Moreover, 
no changes of H3K27 methylation were highlighted in megakaryocytes either. As with 
Hoxa4, Hoxa5 displays similar “overall” pattern in undifferentiated cells and megakaryocytes 
(Figure 4.6, Right panels). Our trial to find a control gene in order to examine the presence of 
H3K27me3 on an inactive gene failed to detect enrichment for this mark.  
The distribution of another histone mark associated with repression, H3K9me2, was also 
examined on Hoxa4 (Figure 4.7). This shows a low level of enrichment (values #2-3) in 
undifferentiated HPC-7 cells, where a slight but probably not significant enrichment is 
observed over both the promoter and the coding regions of the gene (Figure 4.7, Upper 
panel). As with H3K27me3, this distribution is not significantly altered in megakaryocytes 
(Figure 4.7, Lower panel). As a result, no change is observed with the repressive marks 
(H3K27me3 and H3K9me2) upon differentiation.  This may reflect the low levels of these 
marks in both cell types.  
The distribution of the association of two adjacent histone marks (H3K9acS10p) was a 
particular interest for this study. H3S10p is a marker of mitotic chromatin, while its 
neighbour H3K9ac characterises actively transcribed genes; however, the dual mark has also 
been shown to be associated with immediate early gene activation (Dyson et al., 2005). 
Importantly, in vitro studies indicate that phosphorylation of H3S10 prevents the methylation 
of H3K9. Moreover, it was also reported that H3S10 phosphorylation coupled
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Figure 4.6: Distribution of H3K27me3 histone modifications on the Hoxa4 
and Hoxa5 genes in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against H3K27me3. The graphs display the 
relative enrichment [Bound (specific) - Bound (pre-immune)], where non-
specific binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes and was   performed in triplicate from two ChIP experiments. Error 
bars represent the standard error of the mean. 
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Figure 4.7: Distribution of H3K9me2 histone modifications on the Hoxa4 
gene in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panel) were differentiated into 
megakaryocytes (Megs, Lower panel). Chromatin was extracted and 
immunoprecipitated with antibody against H3K9me2. The graphs display the 
relative enrichment [Bound (specific) - Bound (pre-immune)], where non-
specific binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 gene 
and was performed in triplicate from one or two ChIP experiments. Error bars 
represent the standard error of the mean. 
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with H3K9 acetylation leads to the activation of genes (Jenuwein and Allis, 2001; Li, Hall et 
al., 2002). Previous in vitro studies with the MLL1 SET domain show that the combination 
of H3K9ac and H3S10p stimulates MLL1 SET domain histone methyl-transferase activity in 
vitro (Nightingale et al., 2007). It was of interest if this in vitro observation had in vivo 
consequences for MLL1 regulation. The phosphorylation of H3S10 seems to be involved in 
the regulation of genes through its association with other marks. Could therefore the dual 
modification, H3K9acS10p, contribute to the regulation of the Hoxa genes in this model? 
4.2. Is H3S10p contributing to the regulation of the Hoxa genes? 
To address this question, the distribution of phosphorylated H3S10 associated with the 
acetylated H3K9 was examined using an antibody recognising the dual mark, H3K9acS10p, 
in undifferentiated HPC-7 cells and in megakaryocytes (Figure 4.8). Examination of the 
distribution of this association of epigenetic marks on Hoxa4 (Figure 4.8, Left panels) in 
undifferentiated HPC-7 cells, shows a clear enrichment over the transcription start site, 
correlating with the peaks of H3K4me3 and H3K9ac. This peak is removed in 
megakaryocytes. Similarly, an analogous pattern is seen on Hoxa5 (Figure 4.8, Right panels): 
an enrichment of this dual mark over the transcription start site in undifferentiated HPC-7 
cells, also followed by a four-fold reduction in megakaryocytes. It should be noted that a 
general increase of H3S10p was previously observed in megakaryocytes (i.e. Figure 3.8). 
Localised Hoxa-specific decrease in H3S10p suggests that proteins with phosphatase activity 
contribute to Hoxa regulation.  
Moreover, the distribution of this phosphorylated mark follows the distribution of the H3K4 
methylation, in undifferentiated HPC-7 cells and in megakaryocytes. This suggests that these 
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Figure 4.8: Distribution of H3K9acS10p histone modifications on the Hoxa4 
and Hoxa5 genes in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against the dual H3K9acS10p. The graphs 
display the relative enrichment [Bound (specific) - Bound (pre-immune)], where 
non-specific binding (ns) obtained from pre-immune bound is subtracted. PCR 
was performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes and was   performed in triplicate from two or three ChIP 
experiments. Error bars represent the standard error of the mean. (**p<0.001, 
*p<0.02, student test, comparing binding at Hoxa4/1 and Hoax4/2 Left panel. 
Comparing Hoxa5/2 and Hoxa5/3, Right panel). 
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marks may be related, though it is important to note that the apparent correlation between 
these two marks does not necessarily imply that the enzymes or processes that drive these 
changes are linked. This is consistent with our knowledge of the MLL complex, which has no 
known histone kinase subunit. 
This suggests novel kinase and phosphatase proteins (or kinase and phosphatase complexes) 
take part in the regulation of Hoxa genes through their histone modification activity (Figure 
4.9).  The identity of the kinase protein will be discussed in the following chapter.
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Figure 4.9: Suggested model of interaction  
Other proteins were proposed to interact with the MLL complex in order to 
participate in the regulation of Hoxa genes during differentiation: a histone 
H3S10p-specific kinase, and a histone phosphatase !
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5. HOW ARE HISTONE MARKS REGULATED? 
Specific enzymes deposit histone modifications. Histone methylation is deposited by histone 
methyl-transferases on lysines and arginines, whereas histone acetylation is deposited by 
histone acetyl-transferases on lysines. These modifications are typically recognised by 
“effector proteins”, which induce functional changes in chromatin and are associated with 
regulation of gene expression. In this chapter we focus on the histone methyl-transferase 
MLL, which is involved in the regulation of Hox gene expression during haematopoiesis 
(Ernst et al., 2004b). As described earlier, Mll1 is expressed in undifferentiated HPC-7 cells 
and in megakaryocytes. 
5.1. Global abundance of MLL complex proteins upon differentiation 
As differentiation is associated with the down-regulation of several MLL-target genes, 
(Chapter 4), we initially wondered whether this was driven by the down-regulation of 
proteins of the MLL complex. MLL1 is part of a multi-protein complex, including the DNA 
binding protein menin, and other proteins such as transcriptional co-activating factors and 
enzymes involved in the modification of histone marks. As the enzyme of interest, MLL 
abundance was first assessed in undifferentiated HPC-7 cells and in megakaryocytes (Figure 
5.1a), using an antibody raised against the C-terminal part of MLL1 (Upstate).  The protein 
loading was normalised with ß-actin. It was observed that MLL1 abundance is similar in both 
HPC-7 cells and megakaryocytes. This is perhaps a surprise, given the substantial changes 
between these two cell types, especially the increase in ploidy. Could then MLL1 still be 
present in the cells, but relocated, regulated by another protein in the MLL complex? As a 
component of the MLL complex, menin is a DNA binding protein, presumed to be involved 
in the recruitment of the MLL complex to the DNA. As with MLL1, menin abundance was 
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Figure 5.1: Protein quantification of (a) MLL1 and (b) menin  in 
undifferentiated HPC-7 cells and megakaryocytes 
MLL1 and menin abundance was assessed by Western blotting with an anti-
MLL1-C terminal antibody (UpState), and an anti-menin antibody (AbCam), in 
undifferentiated HPC-7 (Undiff) and in megakaryocytes (Megs). Equal loading 
was assessed using ß-actin. 
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assessed by Western blotting using a menin-specific antibody (AbCam) (Figure 5.1b). 
Interestingly, there is a substantial drop in the abundance of menin in megakaryocytes. This 
reduction is also observed for what is assumed to be phosphorylated menin (Upper band). 
Since menin is involved in the recruitment of the MLL complex to the DNA, the reduction of 
the abundance of menin could suggest reduced MLL1 recruitment.  
This suggests a possible mechanism for the relocation of the MLL complex during 
differentiation. However this is a global change in protein, we were interested in similar 
events occurring at individual MLL-target genes.  
5.2. Is there a relationship between histone marks and proteins of the MLL 
complex? 
In order to examine the relationship between the distribution of histone marks and the 
presence of proteins of the MLL complex, the distribution of some components of the MLL 
complex was assessed on Hoxa4 and Hoxa5 in both undifferentiated HPC-7 cells and 
megakaryocytes. This investigation was performed using chromatin immunoprecipitation on 
formaldehyde cross-linked chromatin (X-ChIP) in both cell types. The proteins analysed 
were MLL1, menin, the MLL complex component histone acetyl-transferase CBP as well as 
the complex RNA Polymerase II.  
The results displayed correspond to the ratio of the amount of DNA in bound fractions and 
normalised to the input (amount of DNA in the bound fraction performed with the pre-
immune IgG). The distribution of the primer sets along the gene are represented on a picture 
above the graphs.  
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5.2.1.  Distribution of MLL1 binding on Hoxa genes 
The distribution of specific proteins of the MLL complex was analysed over the Hoxa4 and 
Hoxa5 genes, and compared with the deposition of histone marks (Figure 5.2). MLL1 was 
then the first protein examined. The antibody used to assess MLL1 distribution over these 
genes targets the C-terminal part of MLL1 (Upstate/Millipore). On Hoxa4 (Figure 5.2, Left 
panels), an enrichment of MLL1 was observed upstream of the transcription at start site of 
the gene (Hoxa4/1 primer set) in undifferentiated HPC-7 cells (Upper panel). Surprisingly, 
this location is upstream of the site of enrichment of H3K4me3 (Cf. Figure 4.3). There is a 
18-fold drop of this enrichment in megakaryocytes (Lower panel), consistent with the 
reduction in H3K4me3 at this gene after differentiation. Similarly, on the Hoxa5 gene (Figure 
5.2, Right panels), an enrichment of the C-terminal part of MLL1 is detected in 
undifferentiated HPC-7 cells, again just upstream of the transcription start site (Upper panel) 
(Hoxa5/2). Again, it is noticeable that this enrichment is situated upstream of the enrichment 
of H3K4me3 (Hoxa5/3), and is lost in megakaryocytes when the gene is silenced.  
Furthermore, it should be noticed that the enrichment detected over the Hoxa4 gene is larger 
and more variable than that seen on Hoxa5: this may reflect that the primer sets used to 
characterise this enrichment on Hoxa5 (Hoxa5/2, at -129 bp) are closer to the transcription 
start site than the primer sets used on Hoxa4 (Hoxa4/1, at -1,342 bp). However, the peak of 
H3K4me3 is at the TSS on both genes. 
In order to examine the apparent inconsistency between the site of MLL1 binding, and the 
mark that it deposits, the distribution of MLL1 on Hoxa4 was assessed using an alternative 
antibody against the N-terminal of MLL1, in undifferentiated HPC-7 cells and 
megakaryocytes (Figure 5.3) (thanks to L. Ringrose’s group, Vienna, Austria). This indicates 
that the N-terminal domain displays a similar pattern of enrichment to that observed with the 
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Figure 5.2: Distribution of Histone Methyl Transferase MLL1 (C-Term) on 
the Hoxa4 and Hoxa5 genes in undifferentiated HPC-7 cells and 
megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against the C-terminal part of MLL1. Graphs 
display the relative enrichment [Bound (specific) - Bound (pre-immune)], where 
non-specific binding (obtained from pre-immune bound) is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes, and was performed in triplicate from one or two ChIP 
experiments. Error bars represent the standard error of the mean. 
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C-terminal domain on Hoxa4 in undifferentiated HPC-7 cells (Upper panel). The peak over 
Hoxa4/1 is then lost in megakaryocytes (Lower panel), as with the C-terminal domain of 
MLL1 (Cf. Figure 5.2). This confirms that the two domains of MLL1 protein are present and 
recruited to these genes, and that the MLL complex does occupy a promoter, rather than 
TSS-adjacent site.  
5.2.2. Distribution of menin 
As a key factor in the recruitment of the MLL complex, the distribution of menin was 
subsequently examined on Hoxa4 and Hoxa5 (Figure 5.4). An enrichment of menin binding 
was observed upstream of the TSS on Hoxa4 in undifferentiated HPC-7 cells (Figure 5.4, 
Left panels), similar to the one observed with the C and N-terminal domains of MLL1 (Cf. 
Figures 5.2 and 5.3). This correlates with the idea that the MLL complex is recruited to the 
DNA along with menin. Moreover, there is a loss of menin binding in megakaryocytes 
(Lower panel). As shown previously, there is a global reduction in menin abundance upon 
differentiation, whereas the global MLL1 abundance displayed no changes. But these X-ChIP 
results show that the presence of MLL1 on the Hoxa4 gene decreases, in parallel with a 
reduction in menin binding at the same site (Cf. Figures 3.4, 3.5 and 3.6). This confirms 
earlier reports that MLL1 and menin act as part of the same complex, both binding the same 
sites on the Hoxa4 gene. This could suggest that in megakaryocytes, the down-regulation of 
menin impacts on MLL1 function, which could be either relocated to different loci in the cell 
after differentiation, or become functionally inactivated, despite being maintained at pre-
differentiation levels. Looking at the distribution of menin on the Hoxa5 gene (Figure 5.4, 
Right panels), similar observations were made: there is an enrichment of menin upstream to 
the gene (Hoxa5/2) (Upper panel), which is lost in megakaryocytes (Lower panel). 
Interestingly, the distribution of menin on both Hoxa genes follows that of the C-terminal 
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Figure 5.3: Distribution of Histone Methyl Transferase MLL1 (N-Term) on 
the Hoxa4 gene in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panel) were differentiated into 
megakaryocytes (Megs, Lower panel). Chromatin was extracted and 
immunoprecipitated with antibody against the N-terminal part of MLL1. Graphs 
display the relative enrichment [Bound (specific) - Bound (pre-immune)], where 
non-specific binding (ns) obtained from pre-immune bound is subtracted. PCR 
was performed with primer sets corresponding to specific sites on the Hoxa4 
gene, and was performed in triplicate from one ChIP experiment. 
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Figure 5.4: Distribution of menin on the Hoxa4 and Hoxa5 genes in 
undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against menin. Graphs display the relative 
enrichment [Bound (specific) - Bound (pre-immune)], where non-specific 
binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes, and was performed in triplicate from one or two ChIP 
experiments. Error bars represent the standard error of the mean. 
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part of MLL1. Furthermore, these sites are detected upstream of the TSS of the gene 
(Hoxa4/1 and Hoxa5/2), whilst a peak of H3K4 methylation was observed over the TSS (Cf. 
Figure 4.3: Hoxa4/2 and Hoxa5/3).  
5.2.3.  Distribution of a specific histone acetyl-transferase: CBP 
Previous studies indicate that transcriptional co-activators, like CBP and MOF, may modify 
components of the basal machinery or Polymerase II, as well as targeting chromatin. 
However, recent studies also indicate that both histone acetyl-transferases are members of the 
MLL complex. Therefore, it was first investigated how another enzyme belonging to the 
MLL complex, CBP (CREB Binding Protein), was recruited along these genes, in 
undifferentiated HPC-7 cells (Figure 5.5). CBP is a histone acetyl transferase involved in the 
acetylation of a number of residues. Assessment was performed by X-ChIP, as with MLL1 
and menin. It was first observed that the Hoxa4 gene is enriched with CBP, in the coding 
region of the gene (Hoxa4/3) (Figure 5.5, Left panel). Although, it is striking that the CBP 
distribution does not reflect the distribution of H3K9ac in undifferentiated cells, it does 
reflect the distribution in megakaryocytes (Cf. Figure 4.4). Thus, unlike MLL1 and menin, 
CBP appears to be located in a more downstream region. On the other hand, CBP is enriched 
over the TSS on Hoxa5 (Figure 5.5, Right panel) in undifferentiated HPC-7 cells. This 
enrichment is slightly weaker than on Hoxa4 though. Moreover, CBP is also observed to bind 
on the downstream region of the coding part of the gene. It is clear that CBP distribution 
warrants further investigation.  
5.2.4.  Distribution of RNA Polymerase II 
Finally, the distribution of the RNA Polymerase II was assessed on the Hoxa4 and Hoxa5 
genes (Figure 5.6). On Hoxa4 (Figure 5.6, Left panels), in undifferentiated HPC-7 cells 
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Figure 5.5: Distribution of Histone Acetyl Transferase CBP on the Hoxa4 
and Hoxa5 genes in undifferentiated HPC-7 cells 
Chromatin of undifferentiated HPC-7 cells (Undiff) was extracted in 
undifferentiated cells, and then immunoprecipitated with antibody against CBP. 
Graphs display the relative enrichment [Bound (specific) - Bound (pre-
immune)], where non-specific binding (ns) obtained from pre-immune bound is 
subtracted. PCR was performed with primer sets corresponding to specific sites 
on the Hoxa4 and Hoxa5 genes, and was performed in triplicate from one ChIP 
experiment. 
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(Upper panel), an enrichment of RNA Polymerase II binding was observed over the TSS 
(Hoxa4/2). Thus, RNA Polymerase II appears to bind on, or near to the site carrying a high 
level of H3K4 methylation. Surprisingly, this protein remains bound on this same site in 
megakaryocytes (Lower panels), despite Hoxa4 gene expression being substantially reduced 
in megakaryocytes. As with Hoxa4, RNA Polymerase II is present on Hoxa5 (Figure 5.6, 
Right panels), with a peak of enrichment upstream to the TSS of the gene (Hoxa5/2) in 
undifferentiated HPC-7 cells (Upper panel), but in megakaryocytes (Lower panel), binding 
decreases, and the peak shifts some 100bp downstream (Hoxa5/3). This might reflect the 
down-regulation of this gene in megakaryocytes (characterised by a reduction of Hoxa5 
transcript abundance). However, the presence of RNA Polymerase II on both Hoxa4 and 
Hoxa5 genes in megakaryocytes, whilst the abundance of the transcripts of these genes is 
decreased, could also reflect RNA Polymerase promoter-proximal pausing, a mechanism 
seen on silenced genes (Strobl and Eick, 1992). 
5.2.5.  Could another histone methyl-transferase be involved in Hoxa regulation? 
These results indicate that active Hoxa genes are associated with an enrichment of H3K4 
methylation, which associates with a peak of MLL1 at an adjacent site. However, MLL1 is 
not the only enzyme with the binding capacity to generate this mark (H3K4me3). Indeed, 
mouse and human MLL1 possess a close homologue, MLL4, which can also trimethylate 
H3K4. Mouse Mll1 and Mll4 genes are orthologues (Glaser et al., 2006; Bach et al., 2009) 
and share a high degree of homology, contain very similar SET domains (Glaser et al., 2006), 
and associate with the same proteins including WDR5, ASH2, RbBP5 and menin (Eissenberg 
et al. 2009). The distribution of MLL4 was then assessed using an antibody (Ab39267) raised 
against the C-terminal domain of human MLL4 (also called MLL2), the homologue of the 
Drosophila trithorax gene (Huntsman et al., 1999), and that we will call “MLL4”. The 
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Figure 5.6: Distribution of the RNA Polymerase II on the Hoxa4 and Hoxa5 
genes in undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against the C-terminal part of RNA 
Polymerase II. Graphs display the relative enrichment [Bound (specific) - Bound 
(pre-immune)], where non-specific binding (ns) obtained from pre-immune 
bound is subtracted. PCR was performed with primer sets corresponding to 
specific sites on the Hoxa4 and Hoxa5 genes, and was performed in triplicate 
from one or two ChIP experiments. Error bars represent the standard error of the 
mean. 
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distribution of MLL4 was examined on Hoxa4 and Hoxa5 in undifferentiated HPC-7 cells 
(Figure 5.7), and showed an enrichment of this protein over the TSS of Hoxa4 (Figure 5.7, 
Left panel), correlating with an enrichment of H3K4 methylation at the same site. Thus, 
MLL4 occupies a site just downstream of MLL1, though it seems unlikely that these two 
large complexes co-occupy the same promoter. On Hoxa5 (Figure 5.7, Right panel), an 
enrichment of MLL4 is observed over the transcription start site of the gene, as with MLL1. 
However, MLL4 is also present at a same level within the body of the gene, raising the 
question of whether both complexes can bind simultaneously, how they are recruited to the 
promoter, and what the functional consequences of the two complexes are. 
The presence of these two histone methyl-transferases at different sites within the Hoxa4 
gene suggests that the MLL1 and MLL4 antibodies recognise distinct proteins. However, 
MLL1 and MLL4 are highly similar, so we checked whether the corresponding antibodies 
were specific for their target proteins. This was assessed by Western blotting using both anti-
MLL1 and anti-MLL4 antibodies to probe whole cell extract: in both case, bands of distinct 
size were detected, corresponding either to MLL1C (MW=180kDa) or MLL4 
(MW=293kDa). The blot performed with the MLL4 antibody shows multiple proteins in 
addition to the one of expected size though (Data not shown), suggesting it is at least partially 
non-specific.  
In the previous chapter, it was highlighted that another two histone modifying enzymes could 
also be involved in the regulation of Hoxa genes, through the phosphorylation and 
dephosphorylation of H3S10. Indeed, it has been shown that the Hoxa4 and Hoxa5 promoters 
are enriched with H3S10 phosphorylation in undifferentiated cells. This pattern of 
distribution mirrors that of H3K4 methylation and is also reduced in megakaryocytes. Only a 
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Figure 5.7: Distribution of Histone Methyl Transferase MLL4 on the Hoxa4 
and Hoxa5 genes in undifferentiated HPC-7 cells 
Chromatin of undifferentiated HPC-7 cells (Undiff) was extracted in 
undifferentiated cells, and then immunoprecipitated with antibody against 
MLL4. Graphs display the relative enrichment [Bound (specific) - Bound (pre-
immune)], where non-specific binding (ns) obtained from pre-immune bound is 
subtracted. PCR was performed with primer sets corresponding to specific sites 
on the Hoxa4 and Hoxa5 genes, and was performed in triplicate from one ChIP 
experiment. 
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small number of kinases are known to show H3-specifity, or might be involved in the 
regulation of Hoxa genes. One appeared to be a good candidate: Msk1 (Figure 5.8). Indeed, 
Msk1 has been shown to phosphorylate H3 on serine 10 (Vicent et al., 2006), and is recruited 
to promoters, leading to H3S10 phosphorylation over the promoter of these genes (Bruck et 
al., 2009). Moreover, it was suggested that the phosphorylated H3S10 mark, in association 
with other histone modifications, could be a platform for the subsequent recruitment of 
chromatin-remodelling complexes (MacDonald et al., 2005; Vicent et al., 2006; Bruck et al., 
2009). We therefore examined Msk1 distribution over the Hoxa4 and Hoxa5 genes to 
determine whether it contributes to MLL target gene regulation.  
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Figure 5.8: Suggested model of interaction of Msk1 with the MLL complex 
Histone modification distributions suggest that a histone H3S10-specific kinase 
and phosphatase contribute to Hoxa gene regulation. It is unclear whether the 
kinase Msk1, which is detected on these genes, is part of the MLL complex, or is 
recruited independently. !
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6. DOES MSK1 CONTRIBUTE TO HOXA GENE REGULATION? 
6.1. How is Msk1 distributed along Hoxa genes? 
Msk1 (Mitogen- and Stress- activated Protein Kinase 1) is a protein kinase involved in the 
phosphorylation of H3S10 (Soloaga et al., 2003), but is also downstream of the Jnk 
signalling pathway (Huang et al., 2006). Our data suggests that H3S10p contributes to Hoxa 
gene activation. In order to examine the role of Msk1 as part of the mechanism of regulation 
of Hoxa genes, its distribution was examined on Hoxa4 and Hoxa5, in undifferentiated HPC-
7 cells and megakaryocytes (Figure 6.1). An enrichment of Msk1 was observed over the TSS 
of Hoxa4 in undifferentiated HPC-7 cells (Hoxa4/2) (Figure 6.1, Upper left panel), whereas 
this peak is lost in megakaryocytes (Lower panel). Interestingly, this distribution mirrors the 
patterns of both H3K9acS10p and RNA polymerase II, in undifferentiated HPC-7 cells, with 
the peak of Msk1 binding just downstream of the MLL1 and menin binding sites. In contrast, 
on the Hoxa5 gene (Figure 6.1, Right panels), there is only a slight enrichment of Msk1 over 
the TSS of the gene in undifferentiated HPC-7 cells (Upper panel), but a similar absence of 
the protein in megakaryocytes (Lower panel). This distribution also follows the distribution 
of proteins of the MLL complex and of RNA polymerase II (with a peak on Hoxa5/2), with 
the Msk1 binding site positioned just upstream of the peaks of H3K9acS10p and H3K4 
trimethylation (Hoxa5/3). However our inability to detect an equivalent peak of Msk1 on 
Hoxa5 is surprising, given the large peak of H3S10p found on the gene. Thus, on both genes, 
the sites of Msk1 binding correlates with the modifications deposited by proteins of the MLL 
complex, but the relative abundance of the enzymes and modifications do not correlate. 
These data suggest that Msk1 is either part of the MLL complex or acts together with the 
MLL complex to regulate Hoxa gene expression. 
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Figure 6.1: Distribution of Msk1 on the Hoxa4 and Hoxa5 genes in 
undifferentiated HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Undiff, Upper panels) were differentiated into 
megakaryocytes (Megs, Lower panels). Chromatin was extracted and 
immunoprecipitated with antibody against Msk1. Graphs display the relative 
enrichment [Bound (specific) - Bound (pre-immune)], where non-specific 
binding (ns) obtained from pre-immune bound is subtracted. PCR was 
performed with primer sets corresponding to specific sites on the Hoxa4 and 
Hoxa5 genes, and was performed in triplicate from one, two or three ChIP 
experiments. Error bars represent the standard error of the mean. 
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In order to assess whether Msk1 is a component of the MLL complex, we performed co-
immunoprecipitation assays using several antibodies recognising components of the MLL 
complex (MLLC, MLLN, and CBP) and Msk1. We also used NF!B as an Msk1 - NF!B 
interaction has been previously described (Reber et al., 2009) (Figure 6.2). A whole-cell 
extract of undifferentiated HPC-7 cells was used as a source of material, and 
immunoprecipitated with either MLL1 (C- or N-terminal), NF-!B, Msk1 or CBP antibody. 
Each of these samples was separated on a 7% SDS gel, before transfer to a nitrocellulose 
membrane. The interaction between MLL1 and Msk1 was assessed by Western Blotting of a 
membrane containing proteins immunoprecipitated with either MLLC, MLLN or CBP 
antibodies. Western blotting with Msk1 was performed several times with reproducible 
results (Figure 6.2a). Msk1 (87kDa) is observed to associate with MLLC and NF!B, but the 
interaction is consistently weaker for binding to MLLC (lane 1) than to NF!B (lane 5). In 
contrast, no interaction of Msk1 was observed with MLLN (lane 2) or CBP (lane 4).  
As a control, the “reverse” IP was performed (Figure 6.2b). An anti-NF!B was shown to 
successfully immunoprecipitate NF!B (lane 2), but failed to co-immunoprecipitate Msk1 
(lane 3). Similarly, probing with MLLC or MLLN antibodies failed to show the reverse 
interaction of MLLC with Msk1. These experiments suggest that if MLLC and Msk1 interact, 
these interactions are likely to be weak or transitory (Figure 6.2a). Further IP studies with 
other Msk antibodies (currently unavailable) will be necessary to confirm this interaction. 
6.2. Importance of Msk1 as an actor of Hoxa gene regulation? 
The previous data seems to suggest that Msk1 is an essential component of the mechanism of 
regulation of the Hoxa genes. We intended to assess the importance of Msk1 in the regulation 
of Hoxa genes, by artificially altering the distribution of Msk1 deposited histone 
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Figure 6.2: Co-immunoprecipitation of MLL complex interacting proteins 
Interactions between MLL, NF#B, CBP and Msk1 were assessed by 
immunoprecipitation with the corresponding antibodies (anti-MLL1C antibody 
(Upstate), anti-MLL1N antibody (Upstate), anti-NF#B antibody (AbCam), anti-
Msk1 antibody (AbCam) and anti-CBP antibody (Upstate), and then by Western 
Blotting with (a) Msk1 or (b) NF#B antibodies. Proteins of interest are indicated 
with an arrow. 
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modifications. Thus, two different drugs were used to alter the normal abundance of 
phosphorylation of H3S10 in HPC-7 cells, in order to examine whether this induced changes 
in Hoxa gene expression.  
6.2.1.  What are the global changes on histone modifications after treatment with 
okadaic acid?  
In a first instance, the toxin okadaic acid, which strongly inhibits serine/threonine 
phosphatases, was used in order to increase the abundance of phosphorylated histone marks 
by preventing their removal. Undifferentiated HPC-7 cells were treated with a range of 
okadaic acid concentrations, and a time-course experiment was performed, in order to 
determine the effect of this agent on global histone modifications. Cells were treated with 1, 
5 or 10nM okadaic acid, histones were extracted and histone modification abundance 
quantified by Western blotting using a range of appropriate antibodies including 
H3K9acS10p (Ab12181), H3S10p (Ab14955), H3T3p (Ab17352). We also analysed the non-
phospho-isoform H4K16ac (Lab 252) as a control to examine whether okadaic acid only has 
impacts on histone phosphorylation (Figure 6.3a). The bottom panel shows after Coomassie 
staining that histones were equally loaded (“Total histone”), though Western analysis with a 
Histone H3 C-terminal antibody (AbCam) was used to normalise for protein loading. All 
marks examined show an increased abundance following the addition of a gradient of 
okadaic acid (Figure 6.3b). The highest increase is observed for the dual mark H3K9acS10p, 
which shows a #2.5-fold rise, whilst H3S10p is only slightly increased (It appears to be 
reduced due to unequal histone loading). In addition, another phosphorylated mark, H3T3p, 
shows a #2-fold increase after treatment with 10nM okadaic acid, confirming that the agent is 
not selective for serine-specific phosphatases. Perhaps not surprisingly, H4K16ac abundance, 
which would not be expected to increase as a direct effect of okadaic acid, also shows a small 
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Figure 6.3: Quantification of histone modifications after exposure to 
gradient of concentration of okadaic acid in undifferentiated HPC-7 cells 
Undifferentiated HPC-7 cells were treated with 1, 5 or 10nM of okadaic Acid for 
24 hours. Histones were extracted and specific marks were examined by (a) 
Western blotting using appropriate antibodies (H3K9acS10p, H3T3p, H4K16ac 
and H3S10p).  The gel is shown to be equally loaded (SDS gel). (b) 
Quantification is presented on a graph, normalised to the control, set at 1. 
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increase, suggesting that either “histone cross-talk” effects, or secondary, indirect gene 
effects take place after treatment.  
Subsequently, a time-course experiment with 10nM okadaic Acid treatment of 
undifferentiated HPC-7 cells was performed in order to identify the ideal window of 
treatment with this toxin. Undifferentiated HPC-7 cells were treated with 10nM okadaic acid 
for 1, 2, 4, 8, 12, 18 and 24 hours. Histone were extracted as previously described and their 
abundance was quantified by Western blotting using H3K9acS10p or H4K16ac antibodies 
(Figure 6.4), using detection by the H3 C-terminal antibody (AbCam) to normalise for protein 
loading. As shown before, H4K16ac shows a small change (10% increase) during the time-
course. By this assessment, global H3K9acS10p modification seems to be the highest 
between four and eight hours treatment.  
In undifferentiated HPC-7 cells, active Hoxa genes were associated with H3S10p enrichment 
over the promoter of genes, whilst a reduction of Hoxa gene expression in megakaryocytes 
was associated with the loss of this mark. We hypothesised that the increase in H3S10P 
abundance due to okadaic acid treatment would lead to an increase of MLL target gene 
expression in both undifferentiated HPC-7 cells and megakaryocytes (Figure 6.5). We 
therefore examined the transcript abundance of specific Hoxa genes following treatment of 
undifferentiated HPC-7 cells and megakaryocytes with 1, 5 or 10nM okadaic acid for 8  (data 
not shown) and 24 hours (Figure 6.6). After eight hours of treatment, slight changes of the 
level of MLL target gene expression in undifferentiated HPC-7 cells were observed, with 
only small changes at Hoxa4 and Gapdh (1.2 and 1.5-fold changes respectively). No changes 
were observed with Hoxa2, Hoxa3 and Hoxa5.  
Changes in the level of gene expression following 24 hours of 10nM okadaic acid treatment 
were then examined in undifferentiated HPC-7 cells and megakaryocytes (Figure 6.6). The 
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Figure 6.4: Effect of okadaic acid on histone modification abundance in 
undifferentiated HPC-7 cells 
Undifferentiated HPC-7 cells were treated with 10nM okadaic acid for 1, 2, 4, 8, 
12, 18 and 24 hours. Histones were extracted and specific marks were examined 
by Western blotting using appropriate antibodies (H3K9acS10p, and H4K16ac). 
Mark abundance is normalised to untreated control cells. 
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Figure 6.5: Model of changes possible after treatment with okadaic acid 
In undifferentiated HPC-7 cells, active Hoxa genes are associated with a 
H3S10p enrichment over the promoter of genes, whilst a reduction of Hoxa gene 
expression in megakaryocytes is associated with the loss of this mark. In this 
model, it is suggested that the prevention of phosphate removal at H3S10 by the 
phosphatase inhibitor, okadaic acid, would lead to an increase of gene 
expression in both undifferentiated HPC-7 cells and megakaryocytes. 
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expression of several genes (Hoxa2, Hoxa3, Hoxa4, Hoxa5 and Gapdh) was examined in 
response to this treatment, where gene expression is normalised with the level of expression 
in control cells (cells treated with DMSO). In undifferentiated cells (Figure 6.6, Upper 
panel), an increase of gene expression Hoxa4 and Gapdh (1.4 and 3-fold respectively) was 
observed in correlation with an increased concentration of okadaic acid. No changes were 
observed for Hoxa2, Hoxa3 and Hoxa5. In megakaryocytes (Figure 6.6, Lower panel), only 
Hoxa3 showed a 8-fold increase of its level of expression following okadaic acid treatment, 
possibly reflecting the lower abundance of this transcript in megakaryocytes. No changes 
were observed for Hoxa2, Hoxa4, Hoxa5 and Gapdh. It should be noted that the addition of 
okadaic acid was performed after five days of megakaryocyte differentiation, suggesting that 
the Hoxa genes would be expected to have already lost H3S10 phosphorylation, as the genes 
are down-regulated. 
6.2.2.  What are the local changes on Hoxa genes after treatment with okadaic acid?  
In undifferentiated HPC-7 cells, okadaic acid induced an increase in gene expression at three 
MLL-target genes; Hoxa4, Gapdh and Hoxa5. To investigate if this increased level of gene 
expression is associated with an increase of histone phosphorylation, the distributions of 
H3S10 phosphorylation, H3K9acS10 phosphorylation and another phosphorylation mark, 
H3T3p, were examined on these genes after treatment with okadaic acid (10nM okadaic acid 
for 24 hours). As a control, cells were cultured with the addition of DMSO in the medium. 
The distribution of these marks along these genes was assessed by N-ChIP.  
The distribution of H3K9acS10p was first examined along Hoxa4 and Hoxa5 genes in 
untreated (Upper panels) and treated HPC-7 cells (Lower panels) (Figure 6.7). Both Hoxa4 
and Hoxa5 genes display the same distribution as previously described (Cf. Figure 4.8). On 
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Figure 6.6: Effect of okadaic acid on gene expression in undifferentiated 
HPC-7 cells and megakaryocytes 
Undifferentiated HPC-7 cells (Upper panel) or megakaryocytes (Lower panel) 
were treated with 1, 5 or 10nM okadaic acid for 24 hours. qRT-PCR was 
performed with primer sets corresponding to  the coding region of Hoxa2, 
Hoxa3, Hoxa4, Hoxa5 and Gapdh, and was performed in triplicate from one or 
two experiments. Error bars represent the standard error of the mean. 
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the Hoxa4 gene (Figure 6.7, Left panels), an enrichment of H3K9acS10 phosphorylation was 
observed over the transcription start site of the gene (Hoxa4/2) (Upper panel), which showed 
a 1.5 fold increase after treatment with 10nM okadaic acid (Lower panel). Similarly, on 
Hoxa5 (Figure 6.7, Right panels), an enrichment of the dual mark H3K9acS10p was 
observed over the TSS (Hoxa5/3) (Upper panel), which is then increased by 10-fold after 
treatment with 10nM okadaic acid (Lower panel). This suggests that the enhancement of 
Hoxa4 and Hoxa5 gene expression in undifferentiated HPC-7 cells, after treatment with 
okadaic acid, is associated with an increase in H3K9acS10p abundance at their promoters, 
but also implies that an unknown phosphatase is acting at these loci.  
Then, the distribution of the particular mark H3S10p was assessed on the Hoxa4 and Hoxa5 
genes in undifferentiated HPC-7 cells (Figure 6.8). Surprisingly, on Hoxa4 (Figure 6.8, Left 
panels), this mark is essentially absent in untreated cells (Upper panel), and only shows a 
minor increase in treated cells (Lower panel). This is difficult to explain given the peak of 
H3K9acS10p at the TSS of Hoxa4, and that a similar peak of H3S10p is observed at the TSS 
of Hoxa5 (Hoxa5/2) in untreated cells (Figure 6.8, Right panels). This enrichment is then 
increased by 30-fold in treated cells (Lower panel). Interestingly, the enrichment of H3S10p 
is situated on a site just upstream (Hoxa5/2) to the site enriched with H3K9acS10p 
(Hoxa5/3). Thus, in both cases, Hoxa4 has lower levels of these marks (H3K9acS10p, 
H3S10p) despite showing similar levels of H3K4me3 (Cf. Figure 4.3). This is consistent with 
the output of the two genes: Hoxa4 (Ct = 30) is much less transcriptionally active than Hoxa5 
(Ct = 23) (Cf. Figure 3.3), and may suggest that these phospho-marks, rather than H3K4me3, 
reflect the level of transcription.  
Finally, the distribution of another phosphorylated mark, H3T3p, was assessed in untreated 
and okadaic acid treated HPC-7 cells, on Hoxa4 and Hoxa5 (Figure 6.9). This mark is a 
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Figure 6.7: Distribution of H3K9acS10p histone modifications on the Hoxa4 
and Hoxa5 genes in the control undifferentiated HPC7 cells and after 
treatment with 10nM of okadaic acid 
Undifferentiated HPC7 cells were treated with either DMSO (as a control, 
Upper panels) or with 10nM of okadaic acid (Lower panels), for 24 hours. 
Chromatin was extracted and immunoprecipitated with antibody against 
H3K9acS10p. Graphs display the relative enrichment [Bound (specific) - Bound 
(pre-immune)], where non-specific binding (ns) obtained from pre-immune 
bound is subtracted. PCR was performed with primer sets corresponding to 
specific sites on the Hoxa4 and Hoxa5 genes and was   performed in triplicate 
from one or two ChIP experiments. Error bars represent the standard error of the 
mean. 
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Figure 6.8: Distribution of H3S10p histone modifications on the Hoxa4 and 
Hoxa5 genes in the control undifferentiated HPC7 cells and after treatment 
with 10nM of okadaic acid 
Undifferentiated HPC7 cells were treated with either DMSO (as a control, 
Upper panels) or with 10nM of okadaic acid (Lower panels), for 24 hours. 
Chromatin was extracted and immunoprecipitated with antibody against 
H3S10p. Graphs display the relative enrichment [Bound (specific) - Bound (pre-
immune)], where non-specific binding (ns) obtained from pre-immune bound is 
subtracted. PCR was performed with primer sets corresponding to specific sites 
on the Hoxa4 and Hoxa5 genes and was   performed in triplicate from one or 
two ChIP experiments. Error bars represent the standard error of the mean. 
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control, as we have little insight into its regulatory role, but it is known to have an inhibitory 
effect on MLL activity (Southall et al., 2009). Interestingly, H3T3p displays a similar pattern 
of distribution on Hoxa4 to that of H3S10p (Figure 6.9, Left panels). Indeed, in untreated 
cells (Upper panel), the low levels of H3T3p, suggesting this mark is essentially absent, 
indicate that this does not contribute to Hoxa4 regulation (Lower panel). However, on Hoxa5 
(Figure 6.9, Right panels), an enrichment of H3T3p was observed over the transcription start 
site of the gene (Upper panel), which is then reduced (three-fold decrease) after treatment 
with okadaic acid (Lower panel) (Southall et al., 2009). This is in contrast with the global 
increase in this mark upon okadaic acid treatment, but is consistent with the increase in 
Hoxa5 gene activity. 
6.2.3.  Changes after treatment with an inhibitor of H3S10 phosphorylation? 
Having investigated gene expression and histone modification changes occurring after 
treatment with a phosphatase inhibitor, we examined the changes induced following 
treatment with an inhibitor of H3S10 phosphorylation, the Jun N-terminal Kinase inhibitor 
SP6000125 (Huang et al., 2006). As with okadaic acid, a time-course was performed in order 
to determine the effect of this agent on global histone modifications (Figure 6.10).  
Undifferentiated HPC-7 cells were treated with 10nM Jnk inhibitor for 1, 2, 4, 8, 12 and 24 
hours, and the global changes in H3K9acS10p, H3S10p and H4K16ac were examined. All 
three histone marks display a major decrease in abundance between four and eight hours 
(#30%). The parallel response H4K16ac is an indication that these cannot be “clean” 
experiments in which a single class of modifications are modulated without functional 
impacts elsewhere in the nucleus. This is perhaps not surprising given that the five-hour 
treatment allows a broad range of processes to occur. The impact on H3K16ac could reflect 
direct histone cross-talk, for example MOF, an H4K16 acetyl-transferase, is dynamically 
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Figure 6.9: Distribution of H3T3p histone modifications on the Hoxa4 and 
Hoxa5 genes in the control undifferentiated HPC7 cells and after treatment 
with 10nM of okadaic acid 
Undifferentiated HPC7 cells were treated with either DMSO (as a control, 
Upper panels) or with 10nM of okadaic acid (Lower panels), for 24 hours. 
Chromatin was extracted and immunoprecipitated with antibody against H3T3p. 
Graphs display the relative enrichment [Bound (specific) - Bound (pre-
immune)], where non-specific binding (ns) obtained from pre-immune bound is 
subtracted. PCR was performed with primer sets corresponding to specific sites 
on the Hoxa4 and Hoxa5 genes and was   performed in triplicate from two or 
three ChIP experiments. Error bars represent the standard error of the mean. 
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Figure 6.10: Changes in cellular histone modifications after exposure to 
10nM Jnk inhibitor in undifferentiated HPC-7 cells 
Undifferentiated HPC-7 cells were treated with 10nM Jnk inhibitor (SP6000125) 
for 1, 2, 4, 8, 12, 18 and 24 hours. Histones were extracted and specific marks 
were examined by Western blotting using appropriate antibodies (H3K9acS10p, 
H3S10p and H4K16ac).  Mark abundance is normalised to untreated control 
cells. The protein level was normalised with the H3 C-terminal antibody. 
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recruited to chromatin by 14-3-3, a protein that recognises the H3S10p mark (Zippo et al., 
2009). However, this could also reflect indirect or secondary gene effects (i.e. increased 
H3S10p stimulates gene activity, and these gene products increase H4K16ac elsewhere in the 
genome.) 
Transcript abundance was then assessed in undifferentiated HPC-7 cells treated with 1, 25 or 
50nM Jnk inhibitor for eight hours in order to examine the changes in gene expression 
following the inhibition of H3S10 phosphorylation (Figure 6.11). Levels of gene expression 
were examined for Hoxa2, Hoxa3, Hoxa4, Hoxa5 and Gapdh. The graph displays the 
transcript abundance of each of these genes, normalised to the transcript abundance of ß-
actin. Generally, these show only small effects after eight hours of treatment, but a number of 
genes show increases (rather than the expected decreases) in transcript abundance, for 
example, Hoxa2, Hoxa3 and Hoxa5 show 1.4 - 2-fold increases at 50nM, correlating with the 
increase of the concentration of the inhibitor. No substantial changes were observed with 
Hoxa4 and Gapdh. Despite this treatment giving an unexpected increase in transcriptional 
activity, it is interesting to note that the effects at specific genes are the reverse of those seen 
with okadaic acid (okadaic acid induces changes in the order Hoxa4, Gapdh, Hoxa5, Hoxa3, 
Hoxa2 with Hoxa4 being the most expressed, i.e. Figure 6.6, whereas the Jnk inhibitor 
induces changes in the order Hoxa2, Hoxa3, Hoxa5, Hoxa4 and Gapdh with Hoxa 2 being 
the most expressed in cells treated with the highest concentration of Jnk inhibitor, ie. Figure 
6.11). 
The contribution of MLL in the regulation of Hoxa was examined in the previous chapter. It 
was shown that up-regulation of specific Hoxa genes is related to the recruitment of MLL1 to 
the promoter of these genes, and associated with the methylation of H3K4 over the 
transcription start site. Moreover, other proteins of the MLL complex, such as CBP and 
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Figure 6.11: Hoxa gene expression in response to Jnk inhibitor treatment 
Undifferentiated HPC-7 cells were treated with 1, 25 or 50nM Jnk inhibitor for 8 
hours. PCR was performed with primer sets corresponding to the coding region 
of Hoxa2, Hoxa3, Hoxa4, Hoxa5 and Gapdh, and was performed in triplicate 
from one experiment. 
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menin, were shown to interact with the same sites. The presence of CBP was shown to be 
associated with the acetylation of H3K9 over the transcription start site of these genes. In 
addition, it was shown that the TSS of MLL target genes was also enriched with H3K9acS10 
phosphorylation on active genes, followed by a decrease of this mark upon transcriptional 
silencing. In this chapter we show a correlation between the distribution of this mark and the 
distribution of the kinase Msk1, on the Hoxa4 and Hoxa5 genes, implying that this mark is 
regulated by the kinase. In addition, co-immunoprecipitation experiments detect a weak 
interaction between MLLC and Msk1, though this observation needs to be confirmed using 
other antibodies for the observation to be secure. Artificial (i.e. drug-induced) changes in 
histone phosphorylation impact on the activity of MLL-target genes, but the mechanism of 
their activity is clearly too complex for simple relationships to be identified. 
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7. ESTABLISHING SIRNA KNOCKDOWN PROTOCOLS FOR MLL1 
FAMILY MEMBERS 
In this final chapter, we discuss experiments that aimed to assess the contribution of MLL 
histone methyl-transferases to gene expression and to examine which histone modifications 
MLL complex enzymes bring to the promoter, and whether other enzymes are required. We 
proposed to use siRNA-mediated knockdown to address those questions. In order to develop 
this approach, vectors that generate siRNAi against Mll1 were designed using an open access 
website “siRNA-Wizard”. As members of the MLL family, vectors were also generated for 
Mll3 and Mll5 to investigate their contribution. Three sequences were designed to knock 
down Mll3 and Mll5 (Sequences in supplementary data) and were cloned into a commercial 
knock down vector system (pENTR/U6) (Invitrogen). In contrast commercial vectors were 
used to knock down Mll1 (Open BioSystems). MLL1 contribution was first discussed in this 
chapter.  
HPC-7 cells cannot be efficiently transfected using standard lipofection reagents (i.e. 
Lipofectamine 2000 or DMRYE C, Invitrogen). However, the transfection efficiency of 
Amaxa nucleofection in HPC-7 cells was previously optimised by Dr Fiona Tavner by 
transfecting HPC-7 cells with a GFP expressing vector or without DNA as a control (Figure 
7.1). This resulted in significant cell death, showing only 50.5% cell viability after 24 hours 
transfection (as assessed by Flow cytometry), but the percentage of transfection in these 
remaining cells was shown to be 81%  (Figure 7.1). Because of cell death, the analysis was 
limited to 24 hours post-transfection.  
 
!!!
!!!!
">J!
!
!
!
!
!
!
!
Figure 7.1: Optimisation of  transfection in HPC-7 cells 
The efficiency of Amaxa nucleofection-based transient transfection was 
previously assessed by GFP expression and subsequent flow cytometry by Dr 
Fiona Tavner. It was observed that 50.5% of cells are viable after transfection 
(Left panel). 81% of these cells have been efficiently transfected (Right panel). 
Cell viability was assessed by propidium iodide exclusion 
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7.1. Establishing conditions for Mll1 knockdown 
7.1.1.  Knockdown of Mll transcripts 
In order to optimise the knockdown, a time-course after transient transfection was performed 
(Figure 7.2a), initially using Mll1 transcript abundance to determine the optimal period for 
Mll1 knockdown. Gene expression was quantified in relation to Mll1 transcripts in “mock” 
transfected cells. For example, Mll1 gene expression was knocked down by #50% at eight 
hours post-transfection, by 66% at 13 hours, but by only #10% at 18 hours. By 23 hours post-
transfection the knockdown was poor, suggesting that the siRNA was degraded and Mll1 
transcript levels had recovered. These results allowed us to choose the 12-13 hours time 
window as the optimum point for transcript knockdown. Importantly, transfection with Mll1 
siRNA did not affect the abundance of the control gene, ß-actin, which was used to normalise 
Mll1 gene expression, suggesting that MLL1 knockdown was specific rather than a global 
response to the transfection technology.  
7.1.2.  Knockdown of MLL1 protein  
The reduction of Mll1 gene expression was confirmed by assessing MLL1 protein abundance 
at 15 (Data not shown) and 18 hours post-transfection (Figure 7.2b). Knockdowns were 
assessed by western blot using a MLL1 C-terminal antibody (Upstate/Millipore). From these 
two time points, the optimal time for MLL1 protein knockdown was shown to be at 18 hours 
post-transfection (Figure 7.2b), with a 77% protein knockdown obtained, suggesting it takes 
several hours after transcript depletion (maximal at 13 hours post-transfection) to be reflected 
in protein abundance. Nonetheless, this represents an experimentally useful level of MLL1 
knockdown, which we subsequently used to examine MLL1 function.  
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Figure 7.2: Assessing MLL1 knockdown: transcript and protein levels 
a) Mll1 expression was quantified over a time scale after transfection (8, 12, 13, 
18 and 23 hours). HPC-7 undifferentiated cells were transfected with 2 Mll1 
siRNA vectors (kd1 and kd2). Gene expression was normalised with ß-actin 
gene expression (set at 1). Knockdowns are relative to the mock (transfection 
with a vector containing GFP). Optimal Mll1 knockdown (66%) was observed 
after around 13 hours of transfection. 
b) Mll1 knockdown were examined at a protein level, 18 hours after transfecting 
HPC-7, with GFP (Mock) or with siRNA vectors (MLL1 knockdown). The 
percentage MLL1 knockdown was assessed by Western blotting with an anti-
MLL1C antibody (UpState/Millipore), using ß-actin as a loading control. A 77 % 
knockdown was obtained. 
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7.1.3. Mll1 knockdown: Impact on MLL1 target genes 
MLL1 is involved in Hoxa gene expression. A reduction of Hoxa9 gene expression has 
already been shown after transfection with MLL1 siRNA in HeLa cells, reflecting reduced 
H3K4 methylation on the Hoxa9 promoter (Nakamura et al., 2002). This gene and Meis1, 
another MLL1 target gene (Milne et al., 2005), are up-regulated by MLL-fusion proteins. 
Thus, a reduction of Hoxa9 and Meis1 gene expression was expected after siRNA-mediated 
MLL1 knockdown. 
 Initial studies examined Hoxa9 gene expression after 12 hours of transfection with 
Mll1 siRNA vectors: a 64% reduction in Hoxa9 expression was observed, which is consistent 
with the level of MLL1 depletion (62% knockdown) (Figure 7.3a). In contrast, Meis1 gene 
expression shows no substantial difference at first glance. This difference between Hoxa9 
and Meis1 sensitivity to MLL1 knockdown may reflect two underlying causes: Meis1 may be 
more stable, but it also is a substantially more abundant transcript (Meis1 Ct value is around 
22 while Hoxa9 Ct value is around 36).  Assuming that Hoxa9 and Meis1 primers efficiency 
and sensitivity is the same, Ct values are therefore comparable; the results suggest that the 
impact of Mll1 knockdown on Meis1 transcripts is also substantial. Following this argument, 
Ct values indicate that there are 32,000 more transcripts of Meis1 than Hoxa9. Therefore, a 
60% depletion of Hoxa9 transcript levels is substantially smaller at absolute transcript levels 
than a 6% reduction in Meis1. This small effect on Meis1 levels suggests that MLL1 
knockdown is insufficient for abundant MLL1-driven transcripts. 
7.1.4.  Mll1 knockdown: impact on other MLL family member transcripts 
The observation that MLL1 is a member of a family of related methyl-transferases, which all 
contain chromatin-binding and SET domains, suggests there may be some functional 
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Figure 7.3: Gene expression after Mll1 knockdown (12 hours post-
transfection) 
Quantification of Hoxa9, Meis1 and Mll family gene expression was examined 
12 hours after transfection with Mll1 siRNA. Gene expression was normalised 
with ß-actin gene expression (with ß-actin expression set at 1). Knockdowns are 
relative to the mock (transfection with GFP). PCR was performed in triplicate 
from one experiment. Error bars represent the standard error of the mean. 
a) MLL1 target gene transcript abundance: Mll1 transcript, and Hoxa9 
transcripts are reduced at 12 hours post-transfection (36%), whereas Meis1 
shows minimal changes. 
b) MLL familly members transcripts: MLL1 knockdown is associated with 
upregulation of Mll4 (158%), whereas Mll3 and Mll5 transcripts remain 
unchanged. 
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redundancy between the different family members. To assess this, the impact of Mll1 
knockdown on the transcript abundance of other MLL family members (i.e. Mll4, Mll3 and 
Mll5) was then examined (Figure 7.3b). We observed that conditions that lead to a 60% 
knockdown in Mll1 transcripts are associated with minimal changes in the abundance of Mll3 
and Mll5, two genes coding for proteins with substantial differences with MLL1. In contrast 
Mll4, a gene coding for a protein homologous to MLL1 and which forms a similar complex, 
is upregulated by #1.6-fold. This observed enhancement suggests that MLL1 and MLL4 
functionally interact at the same level of gene regulation. 
 
Therefore, using siRNA technology, Mll1 knockdown was optimised, with an optimal time 
point at around 13 hours for transcript downregulation and at around 18 hours post-
transfection to maximise protein depletion. In both cases, about 70% Mll1 knockdown was 
obtained. This knockdown has functional consequences, as the expression of Hoxa9, a 
MLL1-regulated gene, is subsequently decreased (to 36%). Nevertheless, Meis1 expression, 
another MLL1 target, is unchanged at 12 hours. This may reflect the time point used being 
too early to observe changes at Meis1 expression. Other MLL family members were 
investigated for their expression in Mll1 knockdown cells: Mll3 and Mll5 expression 
remained unchanged though a significant increase of Mll4 expression was observed (158%). 
Therefore, Mll4 may be down-regulated by MLL1. This result could explain Meis1 
expression maintenance: Meis1 could be positively regulated by MLL4 in the absence of 
MLL1. Therefore, this shows that MLL1 contributes to the regulation of specific genes, and 
that its presence has an effect on other potential factors of gene regulation.  
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7.2. Mll3 and Mll5 knockdowns 
A similar approach has also been used to establish knockdowns for other MLL family 
members: MLL3 and MLL5. Three vectors were designed for each Mll type (Mll5-1, Mll5-2, 
Mll5-3, Mll3-1, Mll3-2 and Mll3-3) and cloned into “Block-it” vectors (Invitrogen). A first 
step was to examine knockdown efficiency and to identify optimal conditions for the 
knockdowns (Figure 7.4). For each Mll gene, 2 !g of each vector was transfected, either 
individually or with the other two vectors (2!g in total). As a control, HPC-7 cells were 
transfected with 2 !g of a vector expressing GFP (“mock”). Mll3 and Mll5 knockdowns were 
quantified by semi-quantitative PCR by using [32P]-dCTP incorporation, and normalised with 
the “mock” transfection. The knockdown of Mll3 and Mll5 transcripts were assessed at 8 and 
24 hours post-transfection. Optimal knockdown was established with the Mll5-2 vector 
(73.9% knockdown at 24 hours post-transfection) and the Mll3-1 vector (83% knockdown at 
8 hours post-transfection). These vectors were then used to perform subsequent knockdowns.  
We found a time-window between six and ten hours post-transfection for Mll3 knockdown 
(optimal at eight hours - 72%, Figure 7.5a), and between 12 and 24 hours post-transfection 
for Mll5 knockdown (70%, Figure 7.5b). It was then intended to assess the impact of these 
knockdowns on other Mll1 gene expression as well as Hoxa9 and Meis1 gene expression. At 
the time these experiments were performed, we were lacking MLL3 and MLL5 antibodies in 
order to confirm these results at the protein level.  
Finally, the level of cell death was assessed for each Mll knockdown (Data not shown). Both 
Mock and Mll siRNA transfected cells, display a high percentage of cell death, which 
increases during the 12 first post-transfection hours (30-50% cell death) before reaching a 
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Figure 7.4: Optimisation of knockdown vectors in HPC-7 cells and 
transfection 
Knockdowns for both Mll3 and Mll5 were examined for each vector individually 
or all together, normalised with the mock (transfection with GFP). Knockdowns 
were quantified by semi-quantitative PCR, using [32P]-dATP incorporation. A 
73.2 % knockdown was obtained with the Mll5-2 vector after 24 hours of 
transfection, while a 83% knock-down was obtained with the Mll3-1 vector after 
eight hours of transfection. 
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Figure 7.5: Establishing Mll3 and Mll5 knockdown conditions 
A time-scale was established to find the optimum time point for Mll3 and Mll5 
knockdown. Quantifications were normalised with ß-actin (set at 1). 
Knockdowns are relative to the mock (transfection with GFP). 
a) Mll3 transcript abundance was examined by real-time PCR after 6, 8 and 10 
hourspost-transfection transfection. An optimal knockdown was obtained at 8 
hours post-transfection (72%). 
b) Mll5 transcript abundace was examined by real-time PCR after 12, 15, 18 and 
24 hours of transfection. Optimal knockdown is on extended period from 12 to 
18 hours post-transfection; 
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plateau. However, this seems to be highly variable, as only about 25% cell death was 
observed after 18 hours transfection for the last experiment (see previously).  
As with Mll1 knockdown, efficient Mll3 and Mll5 knockdowns were achieved. The 
optimisation of another MLL family member knockdown was trialled, but failed. However, 
these experiments on MLL family members are just the premise to what could be done to 
assess their contribution to gene regulation. The assessment of level of protein after 
performing these knockdowns also needs to be examined. 
 
Because the transfection rate is at 81% and we cannot get a higher percentage of knockdown 
than 70%, it might be that the decrease of transcript abundance we expect is masked by 
transcripts from non-transfected cells. In order to optimise these knock downs, it was 
suggested to transfect HPC-7 cells with a vector containing both the sequence generating 
siRNA against Mll and GFP. The transfected cells would then be collected by flow 
cytometry, GFP-transfected cells kept. This would therefore increase the percentage of 
knockdown observed, and increase the quality of the experiment. Nevertheless, this also 
implies that a smaller yield of cells would be collected after sorting. Therefore, more HPC-7 
cells would need to be transfected.  
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8. DISCUSSION 
The expression of genes is cell-specific, time and environment dependent, and requires the 
contribution of multiple genetic and epigenetic mechanisms. More specifically, 
differentiation requires the coordinated activity of multiple genes to determine their cell fate. 
In this study, we aimed to elucidate the role of a key developmental regulator, the histone 
methyl-transferase MLL1 and its core complex components on target gene regulation.  
Establishing and characterising a differentiation model 
Previous studies have shown that MLL1 is part of a multi-protein complex (Nakamura et al., 
2002; Yokoyama et al., 2004), whose subunits catalyse the deposition of methyl and acetyl 
groups on specific histone residues, such as H3K4me3 catalysed by MLL1 and H4K16ac 
catalysed by MOF (Dou et al., 2005). MLL1 targets several genes (Wang et al., 2009), in 
particular the Hoxa genes (Milne et al., 2002). However, little is known about the process(es) 
of gene regulation to which MLL1 contributes. The protein composition of the MLL complex 
is diverse and complicated, and still only poorly understood. Furthermore, studies 
characterising differences between actively transcribed and silent MLL target genes have 
generally focussed on comparing two separate cell lines (such as wild type cells versus Mll-
deficient cells or leukaemic cells), without looking at the dynamic changes on MLL target 
genes that occur in a single cell type. We therefore developed a haematopoietic 
differentiation model to give insight into the differentiation-induced transcriptional changes 
at MLL target genes. This is an appropriate model as MLL1 has a critical role in 
haematopoiesis (Yu et al., 1995; Hess et al., 1997). We made use of HPC-7 cells, a cell line 
derived from haematopoietic stem cells, in which differentiation can be induced to generate a 
range of differentiated cell types, focussing on megakaryocytes as these cells are easy to 
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purify to a homogenous population in quantities that permit biochemical analysis. Upon 
megakaryocyte differentiation, morphological and epigenetic changes occur, simultaneously 
with the appearance of characteristic large cells. Similarly, megakaryocyte nuclei show an 
increase of ploidy, due to endoremitosis; DNA is replicated, followed by incomplete mitosis 
due to the absence of cytokinesis and karyokinesis (Vitrat et al., 1998). Thus from 2N 
undifferentiated cells we were able to obtain a “pure” population of differentiated cells with 
ploidy ranging from 16N to 32N (i.e. Figure 3.1). The degree of cell maturity was also 
validated by the detection of specific control genes (i.e. Figure 3.2), such as Gata-1 and Gp6, 
which are exclusively expressed in mature megakaryocytes (Jandrot-Perrus et al., 2000; 
Holmes et al., 2002). In contrast, down-regulation of the Spi-1/Sfp-1 gene (PU.1, a 
haematopoietic transcription factor and marker of early development), was observed upon 
differentiation (Valledor et al., 1998). Together, these results indicate that morphologically 
and transcriptionally distinct megakaryocytes can be obtained through differentiation of 
HPC-7 cells. 
Our use of megakaryocytes raised the question whether all copies of the genome in these 
cells were equally regulated. This is a key question as subsequent ChIP analysis will “pool” 
and average marks on the multiple copies of the gene examined. We thus used 
immunostaining to examine the histone modification distribution in these giant cells. 
Megakaryocyte nuclei are characterised by multiple lobes, and vacuoles. As expected, 
undifferentiated cells show “all-over” staining throughout the nuclei for most histone 
modifications (i.e. Figure 3.5, Upper panels), though H3K9me shows a “punctate” 
appearance (i.e. Figure 3.5c). In contrast the megakaryocytes show an uneven distribution of 
some histone modifications, with high concentrations in both “vacuoles”, and areas of the 
nuclei where material is “budding off” from the bulk of the nucleus (i.e. Figure 3.5, Lower 
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panels). This was observed after fixing both prior to, or after immunostaining, and a similar 
observation was made in megakaryocytes generated from primary stem cells suggesting this 
is not a protocol-dependent, or HPC-7-associated artefact. Interestingly, these observations 
are only associated with some marks (H3K9ac, H3K4me3), the “punctate” distribution of 
H3K9me is similar in both undifferentiated cells and megakaryocytes. Of these marks, 
H3K9ac is known to be associated with newly deposited chromatin (Kuo et al., 1996), so we 
can speculate that these higher concentrations of histones are associated with stores of 
histones required for generating new copies of the genome. This suggests that not all copies 
of a gene are in equivalent environments, however the small numbers of cells with these 
“buds” (#10%) suggests this is a relatively minor issue (Note: this will be discussed later). 
Previous studies have suggested that differentiation is associated with global changes in 
histone modifications (Rice et al., 2007). Therefore, a 2-dimentional SDS-AUT gel was 
performed to give a global overview of the changes upon differentiation and to identify 
potential general changes in the histones. This analysis showed there were no large changes 
in histone isoform though a novel band was observed in undifferentiated HPC-7 cells but not 
in megakaryocytes (i.e. Figure 3.8), which is likely to be associated with H2B acetylation. 
Mass spectrometric analysis of this histone “spot” suggests that this contains a combination 
of modifications, including acetylation at novel residues (K. Nightingale & Helen Cooper, 
personal communication). We then performed Western analysis to assess whether changes 
actually occurred in this system. Comparison of undifferentiated HPC-7 and megakaryocytes 
showed few significant changes in the global abundance of histone modifications, though a 
small increase of H3K4me2 and H3K4me1 was seen (i.e. Figure 3.9). It is difficult to 
speculate on the molecular basis of this observation, as these changes could reflect 
differentiation-induced changes in the abundance (or activity) of multiple enzyme complexes, 
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including H3K4-specific methyl-transferases (i.e. MLL family members), demethylases (i.e. 
LSD1, JMJD2), or the histone modifications that impact on these enzymes’ activity. 
Nevertheless this could be consistent with a decrease in MLL1 activity as though MLL1 
itself does not show major changes between undifferentiated HPC-7 and megakaryocytes (i.e. 
Figure 5.1), whereas the DNA recruiting subunit menin does (discussed later). These studies 
also showed a significant global increase of H3S10p in megakaryocytes. This is not 
surprising as the mark is involved in two distinct processes: in transcriptional activation 
(H3S10 phosphorylation is followed by H3K14 acetylation) (Clayton et al., 2000; Lo et al., 
2000; Hans and Dimitrov, 2001), but also in chromosomal condensation during mitosis 
(Gurley et al., 1978; Hendzel et al., 1997). Thus, this mark reflects the high proportion of 
chromatin involved in the endomitosis process in megakaryocytes.  
Looking at more specific changes, we examined the epigenetic modifications on defined 
genes upon differentiation, notably on MLL target genes in the Hoxa gene cluster. Initial 
characterisation of Hoxa cluster gene expression showed a broad decrease in Hoxa genes (1-
13) transcript abundance upon differentiation (i.e. Figure 3.3), correlating with observations 
made in other models (Sauvageau et al., 1994). This decrease is more significant in the 
middle of the cluster (i.e. Hoxa5), rather than at the edges (i.e. Hoxa1 and Hoxa13). 
Interestingly, these central genes, especially within the region from Hoxa4 to Hoxa11, are 
implicated during differentiation (Strathdee et al., 2007a; Strathdee et al., 2007b; Atkinson et 
al., 2008). Although we observed a substantial down-regulation at many Hoxa genes, we did 
not see a total loss of expression upon differentiation. This may reflect the high stability of 
their RNA products, as we find that the Hoxa gene transcripts are stable for up to 24 hours in 
"-amanitin treated cells. However, this down-regulation is sufficiently significant to be 
considered as a cause (or consequence) of differentiation, and to investigate the associated 
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mechanisms. Together, these observations suggest that this is an appropriate model to study 
the regulation of differentiation-induced changes at MLL1 target genes.  
This is a powerful model, but there are some limitations to its use here: this study focussed 
on the changes occurring at two extreme stages of the differentiation process, but it would be 
interesting to investigate changes occurring throughout the differentiation process in order to 
obtain a more accurate overview of mechanisms involved in the regulation of gene 
expression. Similarly, the processes characterised with this model could be megakaryocyte-
specific, and ideally would be validated by characterising the changes associated with a 
different cell lineage. To this purpose, monocytes were successfully generated in the 
laboratory. However, it has not been practical to examine these cells, as too few monocytes 
were obtained to enable biochemical studies.  
Characterising histone modification changes on Hoxa4 and Hoxa5 
Once the model was established, we examined the epigenetic changes occurring at specific 
genes in response to the differentiation process. The histone methyl-transferase MLL1 is an 
important regulator of haematopoiesis, especially through its role Hoxa gene maintenance 
(Ernst et al., 2004a; Ernst et al., 2004b; Rice et al., 2007). For this reason, we chose to 
examine changes occurring on Hoxa genes. In numerous studies, the most examined Hoxa 
gene is Hoxa9 as a target of MLL fusion proteins; Hoxa9 is upregulated in leukaemia as a 
consequence of the generation of MLL-fusion protein (Zaisig et al., 2004). However, in our 
model, Hoxa9 transcript levels are too low in abundance to be accurately examined (i.e. 
Figure 3.3). In contrast we focussed on Hoxa4 and Hoxa5, two genes with abundant 
transcripts, which are known to be relevant to the differentiation process. Our data initially 
suggested that these two genes act differently upon differentiation; Hoxa5 showed a 
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significant down-regulation (i.e. a four-fold drop), wheras Hoxa4 did not show a significant 
reduction in transcriptional output. Hoxa4 is the most 3’ gene in the Hoxa cluster to be 
involved during differentiation (Sauvageau et al., 1994), and Hoxa5 down-regulation is 
required for the generation of megakaryocytes (Crooks et al., 1999; Fuller et al., 1999). Thus, 
although we know that MLL-driven Hoxa genes are essential for haematopoiesis, little is 
known about how MLL regulates these events, and how this contributes to differentiation. 
Therefore, the distribution of histone marks on the Hoxa4 and Hoxa5 genes during 
differentiation was examined. We examined marks associated with either transcriptional 
activation (H3K4me3, H4K16ac and H3K9ac) or transcriptional silencing (H3K27me3 and 
H3K9me2). In order to investigate the distribution of these marks, two forms of chromatin 
immunoprecipitation were used: carrier chromatin immunoprecipitation (CChIP) and native 
chromatin immunoprecipitation (NChIP). NChIP is principally used to assess histone mark 
modifications, as the histones are firmly attached to the DNA. However, this technique has 
been developed for a large number of cells (typically more than 106), whereas this stem cell 
system can only yield small numbers of megakaryocytes (#104). Therefore, CChIP, a 
technique that uses Drosophila SL2 cells during the preparation of chromatin, was used in 
order to improve the efficiency of immunoprecipitation. However, this raised the question of 
the quantitative comparability between those two ChIP procedures. Thus, an initial 
experiment compared the two approaches, using a Gapdh housekeeping gene that shows 
similar transcript abundance in the two cell types. We found that the binding values observed 
for marks over the housekeeping gene Gapdh are both qualitatively and quantitatively similar 
(i.e. Figure 4.2), suggesting that the two techniques can be used to compare undifferentiated 
HPC-7 cells and megakaryocytes. We thus examined the distribution of histone marks on 
Hoxa4 and Hoxa5 in these two cell types. 
!!!
!!!!
"K/!
Analysis of these data (i.e. Figures 4.3; 4.4; 4.5) shows a consistent pattern of distribution of 
activating marks (H3K4me3, H3K9ac and H4K16ac), with a peak at the transcription start 
site of the genes, but with minimal binding both upstream of the gene, or within the body of 
the coding region. This is consistent with earlier studies, though we note that ChIP-chip 
studies often yield broader peaks, perhaps reflecting the size of immunoprecipitated material 
(Atkinson, Koch et al., 2008). In undifferentiated HPC-7, Hoxa genes were associated with 
an enrichment of H3K4me3, H3K9ac and H4K16ac close to the transcription start site. These 
“activating” marks were subsequently lost in megakaryocytes, which is associated with a 12-
fold and a 20-fold decrease of H3K4me3 on Hoxa4 and Hoxa5 respectively, and a three-fold 
decrease of H4K16ac on Hoxa4. This loss of “activating” marks is consistent with the 
repression of Hoxa5 upon differentiation (i.e. Figure 3.3), however it is suprising for Hoxa4, 
which does not show a significant decrease in transcriptional activity. This suggests that 
Hoxa4 is in fact down-regulated, but that this is masked by Hoxa4 transcript stability. 
Interestingly, the peak of H3K9ac is also lost on Hoxa4 in megakaryocytes, but to be 
replaced by a broader distribution of acetylation in the body of the gene. 
The high level of H3K9 acetylation retained on the Hoxa genes in megakaryocytes is 
surprising, given that this is a mark typically associated with gene activation (i.e. Mizzen et 
al., 1996). However, this unexpected distribution toward the body of the genes is reminiscent 
of the H3K9me2 distribution (i.e. Figure 4.7) on Hoxa4, which is also in the body of the 
gene. Neither of these apparently antagonistic marks are at the transcription start site of the 
gene - possibly reflecting the unclear, transcriptional status of this gene in megakaryocytes 
(i.e. Figure 3.3), and/or that the cells are in a intermediate state, carrying both marks in the 
body of the gene when examined. The fact that H3K4me3 and H4K16ac (i.e. Figures 4.3; 4.5 
respectively) are decreased on Hoxa4 in megakaryocytesis is consistent with its down-
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regulation, and also suggests that these changes are temporally regulated. However, in 
addition to this change of distribution, there is an increase of H3K9 acetylation. This mark is 
also associated with newly synthesised chromatin and this broad distribution may reflect the 
“pooling” of the marks on Hoxa4 and Hoxa5 from different regions of the nucleus in 
different contexts, in which Hoxa4 and Hoxa5 are in both silent chromatin regions and 
replicative chromatin (Figure 8.1).  
This analysis also showed that active Hoxa4 and Hoxa5 promoters are associated with 
H3S10p, a mark associated with actively transcribed genes (Hazzalin and Mahadevan, 2005; 
Ivaldi et al., 2007), and the dual mark H3K9acS10p which is also associated with early gene 
activation (Dyson et al., 2005). This mark was examined on MLL-target genes as previous in 
vitro studies showed that a combination of H3K9 acetylation and H3S10 phosphorylation 
stimulated MLL SET domain activity (Nightingale et al., 2007). In mammals, H3S10 
phosphorylation favours the recruitment of Gcn5 (Cheung et al., 2000). In addition, it was 
shown in yeast that, as part of the SAGA complex, Gcn5 deposits H3K9ac (Grant et al., 
1999), a mark seen on the Hoxa genes studied. We show that the dual mark H3K9acSer10p 
has a similar distribution to H3K9ac or H3K4me3 on the active Hoxa4 and Hoxa5 genes (i.e. 
Figures 4.4; 4.3, Upper panels): a peak of H3K9acS10p is observed near the transcription 
start site in undifferentiated cells (i.e. Figure 4.8), which is subsequently lost in 
megakaryocytes. This similarity in the distribution of H3K4me3 and H3K9acS10p confirms 
that the mark is involved in Hox gene regulation, suggesting that is might be involved in 
regulating MLL target genes, consistent with its role on other genes. However whether it 
plays a role in regulating MLL activity as observed in vitro remains unclear. It is curious that 
only the dual mark H3K9acS10p had an influence on the SET domain activity, in contrast to 
individual marks that had no noticeable effect (Nightingale et al., 2007). However, previous 
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Figure 8.1: Hypothesis to explain our observation of a surprising H3K9ac 
distribution: 
H3K9ac is a mark associated with transcriptional activation (as seen in 
undifferentiated cells). However, an increase of H3K9ac was observed in 
megakaryocytes on the silent Hoxa4 and Hoxa5 loci, while other activating 
marks were reduced. The mammalian H3K9ac mark is associated with newly 
synthesised chromatin, so the broad distribution observed may reflect the 
“pooling” of the marks on Hoxa4 and Hoxa5 from different regions of the 
nucleus in different contexts (i.e. in silent chromatin regions and replicative 
chromatin). 
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studies have shown the recognition of multiple marks by the same protein (for example, 
TAF1 binds H3K9ac and H3K14ac through its double bromodomain, (Vermeulen et al., 
2007)) suggesting that the cooperative recognition of H3K9ac and H3S10p may act to 
stabilise catalytic activity at H3K4me3. H3K9ac and H3S10p are adjacent residues, and this 
also suggests that these marks are simultaneously recognised to regulate MLL SET domain 
activity. This is consistent with previous data from structural studies (Southall et al., 2009). 
The pattern of distribution of “activating marks” correlates with previous studies (Hebbes et 
al., 1988; Vakoc et al., 2006; Wang et al., 2008), and their decrease in megakaryocytes is 
consistent with the observed (Hoxa5), and assumed (Hoxa4) down-regulation upon 
differentiation (i.e. Figure 3.3). The expected removal of “activating” marks following gene 
repression raised the question whether “silencing” marks also contribute to the change in 
transcriptional activity. However, these marks are not abundant on Hoxa genes. H3K27me3 
is broadly distributed on both Hoxa genes, but shows a very low level of enrichment (i.e. 
Figure 4.6), whereas H3K9me2 shows a slight enrichment over the promoter and the coding 
region (i.e. Figure 4.7). This pattern is replaced by a broad distribution in megakaryocytes, 
notably at the 5’ end of the gene, similar to what was observed with H3K9ac. The absence of 
the H3K27me3 mark on repressed genes is surprising and contradicts what would have been 
expected; an enrichment associated with repressed transcription (Barski et al., 2007). 
Similarly, investigation of the presence H3K27me3 on a gene known to be silent in 
undifferentiated HPC-7 cells (i.e. Gp3) failed, despite the antibody being known to work well 
in ChIP assays. This may reflect megakaryocyte-specific mechanisms; there may be a low 
level of this mark in these cells. However, global staining with H3K27me3 was observed in 
HPC-7 in immunofluorescence assays (i.e. Figure 3.5d). Alternatively, this may reflect a 
regulatory role for CBP, a known subunit of the MLL complex, which is known to target 
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H3K27. Recent studies showed that H3K27me deposition was prevented by acetylation of 
the same residue (Tie et al., 2009), suggesting that CBP-deposited marks may persist into the 
megakaryocytes. Examination of H3K27ac and CBP distribution upon differentiation may 
help to understand the failure of H3K27me3 to increase with Hoxa5 gene silencing. A final 
alternative hypothesis could be that this “repressive” mark is deposited only on long-term 
silenced genes, and that our examination of this mark might be too premature. 
One aspect of these data is that they do not give indications to the relative abundance of the 
different gene transcripts. This is difficult to assess with any accuracy, but if we assume that 
qRT-PCR Ct values give a broad indication of transcript abundance then Hoxa4 (Ct value # 
28) and Hoxa5 (Ct value # 23) are far more abundant than Hoxa9 (Ct value # 36). This is 
consistent with the preliminary analysis of CpG island methylation in differentiating HPC-7 
cells made by Gordon Strathdee (Newcastle; Data not shown): the Hoxa5 and Hoxa4 CpG 
islands are unmethylated whereas the Hoxa9 CpG island was methylated in both 
undifferentiated cells and megakaryocytes. This is consistent with the low Hoxa9 transcript 
abundance, as promoter methylation is associated with an inactive state of the gene. The 
absence of methyl marks on CpG islands on the down-regulated Hoxa5 gene (and Hoxa4, 
which we assume is also down-regulated) could indicate that the megakaryocytes were 
examined too early, before the establishment of these marks. This is consistent with the 
absence of H3K27me3 on repressed Hoxa5 (and apparently repressed Hoxa4). Studies of 
primary cells should establish whether this is a cell-line, or cell-type specific issue, as the 
CpG islands of the Hoxa genes are methylated when repressed in other cell lines (Strathdee et 
al., 2006; Strathdee et al., 2007b).  
In summary, differentiation correlates with both observed (Hoxa5), and assumed (Hoxa4) 
gene down-regulation, which is associated with the loss of “active” marks in the gene 
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promoters. However, gene repression did not correlate with either an increase of “silencing” 
marks, or an increase of DNA methylation on Hoxa4 and Hoxa5. We therefore examined the 
enzyme complexes responsible for regulating these marks. 
How are histone modifications regulated? 
The distinct histone marks described above are associated with specific regulatory enzymes. 
We therefore initially examined the global abundance of the key enzyme regulators of these 
marks, and we then investigated these proteins at a gene-specific level using 
immunoprecipitation of formaldehyde cross-linked chromatin.  
In mammals, six proteins are known or assumed to have H3K4-specific histone methyl-
transferase activity: Set1A, Set1B, MLL1, MLL2, MLL3 and MLL4. During megakaryocyte 
differentiation, as with other active marks, H3K4me3 abundance is rapidly lost from the 
Hoxa4 and Hoxa5 promoters, correlating with their observed (Hoxa5), and presumed 
(Hoxa4), down regulation. This does not reflect changes in MLL family transcripts (i.e. 
Figure 3.9), or in global MLL1 protein abundance upon differentiation (i.e. Figure 5.1, Upper 
panel). This suggests that in megakaryocytes, MLL1 is still present, but unable to maintain 
Hoxa gene expression. In contrast, menin, a component of the MLL complex, shows a 
substantial drop in megakaryocytes (i.e. Figure 5.1, Lower panel). This subunit is believed to 
act with LEDGF in determining DNA binding of the MLL complex, so this is a potential 
mechanism to reduce MLL activity without the wholesale removal of the MLL enzyme.  
Our analysis of specific genes showed that differentiation is also associated with a decrease 
of H4K16ac (i.e. Figure 4.5), H3K4me3 (i.e. Figure 4.3) and H3K9acS10p (i.e. Figure 4.8) at 
the Hoxa genes. The simultaneous loss of these marks at the promoter of Hoxa4 and Hoxa5 
suggests the synchronised release of the associated deposition enzymes or a common 
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regulatory mechanism. The patterns of distribution of H3K4me3 and H4K16ac correlate 
spatially and temporally through differentiation, consistent with the association of the histone 
acetyl transferase MOF (a H4K16 specific HAT) with MLL1 (Dou et al., 2005) in the same 
complex. This raised the question of whether the marks observed are regulated by MLL-
associated factors, in addition to MLL1.  
After initially optimising X-ChIP, the binding of several MLL1 complex-associated factors 
that could contribute to mark regulation was examined. A MLL partner, menin was described 
to associate with MLL1 on Hoxa gene promoters in leukaemic cells, and to be required for 
the maintenance of the expression of these genes (Yokoyama et al., 2005). In this study, both 
MLL (including both MLLC and MLLN subunits) and the MLL-associated factor menin 
bound upstream to the transcription start site on Hoxa4 and Hoxa5, whereas H3K4me3 was 
found closer to the transcription start site. Interestingly, menin binding was stronger than 
MLL1 binding on these genes, which may reflect menin’s tighter interaction with the DNA. 
This correlates with observations that menin recruits the MLL complex to transcriptionally 
active genes through its interaction with the protein LEDGF (Yokoyama and Cleary, 2008). 
The loss of either menin or LEDGF prevents MLL1 recruitment. It has also been shown that 
menin knockdown induces down-regulation of Hoxa9, comparable to that observed for MLL 
knockdown (Yokoyama et al., 2004). Interestingly, in contrast to MLL1 abundance, which 
remains unchanged upon differentiation, menin levels are globally decreased in 
megakaryocytes (see earlier). Menin could be an important factor in determining MLL1 
regulatory function in haematopoiesis.  
In contrast to MLL1 and menin, the histone acetyl-transferase CBP binds in the coding 
region of Hoxa4, whereas it is found at the transcription start site of Hoxa5 in 
undifferentiated HPC-7 cells (i.e. Figure 5.5). This way, CBP is closer to the MLL-deposited 
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histone marks observed than menin and MLL1 (i.e. Figure 5.5). This is surprising given that 
this histone acetyl-transferase is thought to be recruited by the MLL complex (Ernst et al, 
2001), and would be expected to correlate with MLLC binding. However, previous studies 
showed that CBP can also be associated to the phosphorylated p65 subunit of NF!B at the 
H3S10p site (Reber et al., 2009), so this may be an alternative route to recruiting this HAT to 
Hoxa4 and Hoxa5 (discussed later). 
Similarly, RNA polymerase II was found over the transcription start site of both Hoxa4 and 
Hoxa5 in undifferentiated HPC-7 cells (i.e. Figure 5.6), which correlates with a previous 
study showing that H3K4me is located on transcriptionally active genes, associated with 
MLL1 and RNA Pol II binding (Guenther et al., 2005). In megakaryocytes, RNA polymerase 
II is maintained at the same location on Hoxa4. This is consistent with the unclear 
transcriptional status of Hoxa4 in megakaryocytes; the loss of “activating” histone marks 
suggests that the gene is down-regulated, but this is not apparent from transcript levels. In 
contrast RNA Polymerase II binding is reduced and moved downstream on Hoxa5, which 
does show clear differentiation-induced repression. The presence of RNA polymerase II on 
both genes, in particular on Hoxa5, whilst their expression is down-regulated suggests that 
RNA polymerase II may be subject to a pausing mechanism (Strobl and Eick, 1992). This 
would be consistent with the retention of RNA polymerase II near the transcription start site 
of Hoxa4 and Hoxa5. Interestingly, H3S10p appears to play a role in the release of promoter-
proximal “paused polymerase” in Drosophila (Ivaldi et al., 2007; Zippo et al., 2009), 
consistent with a role for this mark in this system. In addition, the weak but distinct 
enrichment of H3K9me2 in the coding region of Hoxa4 may be acting to regulate RNA 
polymerase II elongation (Vakoc et al., 2006). 
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Our data also indicates there are functional interactions between some MLL family members. 
We show that Mll1 knockdown is associated with an increase of Mll4 transcript abundance 
(i.e. Figure 7.3b). Interestingly, menin is also associated with this MLL histone methyl-
transferase complex (Hughes et al., 2004), thus, the loss of MLL1 could be functionally 
redundant with a similar MLL4-menin (and other components) complex, though they cannot 
compensate for each other, as the loss of either molecule is embryonic lethal (Yu et al., 1995; 
Glaser et al., 2006). As with MLL1, MLL4 enzymatic activity is mediated by a SET domain, 
generated by proteolytic cleavage by Taspase-1 (Takeda et al., 2006), and tri-methylates 
lysine K4 on histone H3 (Hugues et al., 2004). We present data suggesting that MLL4 is 
present on Hoxa4 and Hoxa5 genes. However, validation of the specificity of this antibody 
was not convincing, and this would need to be re-examined using another antibody source to 
give confidence in these data. 
To summarise, histone marks and enzymes display distinct patterns of distribution on active 
and repressed Hoxa4 (Figure 8.2) and Hoxa5 (Figure 8.3) genes, consistent with gene 
activity. On active genes, both genes show an enrichment of H3K4me3, H3K16ac, H3K9ac 
and H3K9S10p over the transcription start site, correlating with the binding of MLL1, MOF 
(not examined, but an MLL-associated protein) and Msk1 (see later). However, the binding 
sites of these enzymes did not always correlate with the sites where histone marks are 
deposited, especially on Hoxa4 where the primers are more separated. For example on 
Hoxa4, whilst Msk1 binds over the transcription start site and correlates with the H3S10p 
mark, MLL-complex proteins (MLLC, MLLN and menin) bind upstream of the TSS. 
Similarly, on Hoxa5 histone marks are localised at the TSS whereas the depositing enzymes 
are located just upstream. This suggests that MLLC, MLLN and menin interact as a complex, 
but this is less clear for CBP, as on Hoxa4 this enzyme is found in the body of the gene. 
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Figure 8.2: Alignment of mark and enzyme distributions on Hoxa4 
Distribution of histone marks and modifying enzymes on Hoxa4 in 
undifferentiated HPC-7 cells (Top) and in megakaryocytes (Bottom). Note: The 
relative sizes of peaks are arbitrary as different antibodies cannot be compared 
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Figure 8.3: Alignment of mark and enzyme distributions on Hoxa5 
Distribution of histone marks and modifying enzymes on Hoxa5 in 
undifferentiated HPC-7 cells (Top) and in megakaryocytes (Bottom). 
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Binding at these primer sets (4/1 and 4/2) is separated by #900bp - this could reflect the 
presence of a large complex with distinct domains interacting with DNA (and cross-linking) 
and catalytic sites. Another explanation would be that an element of the promoter looping 
occurs, allowing distant regions to be associated with different components of a same 
complex. Studies have shown long-range interactions, in which regulatory elements are 
brought close to the TSS of target genes causing the formation of DNA looping (Fraser, 
2006; Fraser and Bickmore, 2007; Göndör and Ohlsson, 2008; Wallace and Felsenfeld, 
2007).  
Another alternative to explain the apparent dislocation between modifying enzyme binding 
sites and the location of the marks is that this reflects the protocol used to generate our 
chromatin. A recent publication suggests that nucleosomes that simultaneously contain two 
histone variants, H3.3 and H2A.Z, are less stable, and susceptible to displacement when 
challenged with the salt conditions we use to isolate chromatin (150mM NaCl, Section 
2.3.4,”‘Buffer C” Jin et al., 2009). This paper finds that “double variant” (H3.3/H2A.Z) 
nucleosomes typically occupy a position at and 5’ to the transcriptional start site (TSS) of 
active genes, this correlates with the sites where MLL-deposited marks would be expected. 
Given the lower resolution of our experiments the loss of these (potentially H3K4me / 
H4K16ac  - marked) nucleosomes may explain the apparent absence of these modifications at 
specific sites in chromatin. However, this is unlikely to be a total explanation; other workers 
also see a disparity between the sites of MLL binding and H3K4 methylation (G. Volpe PhD 
thesis, University of Birmingham), but use a formaldehyde cross-linking procedure which 
would be expected to stabilise double variant nucleosomes in the chromatin.  
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Msk1 and H3S10p mark 
As previous in vitro assays have shown that the dual mark H3K9acS10p acts to regulate 
MLL SET domain activity, the novel observation that this mark is found on MLL-target 
genes in vivo (i.e. Figure 4.8) suggested that we analyse Msk1, a protein kinase thought to be 
involved in H3S10 phosphorylation. This showed that Msk1 plays a role in regulation of 
Hoxa4 and Hoxa5 genes, as our experiments showed a correlation between the binding of 
Msk1 (i.e. Figure 6.1) and the enrichment of H3K4me3 (i.e. Figure 4.3) and H3K9acS10p 
(i.e. Figure 4.8) upon the TSS of these genes. Similarly, the kinase is absent when these 
genes are repressed in megakaryocytes (i.e. Figure 6.1, Lower panels). Previous data suggest 
Msk1 interacts with promoters via interactions with NF!B (Reber et al., 2009), but initial 
scanning for NF!B binding sites (GGG RNN YYC C, where R=purine Y=pyrimidine), did 
not reveal this sequence in Hoxa4 or Hoxa5. The observation that Msk1 binds a similar 
location to the MLL complex on these genes prompted our co-immunoprecipitation 
experiments. Msk1 was found to associate with MLLC (i.e. Figure 6.2a), though this 
association seems to be weak. These data suggest that Msk1 and MLL1 may interact in a 
transitory manner, though the co-immunoprecipitation could also reflect an indirect 
interaction via the cross-linking of the common histone substrate (Figure 8.4). In addition, 
Msk1 was shown to associate with NF!B but not with CBP (i.e. Figure 6.2a), whereas Reber 
et al. (2009) showed that p65 (NF!B), CBP and Msk1 co-immunoprecipitated at H3S10-
marked loci. The failure to observe any interaction between CBP and Msk1, whilst these two 
proteins are closely bound on Hoxa4 and Hoxa5 genes could be explained by the high 
molecular weight of CBP (265kDa), which is difficult to immuno-precipitate. Considering 
the diverse interactions attributed to CBP, this failure could also be the consequence of the 
immunoprecipitation of a CBP-containing complex. These experiments suggest that Msk1  
!!!
!!!!
0D>!
!
Figure 8.4: Msk1 contribution to MLL target genes 
These two cartoons illustrate alternative mechanisms of how Msk1 contributes 
to MLL target gene regulation, in line with the ChIP and immunoprecipitation 
results. Msk1 either interacts with the MLL complex in a transitory manner 
(Upper panel), or is present at the same time as MLL complex components on a 
specific region of the gene (Lower panel), and co-immunoprecipitates indirectly, 
probably via the histone proteins. 
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might influence MLL1 enzymatic activity and target gene regulation. We note that Msk1 is 
downstream of the MAPK signalling pathway (Dyson et al., 2005) and recent data suggest 
that Msk1 phosphorylation contributes to gene regulation (Bruck et al., 2009; Reber et al., 
2009). These studies are consistent with the proposal that Msk1 represents a mechanism by 
which the environment may impact on MLL1 activity. 
Our study shows that H3K9acS10p was found on active Hoxa4 and Hoxa5 genes, and 
correlates with sites bound by the histone kinase Msk1. These observations are consistent 
with previous findings on this mark and this enzyme (Soloaga et al., 2003; Hazzalin and 
Mahadevan, 2005; Ivaldi et al., 2007; Zippo et al., 2009). However, it was still unclear 
whether this contributes to Hoxa gene regulation, and whether this influences MLL activity, 
as seen in vitro (Nightingale et al., 2007). We therefore tested whether H3S10 
phosphorylation had a direct effect on Hoxa gene expression by using small molecule 
inhibitors to modulate phosphorylated H3S10 abundance on Hoxa genes. This abundance 
was modulated either by increasing H3S10p mark using a phosphatase inhibitor (okadaic 
acid) or by reducing it using the Jnk kinase inhibitor (SP600125, Huang et al., 2006). 
However, interpreting these experiments was more complicated than expected. For example, 
okadaic acid does induce a global increase in H3S10p in chromatin (i.e. Figure 6.3), and this 
is also observed on the Hoxa5 gene (i.e. Figure 6.8). However, this effect is not directly 
translated into an increase in transcription in either undifferentiated cells or megakaryocytes 
(i.e. Figure 6.6).  
This may reflect the role of H3T3 phosphorylation on MLL activity. An interesting result 
came from the observation of the H3T3p mark after okadaic acid treatment. Whilst no change 
was observed on Hoxa4, a loss of H3T3p was observed on Hoxa5 (i.e. Figure 6.9), 
correlating with an increase in H3K9acS10p and H3S10p enrichment on the same gene. 
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Previous studies suggested an antagonism between H3T3 phosphorylation and H3K4 
methylation; as H3T3 phosphorylation induces a decrease of MLL SET domain activity 
(Southall, Wong et al., 2009). The increased abundance of this repressive mark (i.e. Figure 
6.9) may antagonise the increased H3S10 phosphorylation induced on the Hoxa genes. This 
complexity is difficult to analyse, especially as there may be other impacts on other histones 
and non-histone proteins. Examination of H3K4me3 abundance, and its correlation with the 
balance of H3K9acS10p and H3T3p on a specific locus may help to dissect the role of these 
marks. Experiments with the Jnk inhibitor were affected by modifications at a range of 
residues and were difficult to interprete for the same reasons.  
Pathways to gene activation at MLL target genes 
These data suggest that Msk1 contributes to Hoxa4 and Hoxa5 regulation. However this is 
likely to be via a complex pathway of events, involving multiple histone marks and regulator 
proteins. A recent study consistent with a role for Msk1 shows that histone crosstalk between 
H3S10p and H4K16ac contributes to epigenetic regulation (Zippo et al., 2009). This study 
showed that, under serum stimulation, the 14-3-3 protein binds to phosphorylated H3S10 
(consistent with Macdonald et al., 2005) and leads to the co-recruitment of the H4K16 
specific acetyl-transferase MOF. The recognition of this dual H3S10p/H4K16ac mark by the 
double bromodomain protein BRD4 promotes transcriptional elongation. These data, and 
findings from this project suggest that Msk1 deposition of H3S10p can potentially play an 
initiating role on the Hoxa genes.  
In a speculative mechanism (Figure 8.5), we propose that initial Msk1 deposition of a 
phosphate group on H3S10 is recognised by a complex composed of the 14-3-3 protein and 
the histone acetyl-transferase MOF (Zippo et al., 2009). This results in the deposition of an 
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acetyl group on H4K16 at the same location as H3S10p, which is consistent with our data 
(i.e. Figure 4.5 and 4.8) (An alternative mechanism, in which MOF is recruited by MLL 
(Dou et al., 2005) is also consistent with our observations). In addition, the acetyl-transferase 
Gcn5 is recruited to either H3S10p (Cheung et al., 2000) or H4K16ac (in yeast) (Owen et al., 
2000), and acts to deposit an acetyl group on H3K9 residue (Grant et al., 1999). The 
combination of these marks can be followed by two possible pathways. (1) The P-
TEFb/BRD4 complex, comprising the bromodomain protein BRD4 and the transcriptional 
elongation factor P-TEFb, preferentially associates this combination of marks (i.e. H3K9ac, 
H3S10p and H4K16ac). This complex acts to recruit RNA Pol II (Zippo et al., 2009). An 
alternative (2) is that the SET domain of MLL recognises and is activated by the dual mark 
H3K9acS10p (Nightingale et al., 2007), such that the level of H3K4me3 is increased. These 
two pathways are non-exclusive and both may act to regulate a single gene. 
Developing MLL knockdown in HPC-7 cells 
The studies described give insight into the distributions of histone modification, and correlate 
this with enzyme binding, according to the transcriptional state of genes. However, to assess 
the contribution of MLL1 to these mechanisms, we proposed to use MLL1 knockdown to 
examine the changes occurring as a consequence. Using siRNA technology, MLL1 
knockdown was optimised, with a time point at #18 hours post-transfection found to 
maximise protein depletion (#70% MLL1 knockdown obtained). This knockdown has 
functional consequences, as the expression of Hoxa9, a MLL-regulated gene, is repressed. 
However, Meis1, an abundant MLL target transcript, remained unchanged. This may reflect 
incomplete knockdown, such that the Meis1 decrease we expect is masked by transcripts 
from non-transfected cells. According to qRT-PCR, Meis1 transcripts are more abundant 
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Figure 8.5: Pathways to gene activation at MLL target genes 
A speculative cartoon of the factors involved in regulation of MLL target 
genes. 
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 (>1000-fold) than Hoxa9 suggesting that Mll1 knockdown is more likely to influence the 
transcript levels of lower expressed genes. Alternatively the Meis1 transcript may be more 
stable than Hoxa9. In addition, other MLL family members were investigated for their 
expression in Mll1 knockdown cells; Mll3 and Mll5 transcript levels remained unchanged, 
though a significant increase of Mll4 expression was observed (158%). This suggests these 
two genes functionally interact, for example Mll4 might be down-regulated by MLL1. This 
result may also explain the maintenance of Meis1 expression (i.e., Meis1 could be positively 
regulated by MLL4 in the absence of MLL1), but Meis1 has not been identified as a MLL4 
target gene to date. These preliminary experiments were based on the examination of a 
heterogenous population of cells (transfected and non-transfected), This could be improved 
by using a GFP-tagged knockdown vector to transfect cells, which would allow the 
isolation of GFP-expressing transfected cells by FACS. However, this approach is likely to 
need a substantial increase in the number of cells transfected.  
 
The establishment of knockdown approaches for HPC-7 cells would permit the analysis of 
both MLL and Msk1 contributions to Hoxa4 and Hoxa5 regulation. This study showed 
evidence of the distribution of histone marks, in association with the pattern of binding of 
MLL complex-associated factors. To investigate MLL target gene regulation, these 
distributions would be re-examined in MLL or Msk1 knockdown cells. In addition, 
knockdowns followed by microarray analysis of expression patterns would permit the 
identification of a broad range of MLL and Msk1 target genes.  
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Supplementary data 1 
Relative expression of control genes in undifferentiated HPC7 cells and 
megakaryocytes 
 HPC-7 Megakaryocytes 
Pu.1 1 0.24 
Gata-1 1 3565.78 
Gp6 1 18!
 
Ct values of Hoxa genes in undifferentiated HPC7 cells and 
megakaryocytes 
In megakaryocytes 
Ct 
values 
Gapdh A1 A2 A3 A4 A5 A6 A7 A9 A10 A11 A13 
Megs1 16.03  29.86 27.22 31.48 25.23 28.39   31.04 35.03 33.64 
Megs2 16.35 28  28.78 30.51 25.78 28.53 30.34  30 31.98 35.37 
Megs3 16.1 27.35 28.65 26.82 29.64 24.54 28.43 28.8 37.16 30.08  32 
Megs4 16.23 26.03 28.98 27.32 30.17 25.1 27.71 29.52 36.75  34.82 35.83 
Mean 16.18 27.13 29.16 27.54 30.45 25.16 28.27 29.55 36.96 30.37 33.94 34.44!
 
In undifferentiated HPC-7 cells 
Ct 
values 
Gapdh A1 A2 A3 A4 A5 A6 A7 A9 A10 A11 A13 
Undiff1 15.62 27.01 28.52 26.29 30.04 22.74 25.52 28.41  28.93 32.36 34.62 
Undiff2 16.5 27.71 28.69 26.7 29.1 23.65 27.35 28.91 33.95 29.94  35.97 
Undiff3 16.12  29.05 26.74 29.72 22.89 25.7 31.19 36.93  34.05 33.62 
Mean 16.08 27.36 28.76 26.58 29.62 23.1 26.19 29.5 35.44 29.44 33.21 34.74!
 
Avg 
Ct 
values 
Gapdh A1 A2 A3 A4 A5 A6 A7 A9 A10 A11 A13 
Undiff 16.08 27.36 28.76 26.58 29.62 23.1 26.19 29.5 35.44 29.44 33.21 34.74 
Megs 16.18 27.13 29.16 27.54 30.45 25.16 28.27 29.55 36.96 30.37 33.94 34.44!
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Relative transcript abundance of Hoxa genes in megakaryocytes (relative to 
transcript abundance in undifferentiated HPC7 cells) 
Relative value = 2^-(∆∆Ct) 
∆∆Ct = ∆Ct megs - ∆Ct undiff 
∆Ct undiff = (CtHoxa - CtGapdh) in undiff 
∆Ct megs = (CtHoxa - CtGapdh) in megs 
 
 
Transcript 
abundance 
Undiff A1 A2 A3 A4 A5 A6 A7 A9 A10 A11 A13 
Megs 1 1.25 0.8 0.55 0.6 0.25 0.25 1.03 0.37 0.55 0.64 1.31!
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Supplementary data 2 
Distribution of histone marks in undifferentiated HPC-7 cells on Hoxa4, 
Hoxa5 and Gapdh 
H3K4me3 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 2 18.7 1.79 1.15 
Value 2 0.89 22.31 0.96 1.18 
Value 3 2.03 20.53 1.32 1.27 
Average 1.64 20.51 1.35 1.2 
Std error 0.65 1.80 0.42 0.06 
H3K9ac 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 2.44 6.58 2.2 2.56 
Value 2 3.03 15.88 2.49 2.56 
Average 2.735 11.23 2.345 2.56 
Std error 0.42 6.57 0.20 0 
H4K16ac 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Values 1 1.21 1.77 1.24 1.16 
Value 2 2.77 5.94 2.51 2.06 
Average 1.99 3.855 1.875 1.61 
Std error 1.10 2.95 0.89 0.64 
H3K27me3 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 2 1.14 1.84 1.08 
Value 2 1.6 1.19 1.1 1.34 
Average 1.8 1.165 1.47 1.21 
Std error 0.28 0.03 0.52 0.18 
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H3K9me2 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 2.92 2.69 2.8 1.71 
H3K9acS10p 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 1.23 7.21 2.05 2.78 
Value 2 0.8 7.16 1.57 1.64 
Value 3 1.73 7.88 1.57 2.49 
Average 1.25 7.41 1.73 2.30 
Std error 0.46 0.40 0.27 0.59 
H3K4me3 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 2.34 0.72 30.06 2.02 1.55 
Value 2 0.96 0.32 25.28 1.7 1.14 
Average 1.65 0.52 27.67 1.86 1.34 
Std error 0.97 0.28 3.38 0.23 0.29 
H3K9ac 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.72 2.82 10.92 1.99 1.43 
Value 2 0.59 0.39 10.12 0.49 1.61 
Average 1.15 1.60 10.52 1.24 1.52 
Std error 0.79 1.72 0.56 1.06 0.12 
H3K27me3 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.63 0.88 2.18 1.45 1.22 
Value 2 0.37 0.269 0.73 1.13 1.18 
Average 1 0.57 1.45 1.29 1.2 
Std error 0.89 0.43 1.02 0.22 0.02 
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H3K9acS10p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 2.19 4.34 12.04 1.95 1.49 
Value 2 2.02 2.01 19.29 1.97 1.34 
Value 3 3.07 8.81 19.29 2.41 1.9 
Average 2.42 5.05 16.87 2.11 1.57 
Std error 0.56 3.45 4.18 0.26 0.28 
H3K4me3 
 Gapdh/0 Gapdh/1 Gapdh/2 Gapdh/3 
Value  nd 1.23 6.91 2.94 
H3K27me3 
 Gapdh/0 Gapdh/1 Gapdh/2 Gapdh/3 
Value nd 0.44 0.96 1.23 
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Supplementary data 3 
Distribution of histone marks in megakaryocytes on Hoxa4, Hoxa5 and 
Gapdh 
H3K4me3 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 3.57 6.48 2.31 2.14 
Value 2 0.7 1.35 2.18 1.02 
Average 2.13 3.91 2.24 1.58 
Std error 2.03 3.62 0.09 0.79 
H3K9ac 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 4.4 10.55 27.85 13.36 
Value 2 6.32 11.63 17.38 5.46 
Average 5.36 11.09 22.61 9.41 
Std error 1.35 0.76 7.40 5.58 
H4K16ac 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1.38 1.12 1.73 0.5 
H3K27me3 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 1.62 1.23 2.31 0.69 
Value 2 0.14 0.37 1.28  nd 
Average 0.88 0.8 1.795 0.69 
Std error 1.04 0.61 0.73 nd 
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H3K9me2 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 0.96 0.98 1.89 0.85 
Value 2 0.24 1.74 3.24 0.12 
Value 3 1.36 3.89 3.03 1.04 
Average 0.85 2.20 2.72 0.67 
Std error 0.56 1.51 0.72 0.48 
H3K9acS10p 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 0.14 0.31   0.6 
Value 2 1.26 1.86 1.47 1.04 
Average 0.7 1.08 1.47 0.82 
Std error 0.79 1.09 nd 0.31 
H3K4me3 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 2.9 3.78 1.95 2.77 3.45 
Value 2 0.42 0.38 0.81 0.56 0.71 
Average 1.66 2.08 1.38 1.66 2.08 
Std error 1.75 2.40 0.80 1.56 1.93 
H3K9ac 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 11.15 18.63 11 12.81 6.36 
Value 2 6.49 0.6 9.71 6.58 5.09 
Average 8.82 9.61 10.35 9.69 5.72 
Std error 3.29 12.74 0.91 4.40 0.89 
 
 
!!!
!!! %!
H3K27me3 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.76 1.17 1.08 0.84 0.61 
Value 2 0.18 0.88 0.55 0.87   
Average 0.97 1.02 0.81 0.85 0.61 
Std error 1.11 0.20 0.37 0.02 nd 
H3K9acS10p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 0.26 0.44 0.51 0.38 0.16 
Value 2 8.87 5.31 6.68 8.11 8.63 
Average 4.56 2.875 3.59 4.24 4.39 
Std error 6.08 3.44 4.36 5.46 5.98 
H3K4me3 
 Gapdh/0 Gapdh/1 Gapdh/2 Gapdh/3 
Value  4.28 8.93 8.87 3.97 
H3K27me3 
 Gapdh/0 Gapdh/1 Gapdh/2 Gapdh/3 
Value 1  nd 1.4 0.98 1.17 
Value 2 1.98 1.7 2.62 3.58 
Average 1.98 1.55 1.8 2.37 
Std error nd 0.21 1.16 1.70 
 
!!!
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Supplementary data 4 
Distribution of proteins in undifferentiated HPC-7 cells on Hoxa4, Hoxa5 
and Gapdh 
MLLC 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 10.33 28.44 10.7 8.81 12.21 
Value 2  16.56 7.31 3.07 5.38 
Average 10.33 22.5 9.01 5.94 8.79 
Std error nd 8.40 2.39 4.05 4.82 
MLLN 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 2.98 10.85 5.65 3.5 3.41 
menin 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 17.02 29.65 16.56 12.46 19.15 
Value 2   54.56 22.47 8.22 17.75 
Average 17.02 42.10 19.51 10.34 18.45 
Std error nd 17.61 4.18 2.99 0.98 
Pol II 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 0.99 1.33 3.32 2.92 1.31 
Value 2 1.04 0.87 5.65 1.15 0.43 
Average 1.02 1.1 4.45 2.03 0.87 
Std error 0.04 0.32 1.64 1.24 0.62 
CBP 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 2.2 6.4 13.27 4 
!!!
!!! h!
MLL4/2 
 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 3.16 8.39 4.05 4.56 
Msk1 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1  nd 2.42 8.16 0.58 4.46 
Value 2 nd 0.94 11 2.8 2 
Average nd 1.68 9.58 1.69 3.23 
Std error nd 1.04 2.01 1.56 1.73 
MLLC 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1 2.67 11.47 2.08 4.72 
Value 2 3.83 10.7 1.68   
Average 3.25 11.08 1.88 4.72 
Std error 0.82 0.54 0.28 nd 
menin 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 7.78 18.37 5.35 nd 
Pol II 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 7.21 17.38 6.06 nd 
CBP 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 2.29 6.96 2.73 5.46 
MLL4/2 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 4.25 8.57 2.49 7.41 
!!!
!!! A!
Msk1 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1 2.78 2.51 2.62 3.86 
Value 2 1.33 4.62 1.79 3.27 
Value 3 2.67 3.58 2.34 2.46 
Average 2.26 3.57 2.25 3.19 
Std error 0.80 1.05 0.42 0.70 
MLLC 
 Gapdh4/0 Gapdh4/1 Gapdh4/2 Gapdh4/3 Gapdh4/4 
Value nd 6.58 1.97 2.78 2.2 
menin 
 Gapdh4/0 Gapdh4/1 Gapdh4/2 Gapdh4/3 Gapdh4/4 
Value nd 4.71 0.52 1.235 1.798 
 
!!!
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Supplementary data 5 
Distribution of proteins in megakaryocytes on Hoxa4, Hoxa5 and Gapdh 
MLLC 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 0.22 1.76 1.89 1.59 1.21 
Value 2 2.04 0.77 0.52 7.21 1.08 
Average 1.13 1.26 1.20 4.4 1.14 
Std error 0.91 0.49 0.68 2.81 0.06 
MLLN 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1.95 1.35 1.58 0.83 1.49 
menin 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 0.86 0.82 1.7 0.79 1 
Pol II 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1 0.61 0.51 4.59 0.47 0.98 
Value 2 2.04 1.89 3.65 0.68 1.77 
Average 1.32 1.2 4.12 0.57 1.37 
Std error 1.01 0.97 0.66 0.14 0.55 
Msk1 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 
Value 1.2 0.9 1.27 0.72 1.51 
 
 
!!!
!!! (!
MLLC 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1.8 2.63 2.67 1.54 
menin 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1.3 1.42 1.75 1.11 
Pol II 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1 3.05 3.73 4.99 2.32 
Value 2 2.65 2.8 10.62 6.9 
Average 2.85 3.26 7.80 4.61 
Std error 0.28 0.65 3.98 3.23 
Msk1 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 
Value 1.5 1.1 1.51 1.54 
MLLC 
 Gapdh4/0 Gapdh4/1 Gapdh4/2 Gapdh4/3 Gapdh4/4 
Value 0.97 1.17 2.63 1.54 0.17 
menin 
 Gapdh4/0 Gapdh4/1 Gapdh4/2 Gapdh4/3 Gapdh4/4 
Value 5.31 7.83 19.83 13.26 12.04 
 
!!!
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Supplementary data 6 
Distribution of histone marks on Hoxa4 and Hoxa5 in the control 
undifferentiated HPC-7 cells  
H3K9acS10P 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 1.36 2.81 21.89 4.66 0.83 1 
Value 2 1.27 4.15 21.10 0.17 0.90 1 
Average 1.32 3.48 21.49 2.41 0.86 1 
Std error 0.06 0.94 0.56 3.17 0.04 0 
H3S10p 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 0.11 0.54 0.35 0.13 0.57 1 
Value 2 0.32 0.42 0.45 0.07 0.71 1 
Average 0.22 0.48 0.40 0.10 0.64 1 
Std error 0.14 0.08 0.07 0.03 0.10 0 
H3T3p 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 0.77 0.25 0.38 0.29 0.67 1 
Value 2 1.11 0.65 0.37 0.11 0.52 1 
Average 0.94 0.45 0.37 0.20 0.60 1 
Std error 0.24 0.28 0.01 0.12 0.10 0 
 
 
 
 
NB: Values for the Hoxa4/5 primer set has been set at 1, and data for the other primer sets are 
relative to this one. 
!!!
!!! '!
H3K9acS10p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.37 4.43 62.25 0.69 1 
Value 2 1.94 18.89 73.00 0.80 1 
Average 1.66 11.66 67.62 0.75 1 
Std error 0.40 10.22 7.59 0.07 0 
H3S10p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.32 4.05 0.77 0.86 1 
Value 2 0.99 2.88 0.97 1.29 1 
Average 1.16 3.47 0.87 1.08 1 
Std error 0.23 0.82 0.14 0.29 0 
H3T3P 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 1.10 2.47 0.87 0.76 1 
Value 2 1.43 5.49 0.60 0.65 1 
Average 1.26 3.98 0.73 0.70 1 
Std error 0.23 2.13 0.18 0.07 0 
 
 
 
 
 
 
 
NB: Values for the Hoxa5/5 primer set has been set at 1, and data for the other primer sets are 
relative to this one. 
!!!
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Supplementary data 7 
Distribution of histone marks on Hoxa4 and Hoxa5 in the undifferentiated 
HPC-7 cells after treatment with 10nM of okadaic acid 
H3K9acS10p 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 2.33 6.08 20.19 1.21 1.16 1 
Value 2 4.22 12.55 49.80 2.20 2.65 1 
Average 3.27 9.31 34.99 1.71 1.91 1 
Std error 1.33 4.58 20.94 0.69 1.05 0 
H3S10p 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 2.33 1.10 0.66 0.27 0.94 1 
Value 2 2.95 1 0.38 0.91 1.44 1 
Average 2.64 1.05 0.52 0.59 1.19 1 
Std error 0.43 0.07 0.19 0.45 0.35 0 
H3T3p 
 Hoxa4/0 Hoxa4/1 Hoxa4/2 Hoxa4/3 Hoxa4/4 Hoxa4/5 
Value 1 1.32 0.81 0.28 0.90 1.43 1 
Value 2 3.73 1.47 0.87 0.73 2.02 1 
Value 3 1.36 1.22 0.71 0.28 1 1 
Average 2.14 1.16 0.62 0.64 1.48 1 
Std error 1.37 0.33 0.30 0.31 0.51 0 
 
 
 
 
!!!
!!! _!
H3K9acS10p  
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 4.28 101.92 695.22 3.25 1 
H3S10p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 0.93 1.65 0.53 1.05 1 
Value 2 13.75 138 17.25 17.33 1 
Average 7.34 69.82 8.89 9.19 1 
Std error 9.05 96.40 11.81 11.51 0 
H3T3p 
 Hoxa5/1 Hoxa5/2 Hoxa5/3 Hoxa5/4 Hoxa5/5 
Value 1 0.36 0.28 0.37 0.78 1 
Value 2 0.46 0.44 0.56 1.35 1 
Average 0.41 0.36 0.47 1.07 1 
Std error 0.07 0.10 0.13 0.40 0 
 
!!!
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Supplementary data 8 
PCR Primer Set used for ChIP 
Gene Name  Forward 5’-3’  Reverse 5’-3’   Tm 
Gapdh-0  tgagcctcctccaattcaac  ccaggaagacgcttaaaag  58°C 
Gapdh-1  caccatccgggttcctataa  attttcacctggcactgcac  58°C 
Gapdh-2  cgtcccgtagacaaaatggt  tgaccttgaggtctccttgg  58°C 
Gapdh-3  tcaggtcccctgtttcttgt  gaatttgccgtgagt  58°C 
Gapdh-4  tggacagcactgacttccag  agcccctcttcatggatacc  58°C 
HoxA4/0  ccctctctgctccatttcag  cctttcctgaaccttccaca  58°C 
HoxA4/1  gccgttgttctatcctgctc  tgatgcctcactcgtacctg  58°C 
HoxA4/2  agaggcctaggacagacgtg tggatgctgctagccttcag   58°C 
HoxA4/3  ccctggatgaagaagatcca  agggaccctgggtacaaaag 58°C 
HoxA4/4  tgttggaaggaagccagact  aaaatcccccaaactgctct  58°C 
HoxA4/5  attgtctgccctttgtcagg  caggggtcgttttggtaaga  58°C  
HoxA5/1  atcggctctggctactgaaa  agtcgctcccaagctgtaaa  58°C 
HoxA5/2  agccggggaaataaagttgt  ggggtcgaattgaggttaca  58°C 
HoxA5/3  agccacaaatcaagcacaca  agatccatgccattgtagcc  58°C 
HoxA5/4  gcaagctgctctttctgctt  cttctggcctgaggtttctg  58°C 
HoxA5/5  tcttttgcaggctacgtgtg  caggcagagggaaaagtttg  58°C 
MLL1   ggctccagcaagaacaaaag tcacacctgcaaatgagagc   55°C 
MLL2   cgctgttccatcagtgagaa  cttcgcctttcaggtactcg  55°C 
MLL3   gctccctcagcaaagacaac  gctgtgtctcagccttttcc  55°C 
MLL5   agtcctccacacctcacacc  gttgcctgctgaggattagc  55°C  
Actin   ggacttcgagcaagagatgg  agcactgtgttggcgtacag  55°C 
mPU.1   atggaagggttttccctcaccgcc gtccacgctctgcagctctgtgaa 54°C 
GATA1 ggaattcgggccccttgtgaggccagagag cggggtacctcacgctccagccagattcgaccc 
GPVI   atgtctccagcctcacccac  ctaggccagtgggagggg  54°C 
